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Abstract 
Development of the Regenerative Glycosylation Approach for Manual and 
Automated Oligosaccharide Synthesis 
 
Swati S. Nigudkar 
Doctor of Philosophy 
University of Missouri - St. Louis 
Prof. Alexei V. Demchenko, Chairperson 
 
It has been recognized that carbohydrates are involved in all phases of life beginning with 
the embryonic development and cell growth. However, it is the involvement of 
carbohydrates in the progression of various deadly diseases that gave these natural 
compounds significant roles in diagnostics and as pharmaceuticals. Although 
carbohydrates are highly desirable to the biological and medical communities, these 
molecules are still very challenging targets for chemists. Functionalization, 
derivatization, controlling anomeric stereoselectivity, purification, and characterization 
are all existing experimental hurdles towards producing synthetic carbohydrates in large 
quantities and high purity. Advances in chemistry and biochemistry have certainly 
facilitated the synthesis and purification of carbohydrates. However, the development of 
practical and general methods for chemical glycosylation and expeditious oligosaccharide 
synthesis remain an important and challenging area of research.  
This topic has also become the basis for this doctoral dissertation wherein the focus was 
primarily placed on the development of new leaving groups for chemical glycosylation 
and designing novel methods and technologies for efficient oligosaccharide synthesis. 
 iii 
 
One outcome of this study is the development of two new classes of building blocks for 
chemical glycosylation, O-benzoxazolyl (OBox) and 3,3-difluoro-3H-indol-2-yl (OFox) 
imidates. Based on our observation that the OFox leaving group has the same structure 
before its introduction and after its departure, 3,3-difluoroxindole (HOFox) aglycone, we 
developed a new regenerative concept for chemical glycosylation. This method allows for 
performing glycosylation reactions in a conceptually novel way using catalytic amounts 
of reagents and activators. Further application of the regenerative concept to the HPLC-
assisted synthesis on polymer support, an automated technology being developed in our 
laboratory, was complementary for refining all chemical aspects of both methods.   
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Stereocontrolled 1,2-cis glycosylation as the 
driving force of progress in synthetic 
carbohydrate chemistry 
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1.1.  Introduction 
 Carbohydrates, as polysaccharides or glycoconjugates, represent the largest class of naturally 
occurring compounds and are often found as essential components of many bioactive molecules 
in nature.1-4 Carbohydrates were initially viewed as energy-storage materials, structural 
components, and primary metabolites. Now it is known that carbohydrates mediate many 
fundamental biological processes such as immune defense, fertilization, metastasis, signal 
transduction, cell growth and cell-cell adhesion. In the past few years, we have been learning that 
carbohydrates play crucial roles in pathogenesis of diabetes, bacterial and viral infections, 
inflammation, development and growth of cancers, and many other diseases.5-9 Clearly, 
uncovering the contributions of carbohydrates to cell biology would greatly facilitate advances in 
the field of glycobiology and medicine.10-13  
 For the most part, medicinally important carbohydrates exist as complex oligomers or as 
conjugates with other biomolecules including natural products,4,14,15 lipids,2,16-20 peptides,21-23 
proteins,3,24-26 etc.27-31 The carbohydrate part itself exists in various sizes and shapes ranging 
from monomeric sugars and simple linear chains to highly branched glycoforms. Major obstacles 
in studying the natural carbohydrates are the difficulties in isolating, characterizing, and 
synthesizing these molecules due to their low abundance and heterogeneity in nature. While 
scientists have been able to successfully isolate and characterize certain classes of natural 
carbohydrates, the availability of pure isolates is still low. As a consequence, the systematic 
study of these molecules often relies on synthetic chemistry to provide pure compounds in 
significant quantities.   
Among a variety of glycosidic bonds in nature, it is the O-glycosidic bonds that are of major 
interest and challenge to chemists due to their high abundance and difficulty in synthesis. There 
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are two major types of O-glycosides, which are, depending on nomenclature, most commonly 
defined as - and -, or 1,2-cis and 1,2-trans glycosides. The 1,2-cis glycosyl residues, -
glycosides for D-glucose, D-galactose or -glycosides for D-mannose, L-rhamnose, as well as 
their 1,2-trans counterparts (β-glycosides for D-glucose, β-glycosides for D-mannose) are both 
important and abundant classes of linkages and are found as components in a variety of natural 
compounds. Some other common types of glycosides, for instance 2-deoxyglycosides and 
sialosides, lack the neighboring substituent. These compounds can neither be defined as 1,2-cis 
nor 1,2-trans glycosides, hence, these are commonly referred to as α and β glycosides. 
Representative examples of common glycosides are shown in Figure 1.1.  
Figure 1.1.  Common monosaccharide residues found in the mammalian and bacterial 
glycome. 
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Many oligosaccharides containing 1,2-cis O-glycosidic linkages are of high importance due to 
their biological roles and therapeutic potential. Some representative naturally occurring 
oligosaccharides containing 1,2-cis linkages are shown in Figure 1.2.  
Figure 1.2.  Naturally occurring oligosaccharides containing 1,2-cis linkages  
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For example, immunomodulatory pentasaccharide FPS-1 from Aconitum carmichaeli is 
composed of the α-(16) linked glucosyl backbone with some α-(13)-glucosyl branching.32 
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Fungus Pseudallescheria boydii consists of the glycogen-like α-(14)-linked glucan backbone 
with occasional α-(16)-glucosyl branches.33,34  Zwitterionic polysaccharide A1 found on the 
capsule of the bacterium Bacteroides fragilis has a 1,2-cis-linked glycosaminoglycan motif.35 
Many pneumococcal polysaccharides possess 1,2-cis glycosidic linkages, for instance 
polysaccharide from Streptococcus pneumonia serotype 6B36-39 that is included in all current 
pneumococcal vaccines,40-44 has α-glucose and α-galactose residues. The trisaccharide repeating 
unit isolated from Staphylococcus aureus type 545 possesses uncommon ManNAcA and 
FucNAc, both 1,2-cis-glycosidically linked. High mannose-type N-linked glycans46,47 that 
mediate the pathogenesis of cancers,27 AIDS,48 Alzheimer’s disease,49 idiopathic normal pressure 
hydrocephalus,49 classical galactosemia,50 etc. bear an important β-mannose bond.  All 
glycosphingolipids of the globoside family have an α-linked galactose residue. Amongst these, 
Globo-H, which is a current target for breast and prostate cancer vaccine development,51,52 has an 
α-fucose residue as well. 
 
1.2.  Outline of chemical glycosylation: mechanism, general principles and special cases  
Over the last two decades, synthetic carbohydrate chemistry has witnessed a dramatic 
improvement in the methods available. Glycosylation is arguably the most important albeit 
challenging reaction in the field of carbohydrate chemistry. Most commonly, it involves the 
reaction between a glycosyl donor and glycosyl acceptor, in presence of an activator or promoter, 
to form a glycosidic bond. Upon activation, the promoter-assisted departure of the leaving group 
results in the formation of a glycosyl cation, which then gets stabilized via an oxacarbenium ion 
intermediate (Scheme 1.1a). The nucleophile, glycosyl acceptor, can then attack (form the 
glycosidic bond) either from the top or the bottom face of the flattened ring. This would give rise 
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to either 1,2-cis or 1,2-trans glycosides with respect to the neighboring substituent at C-2, and 
uncontrolled reactions may lead to the mixture of both.  
Scheme 1.1.  General outline of glycosylation and the key intermediates involved 
 
 
The formation of 1,2-trans linkages can be accomplished using the participatory effect of the 
neighboring 2-acyl substituent. In this case, the oxacarbenium ion can be further stabilized via a 
bicyclic acyloxonium intermediate, which becomes the key intermediate en route to 
glycosylation products (Scheme 1.1b). Since the bottom face of the ring can be blocked now, the 
nucleophilic attack of the glycosyl acceptor would be directed from the opposite, top face, 
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providing access to 1,2-trans linkage with a high stereoselectivity. Occasionally, substantial 
amounts of 1,2-cis-linked products are also formed. In these cases, glycosylation assumingly 
proceeds via oxacarbenium ion, resulting in the formation of 1,2-trans and 1,2-cis glycosides, 
respectively, or most-commonly mixtures thereof. An orthoester formation is another possible 
process (Scheme 1.1b). 
While the stereoselective synthesis of 1,2-trans linkages can be reliably achieved with the use 
of the neighboring group assistance,53-55 the formation of 1,2-cis linkages is typically much more 
challenging. The presence of a non-participating group is required for the synthesis of 1,2-cis 
glycosides, but the non-participating group alone cannot ensure the stereoselectivity. Although 
the α-product is favored by the anomeric effect,56  the stereoselectivity of glycosylation can be 
poor and requires other modes of stereocontrol. A variety of reaction conditions and structural 
elements of the reactants has been developed to obtain excellent 1,2-cis stereoselectivity, no 
comprehensive method for 1,2-cis glycosylation is yet available. The failure to control the 
stereoselectivity of glycosylations leads to the formation of a mixture of anomers. Thus, the 
effective formation of 1,2-cis glycosidic linkages with high stereocontrol is a major challenge. 57 
In addition to the apparent complexity of the glycosidation process, there are other competing 
processes that cannot be disregarded. Side reactions, such as elimination, substitution (formation 
of unexpected substitution products or hydrolysis at the anomeric center), cyclization (inter- and 
intramolecular orthoesterification), migration, redox, etc,58 often complicate stereocontrol and 
compromise the yields of glycosylations. Several factors are known to affect stereoselectivity 
and yield of glycosylation and those include temperature, solvent, type of donor used, type of 
acceptor used, amount and type of promoter used, protecting groups, etc. (Figure 1.3).  These 
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effects and specifically designed methods to control the stereoselectivity of glycosylation will be 
discussed in the subsequent sections.  
Figure 1.3.  Factors affecting the stereoselectivity of glycosylations 
O
PO
LG
X
:OR
O
PO
:OR
O O:
R'
O
PO :OR
O
O
O :O
R'
R" O
O
H
H
H
H
Steric Hindrance
Leaving Group
Act ivation Mode
Neighboring
or Long-Range
Par ticipat ion or
other ef f ects
Indirect Methods
Structure,
Temperature,
Pressure
Promoter /
Additives
Concentration
O
O
PO LG
P
M
PO
PO
Metal coordination
O
OP
OP
OP
PO
Subst ituent
Conf ormation
O
PO :OR
O
O
H
Solvent Effect
 
 
While some sugars follow general trends, there are classes of compounds and glycosidic 
linkages that require special methods. These special cases of glycosylation require careful 
selection of techniques, their modification, or design of conceptually new approaches. Indirect or 
total synthesis-based technologies have been developed and applied specifically to the synthesis 
of these targets. 
Glycosides of 2-amino-2-deoxy sugars, in particular those of the D-gluco and D-galacto 
series, are widely distributed in living organisms as glycoconjugates (glycolipids, 
lipopolysaccharides, glycoproteins),59 or glycosaminoglycans (heparin, heparan sulfate, 
dermatan sulfate, chondroitin sulfate, hyaluronic acid),60 etc.61  Since a vast majority of 
naturally-occurring 2-amino-2-deoxy sugars are N-acetylated, from the synthetic point of view, a 
2-acetamido-2-deoxy substituted glycosyl donor would be desirable. For this type of glycosyl 
donors however, the oxacarbenium ion rearranges rapidly into an unreactive oxazoline 
intermediate. Therefore, even the synthesis of such 1,2-trans glycosides requires an  additional 
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step and a careful selection of suitable protecting groups. A minimal requirement for the 
synthesis of 1,2-cis glycosides would be the use of a C-2 non-participating moiety, most 
commonly azide. 2,3-Oxazolidinone protection introduced by Kerns and N-p-
methoxybenzylidene protection explored by Nguyen also show good promise to become 
universal approaches to 1,2-cis glycosylation with 2-aminosugars (vide infra). 
β-Mannosyl residues are frequently found in glycoproteins. The chemical synthesis of β-
mannosides cannot be achieved by relying on the anomeric effect, which would favor axial α-
mannosides.  In addition, the formation of β-mannosides is further disfavored by the repulsive 
interactions that would have occurred between the axial C-2 substituent and the nucleophile 
approaching from the top face of the ring. For many years, the only direct procedure applicable 
to β-mannosylation - Ag-silicate promoted glycosidation of α-halides - was assumed to follow a 
bimolecular SN2 mechanism.62,63 The difficulty of the direct β-mannosylation was addressed by 
developing a variety of indirect approaches such as C-2 oxidation-reduction, C-2 inversion, 
anomeric alkylation, and intramolecular aglycone delivery.64-68 This was the standing in the field 
before Crich and co-workers discovered that 4,6-O-benzylidene protected sulfoxide69 or 
thioglycoside70 glycosyl donors provide excellent β-manno stereoselectivity. Detailed 
mechanistic and spectroscopic studies by the Crich group65,71-73 showed that anomeric α-O-
triflates generated in situ are reactive intermediates that can substituted with high stereocontrol at 
low temperatures.  
In comparison to their six-membered counterparts, furanosides are less abundant. 
Nevertheless, their presence in a variety of polysaccharides from bacteria, parasites, and fungi 
makes this type of glycosidic linkage an important synthetic target.74,75 The synthesis of 1,2-trans 
furanosides is relatively straightforward and, similarly to that of pyranosides, can be reliably 
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achieved with the use of glycosyl donors bearing a participating group at C-2. In contrast, 
construction of 1,2-cis glycofuranosidic linkage is difficult, even more so than with pyranosides 
due to the lack of the anomeric effect and the conformational flexibility of the five-membered 
ring. In fact, both electronic and steric effects favor the formation of 1,2-trans glycofuranosides. 
In the past decade, a notable improvement in 1,2-cis furanosylation was made possible with 
glycosyl donors in which the ring has been locked into a single conformation. These examples 
include 2,3-anhydro,76-80 3,5-O-(di-tert-butylsilylene),81,82 and 3,5-O-
tetraisopropyldisiloxanylidene83 protected bicyclic glycosyl donors.  A recent example wherein 
stereoselective 1,2-cis glycofuranosylation was accomplished with the assistance of H-bond 
mediated aglycone delivery will be discussed below. 
2-Deoxyglycosides are important constituents of many classes of antibiotics. The 
development of reliable methods for stereoselective synthesis of both α- and β-2-
deoxyglycosides is critical for the synthesis of natural products, drugs and glycomimetics.84,85  It 
should be noted that due to the lack of anchimeric assistance from the substituent at C-2, the 
synthesis of both types of linkages represents a notable challenge. Direct glycosylation of 2-
deoxy glycosyl donors often results in the formation of anomeric mixtures, though notable recent 
progress in the area has to be acknowledged.86-91 
Sialic acids are nine-carbon monosaccharides involved in a wide range of biological 
phenomena. Their unique structure is characterized by the presence of a carboxylic group, 
deoxygenated C-3, glycerol chain at C-6 and differently functionalized C-5. The natural 
equatorial glycosides and their unnatural axial counterparts are classified as α- and β-glycosides, 
respectively. In spite of extensive efforts and notable progress, the chemical synthesis of 
sialosides remains a significant challenge.92-95 The presence of a destabilizing electron-
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withdrawing carboxylic group and the lack of a participating auxiliary often drive sialylation 
reactions toward competitive elimination reactions resulting in the formation of a 2,3-dehydro 
derivative and/or in poor stereoselectivity (β-anomer). To overcome these problems, a variety of 
leaving groups and activation conditions for direct sialylations have been developed. It was also 
demonstrated that the N-substituent at C-5 plays an influential role in both stereoselectivity of 
sialylation and the reactivity of sialyl donors.96 A particular advance in the recent years has been 
made with 4,5-oxazolidinone derivatives that provide high yields and stereoselectivities in 
sialylations.97-100 
 
1.3.  Effect of the glycosyl donor 
 Varying the nature of anomeric leaving groups in the donor has been exploited in many 
different ways. Glycosylations using trichloroacetimidates101-104 and thioglycosides105 as donors 
have become the most widely  studied methods for chemical glycosylation. There are many 
publications describing the comparison of various glycosylation methods applied for particular 
targets. Our previous reviews on 1,2-cis glycosylation, thoroughly discusses all pros and cons of 
using various leaving groups.106,107 However, only a few principles could be reliably outlined. It 
has been unambiguously demonstrated that halides activated in the presence of a halide ion (from 
e.g. Bu4NBr) often provide the highest ratios of α/β-glycosides.108-112 Since glycosylation 
reactions commonly follow a unimolecular SN1 displacement mechanism, the orientation of the 
leaving group at the anomeric center is of little importance. However, occasionally glycosylation 
reactions proceed via an SN2-like mechanism with inversion of the anomeric configuration: β-
glycosyl halides formed from their α-counterparts with bromonium ion113 or from α-
thioglycosides in the presence of bromine,114 glycosyl thiocyanates,115,116 and anomeric 
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mannosyl triflates formed in situ from sulfoxides or thioglycosides for the synthesis of -
mannosides.69,70  
Protecting groups are introduced into a molecule to temporarily mask a functional group, 
thereby differentiating similar types of functional groups and exposing only the one that needs to 
be reacted.117 It is well known that the stereoselectivity of glycosylation can be profoundly 
influenced by protecting groups.118  Various protecting groups that may have a significant effect 
on the stereoselectivity of glycosylation have been discussed below. Neighboring protecting 
groups at C-2 traditionally known as participating groups for the synthesis of 1,2-trans 
glycosides can now assist in the formation of either 1,2-cis or 1,2-trans glycosides. Remote 
protecting groups at positions C-3, 4 and/or 6 may affect the stereoselectivity via remote 
assistance by means of participation, H-bond mediated aglycone delivery, steric hindrance and/or 
electron withdrawal. Also discussed in this section are protecting groups that restrict the 
conformational flexibility of carbohydrates or force carbohydrate molecules to adopt unusual 
conformation.  
 
1.3.1.  Neighboring protecting group at C-2 
 As aforementioned, neighboring acyl-type protecting group offers one of the most powerful 
tools to direct stereoselectivity toward the formation of a 1,2-trans-linked product. Demchenko 
and co-workers developed glycosyl donors equipped with a 2-picolinyl ether substituent that can 
also participate and form 1,2-trans glycosides stereoselectively.119,120 Boons and co-workers took 
a different approach for developing a participating group capable of the participation from the 
opposite face of the ring giving rise to 1,2-cis linked glycosides.121 According to this approach, 
the C-2 position was protected with a substituted benzyl group that contains a nucleophilic 
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moiety capable of participation at the anomeric center.121 On activation of the glycosyl donor, the 
resulting oxacarbenium ion is attacked by this nucleophilic moiety. This attack, in principle, can 
lead to the formation of a cis- or trans-decalin-like system, Boons and co-workers showed that 
the selectivity is highly dependent on the configuration of the asymmetric center of the chiral 
auxiliary. To accommodate the bulky phenyl group in the pseudo-equatorial position of the 
newly formed six-membered ring, auxiliary with (S)-stereochemistry would lead to a trans-
decalin-like intermediate. This intermediate would help to direct the nucleophilic attack of the 
glycosyl acceptor from the bottom face and hence lead to a 1,2-cis-linked glycoside. Conversely 
a chiral auxiliary with the opposite (R)-configuration could participate via the cis-decalin-like 
intermediate, thereby producing 1,2-trans glycoside. Ethyl mandelate was chosen to test this 
methodology because both the enantiomers are readily available, conditions required for its 
installation are compatible with other protecting groups, and it is stable during the glycosylation, 
but can be readily removed under mild reductive conditions.  
Scheme 1.2.  Stereoselective glycosylations with ethyl (R)- and (S)-mandelate protected 
glycosyl donor 1.1 
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As depicted in Scheme 1.2, when ethyl (S)-mandelate-protected donor (S)-1.1 was 
glycosylated with glycosyl acceptor 1.2, disaccharide 1.3 was obtained with high α-selectivity 
(α/β = 20/1). Conversely, when (R)-1.1 was used as the glycosyl donor, reversal of anomeric 
selectivity was observed (α/β = 1/5). Deprotection of the acyl groups using sodium methoxide in 
methanol and the benzyl groups, including the chiral auxiliary, under Birch reduction conditions 
provided disaccharide 1.4. 
The second generation auxiliary developed to further enhance 1,2-cis stereoselectivity was 
based on (S)-phenyl-thiomethylbenzyl ether moiety at C-2 of the glycosyl donor.122,123 It was 
assumed that this type of moiety would be capable of more efficient and stereoselective 
participation via the formation of a chair and hence more stable trans-decalin-like intermediate. 
This, in turn, would force the (S)-phenyl group into the equatorial position to avoid unfavorable 
1,3-diaxial interactions that would have occurred if the bulky phenyl group was placed into the 
axial position. As depicted in Scheme 1.3, 1-(S)-phenyl-2-(phenylsulfanyl)ethyl ether protected 
trichloroacetimidate donor 1.7 was obtained from glucose tetraacetate 1.5 via sequential 
protection, liberation of the anomeric hydroxyl and the introduction of the imidoyl leaving 
group. Glycosyl donor 1.7 was then reacted with glycosyl acceptor 1.8 in the presence of 
TMSOTf to afford α-glycoside 1.9 in 86% yield and with exclusive α-stereoselectivity. The 
auxiliary can then be removed by acetolysis in the presence of BF3-OEt2 and acetic anhydride. 
This method has been extended to the polymer-supported synthesis of the repeating unit of the 
immune-modulatory polysaccharide from Aconitum carmichaeli composed of an α-(16)-linked 
glucosyl backbone branched with α(13)-linked glucoside moieties.124 
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Scheme 1.3.  Synthesis of C-2 (S)-phenyl-thiomethylbenzyl ether-protected glycosyl 
donor 1.6 and its glycosidation 
 
 
More recently, to simplify this approach, Boons and co-workers adopted a different direction 
towards the synthesis of 1,2-cis glycosides.125 This was certainly inspired by their earlier work 
on chiral auxiliaries and inherent drawbacks related to the necessity of obtaining pure 
enantiomeric substrate, and the relatively low stability of the moiety. Additional inspiration came 
from work by Turnbull et al. who developed a very elegant approach using thioglycoside donors 
having an integral α-directing group.126 As depicted in Scheme 1.4a, these reactions proceeded 
via bicyclic intermediates and the cyclic thioglycoside 1.11 was activated via the oxidation into 
sulfoxide 1.12 and S-arylation to form reactive sulfonium ions 1.13 en route to O-glycosylation.  
In the Boons’ approach depicted in Scheme 1.4b,125 sulfoxide donor 1.16 was prepared from 
thioglycoside 1.15 by the treatment with trimethylsilyl anhydride (TMS2O) in presence of 
TMSOTf, followed by reduction with Et3SiH. The latter 1.16 was subjected to a series of 
protecting group manipulations followed by oxidation with m-CPBA to give sulfoxide 1.17.  The 
glycosidation of donor 1.17 included the treatment with trifluoromethanesulfonic anhydride 
(Tf2O), arylation with 1,3,5-trimethoxybenzene, followed by addition of the glycosyl acceptor. 
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Scheme 1.4.  Stereoselective glycosylation via cyclic sulfonium ions 
 
 
Entry Acceptor (ROH) Product Yield, α/β ratio 
1 1.21 62%, 25/1 
2 1.22 89%, α-only 
3 1.23 72%, α-only 
 
As summarized in Scheme 1.4b, glycosyl acceptors 1.18-1.20 provided the corresponding 
disaccharides 1.21-1.23 in high yields and stereoselectivities.125 It was observed that while the 
donors bearing electron-withdrawing groups at C-3, 4, and 6 gave only the α-anomer, their 4,6-
diether substituted counterpart suffered from a slight loss of α-anomeric selectivity. It was 
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concluded that the highly reactive sulfonium ions partially react via oxacarbenium ion 
intermediate. 
Building upon their previous work, Turnbull and co-workers recently designed a new 
oxathiane donor scaffold where the axial methoxy group was replaced with O-substituent 
constrained in a spirocyclic ring.127 As in the previous methods, the oxathiane spiroketal donor is 
then activated via S-arylation. Overall, a novel class of oxathiane glycosyl donors is easily 
accessible, highly α-selective in glycosylations, and offers high stability towards common 
protecting group manipulations.   
 
1.3.3.  Remote protecting groups 
The effects of the remote substituents have long been considered of somewhat lesser 
importance than that of the neighboring substituent at C-2. However, the idea of participating 
groups at remote positions other than C-2 has been brought to the attention by many researchers. 
There have been various reports, both in favor and in opposition of the idea of remote 
participation, starting from long-range 6-O-acyl or carbonate group assisted synthesis of α-
glucosides.128-132 For derivatives of the D-galacto series a remote effect beneficial for the 
formation of α-galactosides was noted when a participating moiety was present at C-4.132-135. 
Similar effects (including C-3 participation) were also detected for the derivatives of the L-
fuco,136-138 L-rhamno,139 D-manno,140 D-gluco63,141,142 series.  
In 2009, Kim presented a dedicated study of the effect of 3- and 6-O-acetyl donors on the 
stereoselectivity of mannopyranosylation.143  The comparative study showed that there was the 
remote participation by 3-O and 6-O acetyl groups, but no participation by 4-O-acyl group. It 
was observed that when mannopyranosyl trichloroacetimidate donors bearing electron 
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withdrawing ester groups, such as acetyl (1.24) or benzoyl (1.25) at C-3 position, were coupled 
with primary acceptors 1.27-1.29 in presence of TMSOTf as a promoter, the corresponding 
disaccharides were obtained in excellent yields (88-94%) and high β-selectivity (α/β = 1/26-40, 
entries 1-4, Table 1.1). However, when benzyl sulfoxide was used as an electron withdrawing 
protecting group at C-3, the selectivity obtained with donor 1.26 was reversed and the 
corresponding disaccharides were obtained with preferential α-selectivity (α/β = 1/10-16, entries 
5 and 6, Table 1.1). 
Table 1.1.  Effect of 3-O-acyl protection on the stereoselectivity of mannosylation 
 
Entry Donor (EWG) Acceptor (1.0 equiv.) Disaccharide yield α/β ratio
1 1.24 (Ac) 1.27 91% 1/25.9 
2 1.24 (Ac) 1.28 94% 1/39.0 
3 1.24 (Ac) 1.29 92% 1/40.4 
4 1.25 (Bz) 1.28 88% 1/29.6 
5 1.26 (SO2Bn) 1.27 95% 15.9/1 
6 1.26 (SO2Bn) 1.28 93% 10.2/1 
 
Very recently, Nifantiev et al. studied the effect of an acyl substituent at C-3 position on the 
stereoselectivity obtained with conformationally flexible and conformationally restricted 
glucosyl donors.144 Partially acylated N-phenyltrifluoroacetimidate and sulfoxide glycosyl 
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donors showed no significant difference in stereoselectivity between the rigid or flexible 3-O-
acetylated structures. Irrespectively of the protecting group at C-3, the conformationally rigid 
4,6-O-benzylidene-protected glucosyl donors gave excellent α-selectivity at higher reaction 
temperatures (-35 oC to rt).  
Table 1.2.  Effect of an acyl substituent at C-3 position on the stereoselectivity 
 
Entry Donor Acceptor Yield, α/β ratio 
1a 1.30 
 
89%, 5.3/1 
2a 1.30  93%, 11.2/1 
3a 1.31  93%, 16.4/1 
4b 1.32  59%, 6.8/1 
5c 1.33  96%, 5.9/1 
 
Conditions: a - MeOTf, CH2Cl2, AW-300, -35  -15 oC;  b - Tf2O, DTBMP, CH2Cl2, -78 
 0 oC;  c - MeOTf, CH2Cl2, AW-300, 20 oC. 
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Thus, as depicted in Table 1.2, when glycosyl donor 1.30 bearing acetyl protecting groups at 
C-3 and C-6 is reacted with glycosyl acceptors 1.34 and 1.35 the corresponding disaccharides are 
obtained in good yields and with high selectivities (α/β = 5.3-11.2/1, entries 1 and 2). 
Suprisingly, when glycosyl donor 1.31 wherein the C-6 acetyl was replaced with C-6 benzoyl 
was used, further increase in selectivity was observed (α/β = 16.4/1, entry 3).  In this context, 
3,6-di-O-acetyl protected sulfoxide donor 1.32 provided lower yields and stereoselectivities 
(entry 4).  A similar selectivity albeit excellent yield was observed with conformationally 
restricted 4,6-O-benzylidene-protected glucosyl donors 1.33 (96% yield, α/β = 5.9/1, entry 5).  
It was also found that steric bulkiness or strong electron-withdrawing properties of remote 
substituents, particularly those at C-6, are beneficial for 1,2-cis glucosylation and galactosylation 
most likely due to shielding (sterically or electronically) the top face of the ring and therefore 
favoring the nucleophilic attack from the opposite side.63,141,145-150 Ito and co-workers also 
reported that the use of 4-O-pentafluoropropionyl group is beneficial for synthesis of α-
galactosides.151 A study with 2-azido sugars revealed an interesting relationship between the 
stereoselectivity and the effect of remote participating groups in GalN3 and GlcN3 sugars.152 
Over the course of this study it was observed that for GlcN3 sugars, acetyl groups at C-3 and C-6 
positions show more α-directing effect whereas 4-O-acetyl is more β-directing.153 Crich showed 
that bulky 3-O-tert-butyldimethylsilyl (TBDMS) can push the axial 2-O-benzyl of mannosyl 
donors towards the anomeric center, thereby hindering the nucleophilic attack from the top face, 
leading to poor β-selectivities.154 Differently, naphthylpropargyl ether protection at C-2 or C-3 
favors high β-manno selectivity.155  
Codee and co-workers investigated the use of 2-azidomannouronate ester donor for 
glycosidation, and observed high 1,2-cis selectivity.156 On gaining further insight into the 
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mechanism, it was concluded that the first step involves the formation of a mixture of anomeric 
triflates in which the triflate with a 1C4 chair conformation is the predominant species. This 
species accommodates the anomeric triflate in the equatorial position. On decomposition of the 
triflate, oxacarbenium ion intermediate preferentially adopts 3H4 half-chair conformation. In this 
case, the C-5 carboxylate occupies a pseudo-axial position allowing space-stabilization of the 
positive charge at the anomeric center. Accordingly, when thiophenyl donor 1.37 was activated 
in the presence of diphenyl sulfoxide and triflic anhydride, anomeric triflate 1.38 was formed. 
The later was then reacted with acceptor 1.39 to give disaccharide 1.40 in 85% yield and with 
complete β-selectivity (Scheme 1.5.). 
The presence of anomeric triflate, C-5 ester and the C-2 azide together render the anomeric 
center more electron deficient. As a result, the incoming nucleophile attacks the half chair along 
a pseudo-axial trajectory on the β-face of the molecule to produce 1,2-cis linkage. It was also 
shown that the stereoselectivity obtained is independent of the type of donor used and does not 
rely on the preactivation protocol.157 It was also reported that the stereodirecting effect of the C-
5-carboxylate ester is important for obtaining 1,2-cis selectivity. 
Scheme 1.5.  Rationalization of the high β-selectivity achieved with 2-azidomannouronate 
thiophenyl donor 1.30 
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A very different stereodirecting effect was discovered for remote picolinyl  (Pic) and picoloyl 
(Pico) substituents. As aforementioned, picolinyl at C-2 formally participated at the anomeric 
center and gives 1,2-trans glycosides via six-membered ring intermediate.120 The action of the 
remote picolinyl and related picoloyl substituents is totally different. Not being able to 
participate at the anomeric center directly, picolinyl nitrogen forms the hydrogen bond with the 
incoming glycosyl acceptor. As a result, very high facial selectivity, always anti in respect to the 
picolinyl substituent is observed.158 This, rather unexpected involvement of remote picolinyl 
substituents was termed as H-bond-mediated aglycone delivery (HAD). Based on the above 
hypothesis, it was shown that under high dilution conditions (5 mM), 4-O-picoloyl or picolinyl 
glucosyl donors (1.41-1.45) provide faster coupling times and enhanced selectivity compared to 
that obtained under standard concentration (50 mM). Thus, glucosyl donors 1.41 and 1.42 
provided high levels of α-selectivity, particularly with O-picolinyl protection (α/β = >25/1, entry 
1, Table 1.3.). Respectively, galactosyl donor 1.43 and rhamnosyl donor 1.44 gave high β-
selectivity (α/β = >1/ 25, entries 3 and 4). An extension to this study, Demchenko and co-
workers showed that the presence of 3-O-picoloyl group in mannosyl donor 1.45 can effectively 
provide β-selectivities (α/β = 1/18.5, entry 5).159   
The applicability of this approach was demonstrated for the synthesis of an oligosaccharide 
containing both primary and secondary β-mannosidic linkages (Scheme 1.6a). Thus, when 3-O-
picolylated mannosyl donor 1.45 was reacted with glycosyl acceptor 1.27 in the presence of 
DMTST β-linked disaccharide 1.50 was obtained with α/β = 1/18.5 selectivity. The picoloyl 
group at C-3 position of this disaccharide was then selectively deprotected using copper(II) 
acetate. The resulting acceptor 1.51 was then coupled with mannosyl donor 1.52, to provide the 
desired trisaccharide 1.53 in 76% yield and with complete β-selectivity.   
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Table 1.3.  Hydrogen-bond-mediated Aglycone Delivery (HAD) 
 
Entry Donor Conc. Time Product (Yield) α/β Ratio 
1 5mM 4 h 1.46 (73%) >25/1 
2 
 
5mM 5h 1.47 (86%) 5.3/1 
3 
 
5mM 1 h 1.48 (95%) >1/25 
4 
 
50 mM 15 min 1.49 (94%) >1/25 
5 
 
5mM 2.5 h 1.50 (91%) 1/18.5 
 
Further application of this new stereoselective glycosylation reaction has emerged in 
application to the synthesis of linear and branched α-glucans.160 As depicted in Scheme 1.6b, 
when 4-O-picoloylated glucosyl donor 1.41 was glycosylated with acceptor 1.54 in the presence 
of DMTST, disaccharide 1.46 was obtained in 83% yield (α/β = 21/1). The picoloyl group was 
then deprotected with copper(II) acetate to form the second generation glycosyl acceptor 1.55. 
The process was reiterated to obtain pentasaccharide 1.46 (n = 4) with 41% yield and complete 
α-selectivity.   
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Scheme 1.6.  HAD-assisted synthesis of β-mannan and α-glucan 
 
 
Hung and co-workers developed a series of orthogonally protected D-glucoaminyl donors for 
stereocontrolled α-glycosylation.161 The most advantageous protecting group pattern was 
determined to be 2-azido functionality, 2-nphthylmethyl (2-NAP) group at C-4, p-bromobenzyl 
(p-BrBn) at C-3, and TBDPS at C-6 positions.  Azido protection was preferred since it is a small 
protecting group and provides easy analysis of the sugar derivatives, 2-NAP group was used 
because of its flexibility as a temporary or a permanent protecting group, and p-BrBn and 
TBDPS groups were used as sterically bulky groups to prevent the attack of the acceptor from 
the unwanted top face. This orthogonally protected glucosamine-derived trichloroacetimidate 
donor was used for synthesis of heparin-related sequences.161 
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1.3.3. Conformation restraining cyclic protecting groups  
Torsional effects induced by the cyclic protecting groups may also strongly affect the 
stereoselectivity at the anomeric center. The best-known example of this effect is the work by 
Crich and co-workers on the synthesis of β-mannosides. Thus, it has been demonstrated that 4,6-
O-benzylidene-protected thioglycoside donors give superior β-manno selectivity in comparison 
to that achieved with donors lacking this type of protection.65,69,71,162,163 The stereoselectivity 
observed was rationalized by carrying out experiments in which the benzylidene protected 
sulfoxide donor69 164,165 is pre-activated using Tf2O to form a sulfonium salt, which collapses into 
the α-triflate that exists in the dynamic equilibrium with the contact ion pair. The presence of 
glycosyl triflate intermediate in mannosylations was also recognized with thioglycoside,166 
trichloroacetimidate,167 2-(hydroxycarbonyl)-benzyl,168 hemiacetal,169 pentenoate,170 and 
phthalate171,172 donors, all protected as 4,6-benzylidene acetals.  It is believed that the closely 
associated triflate counterion shields the α-face and β-linked product forms preferentially. An α-
deuterium kinetic isotope effect (KIE) study indicated substantial oxacarbenium ion character of 
this reaction pathway ruling out a possibility of the bimolecular displacement.163 Similar 
conclusions were made as a result of KIE experiments with mannosyl iodides.173 The 
deactivating effect of benzyl substituent was found to be a combination or torsional strain174 
restricting the conformational flexibility of the ring and enhanced electron-withdrawal.175 The 
latter effect is due to locking the hydroxylmethyl group in the conformation wherein the C6-O6 
bond is directed away from the O-5. This may cause additional destabilization of the 
oxacarbenium intermediate that seeks for compensation from tight coordination to the counter 
anion.  
This study revealed that 4,6-O-benzylidene protected glycopyranosyl triflates provide high β-
selectivities with glycosyl donors of the mannose series, whereas high α-selectivity is obtained 
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with their glucose configured counterparts.162 The reaction for synthesis of α-glucosides was 
found to be independent on the anomeric stereochemistry of the donor employed. They 
rationalized this finding by the fact that the α-triflate formed undergoes the equilibrium with its 
more reactive β-counterpart rather than with the oxacarbenium ion intermediate. The rate and 
equilibrium constant for formation of β-glucosyl triflate are such that it preferentially forms the 
α-linked product. 
Table 1.4.  Stereodirecting effect of 4,6-O-benzylidene protected glucosyl donors 
activated with PhSOTf and Tf2O 
O
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BnO
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Disaccharides
1.56a
1.56b
1.57a
1.57b
1.39 1.58 1.59
1.60
1.61
1.62  
Entry Donor, Acceptor Coupling reagent Product Yield, α/β ratio 
1 1.56a, 1.39 PhSOTf 1.60 70%, >95/5 
2 1.56b, 1.39 PhSOTf 1.60 80%, >95/5 
3 1.57a, 1.59 Tf2O 1.62 89%, >95/5 
4 1.57b, 1.58 Tf2O 1.61 63%, >95/5 
 
Many useful applications have evolved from the Crich methodology. For instance, the direct 
syntheses of a β-(12)-mannooctaose and of a β-(14)-mannohexaose represent the power of 
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this technique.176 As depicted in Scheme 1.7, the synthesis of the (12)-mannan was achieved 
by means of the sulfoxide coupling protocol. Thus, 2-O-paramethoxybenzyl protected sulfoxide 
donor 1.63 was reacted with cyclohexanol 1.64 in the presence of triflic anhydride and 2,4,6-tri-
tert-butylpyrimidine (TTBP) to afford β-mannoside 1.65 (n = 1) in 77% yield. The latter was 
deprotected with DDQ to give glycosyl acceptor 1.66. Reiteration of glycosylation deprotection 
steps led to a series of (12)-linked mannan homologs. For instance, octasaccharide 1.65 (n = 8) 
was obtained in 64% yield (β/α = 4.5/1). In this context, the (14)-linked mannan was prepared 
from the thioglycoside donors activated using sulfinamide methodology. 
Scheme 1.7.  β-(12)-Linked mannans using sulfoxide coupling protocol
 
 
To study the influence of similar conformationally rigid protecting groups, on the selectivity 
obtained, Werz and co-workers synthesized variety of mannosyl donors with a spiroannulated 
cyclopropane ring at C-5 bearing one hydroxyl group.177 Though very high β-selectivity wasn’t 
observed, it was shown that the spiroannulated cyclopropane motif leads to fixation of the chair-
like conformation, similar to that shown for 4,6-benzylidene protected sugars. 
Kerns discovered that 2,3-trans-oxazolidinone-protected glucosaminyl donor provides 
excellent 1,2-cis selectivity in glycosylations (Scheme 1.8a).178,179 Although high α-selectivity 
could be obtained, the oxazolidinone protected donor showed propensity to undergo side 
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reactions, such as N-glycosylation or N-sulfenylation. As an extension to that, Kerns et al.180,181 
and Oscarson et al.182 reported an N-acetylated version of these oxazolidinones in which the 
nitrogen is protected.178,180 These donors showed switchable stereoselectivity of glycosylations 
that was achieved by tuning the reaction conditions.183-185 This interesting finding stimulated 
further experimental and mechanistic studies. Mechanistically it was suggested that the β-linked 
product is formed initially, which rapidly anomerizes into the corresponding α-anomer. The 
presence of the oxazolidinone ring is the key for this anomerization to occur, which was found to 
proceed via the endocyclic C1-O5 bond cleavage.186,187 For instance, when N-acetyl-2,3-
oxazolidinone protected donor 1.67 was reacted with glycosyl acceptor 1.68 in presence of NIS 
and AgOTf, disaccharide 1.69 was obtained in 82% yield (α-only, Scheme 1.8b.). 
Scheme 1.8.  Selective α-glycosylations with N-acetyl- and N-benzyl-2,3-oxazolidinone-
protected glycosyl donors 1.67 and 1.70 
 
 
Manabe, Ito and their co-workers reported N-benzylated 2,3-oxazolidinone donors for 1,2-cis 
glycosylation.188,189  Thus, when glycosyl donor 1.70 was glycosidated with acceptor 1.71 in 
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presence of N-(phenylthio)-ε-caprolactam and triflic anhydride at rt, disaccharide 1.72 was 
obtained in 52% yield with complete α-selectivity (Scheme 1.8b). 
Crich et al. showed that the 2,3-O-carbonate protecting group is highly α-selective for 
mannosylations and rhamnosylations.154,190 In contrast, 3,4-O-carbonate protected rhamnosyl 
donors showed moderate β-selectivities owing to the electron withdrawing but non-participating 
nature of this group. Crich reported synthesis of β-glucosides using 2,3-O-carbonate protected 
glucosyl donor.191 It was suggested that the conformation restricting trans-fused ring favors the 
formation of an α-triflate intermediate over the formation of an oxacarbenium ion. The effect of 
3,4-O-carbonate protection was found to be weaker with slight preference toward β-selectivity.89 
Ye and co-workers studied 2,3-O-carbonyl protected glucose and galactose donors for pre-
activation based glycosylations.192 These reactions were generally β-stereoselective, but Lewis 
acids additives were found to favor α-stereoselectivity (vide infra).  
A beneficial effect of a bulky 4,6-O-di-tert-butylsilylene (DTBS) protecting group193-195 on 
α-selective galactosylation and galactosamination was recently applied to the synthesis of a 
series of human ABO histo-blood group type 2 antigens by Kiso and co-workers.196 
 
1.4. Effect of the glycosyl acceptor 
Many examples wherein different glycosyl acceptors have different selectivities can be seen 
throughout the text of this Chapter. A general principle is that the alcohol reactivity is inversely 
correlated with the stereoselectivity. Typically the most reactive hydroxyls give the lowest α/β-
ratios: the stronger the nucleophile, the faster the reaction, and therefore the more difficult it is to 
control. Regarding the sugar or aliphatic glycosyl acceptors, the general rule normally states: 
glycosylation of more reactive primary hydroxyl generally provides poorer stereoselectivity in 
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comparison to that when the secondary hydroxyls are involved.197 The same principle is 
applicable for the synthesis of glycopeptides, thus, glycosylation of the secondary hydroxyl of 
threonine typically gives higher α-stereoselectivity than when primary hydroxyl group of serine 
is glycosylated with 2-azido-2-deoxygalactosyl bromide or trichloroacetimidates.198,199 
Occasionally, primary hydroxyls provide somewhat higher stereoselectivity in comparison to 
that of the secondary hydroxyl groups. This can serve as an evidence of the glycosylation 
reaction proceeding via the bimolecular mechanism, at least partially. Primary alcohols gave 
higher stereoselectivity in H-bond-mediated aglycone delivery reactions mediated by the remote 
picolinyl groups.158  
It is well established that ester electron-withdrawing substituents reduce electron density of 
the neighboring hydroxyl group lowering their nucleophilicity.150,200,201 This may improve 
stereoselectivity, as the reaction can be carried out in more controlled manner. As an example, 
glycosylation of axial 4-OH of galactose often gives excellent 1,2-cis stereoselectivity, especially 
in combination with electron-withdrawing substituents (e.g. O-benzoyl, OBz).202 However, less 
reactive hydroxyls can lose their marginal reactivity completely when surrounded by the 
deactivating species, resulting in lower glycosylation yields.   
Recently, Demchenko and co-workers have shown that electron-withdrawing acyl 
protecting groups have significant effect on the stereoselectivity obtained with thiocyanates as 
glycosyl donors.203 Thus, when thiocyanate 1.73 was reacted with acyl-protected acceptors 1.74 
and 1.75, the corresponding disaccharides 1.77 and 1.78 were obtained with complete α-
selectivity (α/β = >25/1, Scheme 1.9). However, when benzyl-protected acceptor 1.76 was used 
instead, the stereoselectivity dropped (1.79, α/β = 8.3/1).  
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Scheme 1.9.  Acyl protecting groups in acceptor enhance stereoselectivity in glycosylations 
 
 
Very recently, Toshima and co-workers reported a novel chemical glycosylation method that 
makes use of the chiral recognition ability of the aglycone.204 Thus, chiral catalysts and chiral 
acceptors may favor the formation of one anomer over another.  
 
1.5.  Effect of the reaction conditions 
1.5.1.  Temperature 
Kinetically controlled glycosylations at lower temperatures generally favor β-glycoside 
formation,108,205-209 although converse observations have also been reported.210,211 Since the α-
glycoside is thermodynamically more favored due to the anomeric effect, it is predominantly 
formed at high temperatures. A number of examples have been discussed throughout other parts 
of this Chapter. 
 
1.5.2.  Solvent 
 Effect of reaction solvents on the selectivity of glycosylation reaction has been widely 
studied. In general, polar reaction solvents increase the rate of the β-glycoside formation via 
charge separation between O-5 and β-O-1. If the synthesis of α-glycosides is desired, CH2Cl2, 
ClCH2CH2Cl or toluene would be suitable candidates as the reaction solvents. However, there 
are more powerful forces than simple solvation that have to be taken into consideration. It has 
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been shown earlier, that ethereal solvents have a tendency to drive the glycosylation in α-
selective fashion, while nitrile solvents increase the amount of β-glycoside formation.129,212 
These observations were rationalized as follows: ether type reaction solvents such as diethyl 
ether,213 tetrahydrofuran,213 or dioxane214 lead to the preferential formation of the equatorial 
intermediate. On the other hand, if the reactions are performed in acetonitrile, the nitrilium cation 
formed in situ exclusively adopts axial orientation, allowing stereoselective formation of 
equatorially substituted glycosides (Scheme 3). This approach permits the formation of 1,2-trans 
glucosides with good stereoselectivity even with glycosyl donors bearing a non-participating 
substituent. Recently, the Mong group proposed a revised mechanism for glycosylations in nitrile 
solvents.215 According to their proposed model, the oxacarbenium ion or intermediates interact 
with the nitrile solvent producing mixtures of α- and β-glycosyl nitrilium intermediates. Though 
the formation of 1,2-cis nitrilium species is favored by the anomeric effect, it is further 
reinforced through the participation of the oxygen atom of the C-2 ether function. The resultant 
glycosyl oxazolinium intermediate is then attacked by a nucleophile from the top face leading to 
the formation of β-product.  
Scheme 1.10.  Effect of the reaction solvents 
 
 
Many applications of solvent systems are known. One recent example employing N-
trichloroacetyl carbamate group introduced by Redlich216 and Vankar,217 showed high 
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selectivities, which can be switched by simply switching the solvent. Thus, Omura et al 218 
showed that the α-selective glycosylations could be performed with a catalytic amount of 
TMSClO4 in Et2O, whereas high β-selectivity could be achieved by activation with TMSOTf in 
EtCN in the presence of 5 Å molecular sieves. For instance, when N-trichloroacetyl carbamate 
1.81 was glycosylated with acceptor 1.28 in the presence of TMSClO4 in diethyl ether as the 
solvent, disaccharide 1.82 was formed with high α-selectivities (entries 1 and 2, Table 1.5)   
Table 1.5.  One-pot synthesis and glycosidation of carbamate 1.81 
 
Entry Activator Solvent Reaction conditions Yield, α/β ratio
1 TMSClO4 (1.5 equiv.) Et2O 0 oC, 0.5 h 99%, 93/7 
2a TMSClO4 (0.2 equiv.) Et2O 0 oC, 0.5 h 88%, 91/9 
3 TMSOTf (1.5 equiv.) EtCN -40 oC, 0.5 h then -23 oC, 0.5 h 88%, 8/92 
a – 5 Å molecular sieves were used 
 
Huang et. al. have recently studied the effect of solvents and additives on the stereochemical 
outcome of preactivation-based one-pot glycosylation strategy using thioglycosides as donors.219 
When donor 1.83 dissolved in diethyl ether was pre-activated with 1 equiv. of p-TolSOTf, 
formed in-situ from p-TolSCl and AgOTf (3 equiv.), disaccharide 1.87 was obtained in 67% 
yield (α/β = 1.1/1, Scheme 1.11.). Interestingly, when the amount of AgOTf was decreased to 1.1 
equiv., significant change in α-selectivity was observed (α/β = 6/1). In addition, when the 
reaction was performed by increasing the volume of diethyl ether by 10 fold, further 
enhancement in α-selectivity was observed (α/β = 10/1).  
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Scheme 1.11.  Effect of solvent and excess amount of AgOTf used on the selectivity 
obtained 
 
 
Moreover, when dichloromethane was used as the reaction solvent, the stereoselectivity was 
switched (α/β = 1/8). With the belief that glycosyl triflates are formed as the reaction 
intermediates, the observed stereoselectivity was rationalized as follows. The reactions 
performed in diethyl ether proceed through a double-inversion mechanism. Under dilute 
conditions and with lower excess of AgOTf, solvent participation becomes more effective, 
resulting in higher α-selectivity. In case of dichloromethane, due to the non-nucleophilic and 
non-polar nature of the solvent, the reaction is likely to proceed via SN2-like pathway, directly 
displacing the α-glycosyl triflate leading to β-glycosides. 
Ito and co-workers developed a high-throughput screening system to study the synergistic 
solvent effect of combined ethereal and halogenated solvents on the course of glycosylation.212 
This study employed the use of glycosyl donors, which were isotopically labeled with per-
 
 
35 
 
deuterated (Bn-d7) benzyl ether protecting groups. The advantage of using Bn-d7 is the 
“disappearance” of all benzylic methylene signals at around 4-5 ppm, thereby making it easier to 
estimate the isomeric ratios of the glycosylated products. The labeled donor was glycosidated 
with various acceptors in the presence of MeOTf as the activator and 2,6-di-tert-butyl-4-
methylpyridine (DTBMP) in various solvents. Although ethereal solvents are known to exert α-
directing effect, the use of mixed solvent systems containing both halogenated and ethereal 
solvents was found even more beneficial for enhancing α-selectivity. Thus, a 1/1 (v/v) mixture of 
CHCl3/Et2O or CHCl3/cyclopentyl methyl ether (CPME) provided the best results and the use of 
such solvent systems was extended to the synthesis of a variety of 1,2-cis linkages.212,220 When 
per-deuterated benzyl ether protected thioglycoside donor 1.88 was reacted with per-deuterated 
glycosyl acceptor 1.89 in presence of methyl triflate (MeOTf) as a promoter, disaccharide 1.90 
with selectivity up to α/β = 19.5/1 was obtained (Scheme 1.12.). 
Scheme 1.12.  Solvent and temperature effects on 1,2-cis glycosylation 
 
 
Mong and co-workers took a different direction in studying reaction solvent by using 
dimethylformamide (DMF) as a co-solvent, rather uncommon reaction solvent in 
glycosylations.221  This procedure is based on pre-activation, where DMF is employed to trap the 
glycosyl oxacarbenium ion as an equilibrium mixture of α/β-glycosyl imidates. Being more 
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reactive, β-imidate reacts preferentially with the glycosyl acceptor producing desired α-glycoside 
with high selectivity.  
Scheme 1.13.  DMF-mediated glycosylation 
 
 
This study employed two conceptually different protocols for glycosylation. First, a 
conventional method (Procedure A), wherein a mixture of glycosyl donor, acceptor, and DMF 
was treated with NIS and TMSOTf.  Second, a pre-activation method (Procedure B), according 
to which the glycosyl donor was reacted with NIS and TMSOTf in the presence of DMF 
followed by the addition of the glycosyl acceptor. Both approaches furnished the desired 
glycosylation product. As shown in Table 1.6, reaction of benzylated donor 1.91 with glycosyl 
acceptor 1.92 gave moderate stereoselectivity (82%, α/β = 6/1, entry 1, Table 1.4). It was also 
demonstrated that the increase in the amount of DMF to 3 and 6 equiv. (entries 4 and 5) 
translated into a significant increase in α-stereoselectivity (up to α/β = 19/1, entry 5). 
Interestingly, the use of ethereal solvents had no benefit for the further improvement of 
stereoselectivity, irrespective of the type of ethereal solvent used.  The results obtained using 
procedure A were then applied to the investigation of the effectiveness of glycosylation 
procedure B. It was observed that due to the modulating effect provided by DMF, all 
glycosylations between thioglycoside donors 1.91, 1.94, or 1.95 and acceptors 1.96-1.100 
proceeded with high α-selectivity (α/β = 11-49/1, entries 4-9, Table 1.4). 
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Table 1.6.  Investigation of DMF-mediated glycosylations 
  
 
 
Encouraged by the α-stereodirecting effect of DMF, the preactivation protocol was extended 
to a sequential one-pot oligosaccharide synthesis.221 Prior to the one-pot synthesis, the efficiency 
of the procedure was tested by carrying out the synthesis of disaccharide and evaluating the 
stereoselectivity obtained. An interesting feature of DMF as an additive to a one-pot multi-step 
synthesis is that it is regenerated after the first coupling and hence can be engaged into the 
subsequent modulation cycle.  As depicted in Scheme 1.14, two contiguous 1,2-cis linkages were 
efficiently assembled and trisaccharide 1.105 was isolated in an overall yield of 52%.    
  
Entry DMF(equiv.)
Temp (oC), 
time (h) 
Yield of 1.93, 
α/β ratio 
1 1.5 -10, 2.0 82%, 6/1 
2 3.0 -10, 2.0 87%, 15/1 
3 6.0 -10, 2.0 87%, 19/1 
Entry Donor AcceptorTemp (
oC) 
time (h) 
Yield, α/β 
with DMF
4 1.91 1.96 -10, 3.0 60%, 36/1 
5 1.91 1.97 0, 3.0 55%, 11/1 
6 1.91 1.98 -10, 3.0 85%, 49/1 
7 1.91 1.99 0, 2.0 50%, 13/1 
8 1.94 1.100 0, 5.0 50%, 49/1 
9 1.95 1.97 -10, 6 61%, 49/1 
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Scheme 1.14.  DMF- mediated synthesis of trisaccharide 1.105  
 
 
1.5.3. Promoter, additives, and chelators 
At the early stages of method development, glycosylations of poorly nucleophilic acceptors 
were sluggish and inefficient. The first attempts to solve this problem gave rise to the 
development of catalytic systems that were actively involved in facilitating the departure of the 
leaving group.222 Zemplen223 and, subsequently, Helferich224 assumed that complexation of the 
anomeric bromides or chlorides with reactive mercury (II) salt catalysts would significantly 
improve their leaving group ability. This approach has become a valuable expansion of the 
classic Koenigs-Knorr method.225 These early attempts to improve the glycosylation process 
have revealed the necessity to find a delicate balance between the reactivity and stereoselectivity 
because it was noted that faster reactions often result in decreased stereoselectivity.226,227 
Recently, Demchenko and co-workers investigated the glycosidation of thioglycosides in the 
presence of bromine.114 It was demonstrated that bromine-mediated glycosylation of 
thioglycoside 1.106 leads to exclusive α-selectivity in product 1.109-1.111 (Scheme 1.15.). This 
reaction was monitored by NMR, and this study demonstrated that β-bromide is the reactive 
intermediate that leads to the product 1.109-1.111 with complete stereoselectivity. The NMR 
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experiment showed that β-bromide can undergo a relatively rapid anomerization into the α-
linked counterpart, and if this anomerization is not suppressed, the yield of the glycosylation 
product can be low.  
Once formed, α-bromide is totally unreactive under the established reaction conditions, but it 
can be reactivated in the presence of mercury (II)-based promoters. This, however, can 
compromise α-selectivity with primary alcohols. This concept complements well-known in-situ 
anomerization procedure introduced by Lemieux and co-workers for reactive bromides113 and 
further adapted to iodides by Gervay-Hague.112,228 
Scheme 1.15.  Stereoselective glycosidation of superdisarmed thioglycoside 1.106 via 
reactive β-bromide intermediate 
O
Br
intermediate O
Brby-product
O
OBz
BzO
BzO
BnO
SEt
bromine
O
1.109-1.111
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(ROH)
oxacarbenium ion
O
OBz
BzO
BzO
BnO OR
HgBr2
1.106
 
Entry Acceptor (ROH) Product Yieldα/β ratio
1 
 
72% 10.5/1 
2 
 
89% >25/1 
3 
 
87% >25/1 
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It is a general trend that milder activating conditions are beneficial for 1,2-cis glycosylation. 
Thus, halide ion-catalyzed reactions gave the best results for the glycosylation with glycosyl 
halides;113 thioglycosides give higher selectivity when activated with a mild promoter, such as 
iodonium dicollidine perchlorate (IDCP) 229,230 or bromine.114  
Many of the current methodologies for glycosylation require the use of stoichiometric 
amounts of promoters.. The use of transition metal catalysts helps achieve greener and milder 
way to construct glycosidic linkages and offers new opportunities for stereocontrol.231 O’Doherty 
developed a well-rounded methodology for palladium(0)-catalyzed glycosylations, wherein 
carbohydrate chirality centers are installed post-glycosylationally.90,232-234 Nguyen and co-
workers studied palladium(II)-catalyzed glycosidation of glycosyl trichloroacetimidates using 
Pd-(CH3CN)4(BF4)2 or similar catalysts.235,236 This study evolved into the investigation of a 
series of nickel catalysts providing an efficient means for glycosidation of N-p-
methoxybenzylidene-protected 2-amino-2-deoxy trichloroacetimidate donor.237,238 The nature of 
the ligand on nickel has been found to be the deciding factor in controlling the stereoselectivity 
of glycosylations. Thus, it was observed that electron-withdrawing substituents help to decrease 
the reaction time, which is translated into increased α-selectivity. The efficiency of the nickel-
catalyzed glycosylations was then extended to glycosylation of a variety of acceptors and applied 
to the synthesis of number of oligosaccharides. As summarized in Table 1.5, N-benzylidene 
trichloroacetimidate donor 1.112 bearing different para substituents was reacted with primary 
(1.27-1.28) and secondary glycosyl acceptors (1.58, 1.113-1.114) under catalysis of Ni(4-F-
PhCN)4(OTf)2, to provide disaccharides (1.115-1.119) with very high α-selectivity.   
  
 
 
41 
 
Table 1.7.  Nickel-catalyzed α-selective glycosidation of N-benzylidene 
trichloroacetimidate donor 1.112 
O
ON
X
NH
CCl3
X = H, OMe, F and CF3
OAc
AcO
AcO Ni(4-F-PhCN)4(OTf)2
5-10 mol %
CH2Cl2, 25
oC,
O
ORN
X
OAc
AcO
AcO
ROH
1.112 1.115-1.119  
Entry R-OH Product 
1 
 
 
2 
 
 
3 
 
4 
  
5 
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Bennett and co-workers recently applied the activation of thioglycosides with Ph2SO in the 
presence of TBAI to the stereoselective synthesis of 1,2-cis glycosides. It was observed that this 
reaction proceeds via the intermediacy of glycosyl iodides.239 The underpinning idea of using 
TBAI is that the conversion of α-glycosyl triflates into β-glycosyl iodides would favor the 
formation of α-glycosides.  Thus, when the armed S-phenyl thioglycoside 1.120 was reacted with 
glycosyl acceptors 1.2 and 1.92 under the Ph2SO/Tf2O conditions followed by the addition of 
TBAI, disaccharides 1.121 (41%, α-only) and 1.122 (79%, α/β = 20/1) were obtained in excellent 
stereoselectivity (Scheme 1.16).  
Scheme 1.16.  Synthesis of 1,2-cis-linked glycosides by activation of 
thioglycosides in the presence of TBAI 
 
 
Recently there has been an explosion in the study of gold-catalyzed activation of alkynes to 
exploit the low oxophilic character of gold and the excellent functional group compatibilities 
these catalysts exhibit.240-244 This includes work by Hotha and co-workers where propargyl 
glycosides were activated using Au(III) chloride to give α/β mixtures of glycosides and 
disaccharides in good yields. Yu and co-workers conducted a similar study with glycosyl ortho-
alkynylbenzoates under the catalytic Au(I) activation conditions.243 244  Another promising new 
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field is the use of chiral thioureas as organocatalysts for glycosylations.245 As of now, this 
approach is limited to the synthesis of 2-deoxy α-glycosides246 and β-selective glycosylations 
with 2-oxygenated sugars.247  
Various additions to the promoter systems often influence the stereochemical outcome of the 
glycosylation. Amongst the most remarkable examples is the use of perchlorate ion additive that 
was found to be very influential in 1,2-cis glycosylations.248,249 Lately, the effectiveness of use of 
silver perchlorate as activator in glycosylations of thioimidates and thioglycosides to provide 
better 1,2-cis selectivity than those achieved with more common triflates, has been studied.250  
Demchenko and co-workers observed that a multi-dentate metal coordination to the leaving 
group, along with a protecting group at O-6 and/or O-5, has a strong effect on the 
stereoselectivity of chemical glycosylation (Scheme 1.16). It was demonstrated that platinum(IV) 
complexation of 6-O-picolinyl or 6-O-bipyridyl to the leaving group, such as thiazolinyl, has a 
pronounced effect on the stereoselectivity of glycosylation.251 While the glycosidation of 
thioimidate donor 1.123 with acceptor 1.27 in the presence of Cu(OTf)2 gave the disaccharide 
1.125 with poor selectivity (α/β = 1.7/1, Scheme 1.17), the complexed glycosyl donor 
counterpart 1.124 showed a significant 5-fold increase in 1,2-cis stereoselectivity (α/β = 9.4/1).  
Scheme 1.17.  Effect of metal complexation on the stereoselectivity of glycosylation 
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While studying 2,3-O-carbonyl protected glucose and galactose donors, which are generally 
β-stereoselective, Ye and co-workers observed that Lewis acids additives favor α-
stereoselectivity in preactivation-based glycosylations.192 Thus, catalytic amount of BF3-OEt2 or 
AgBF4 as well as 1 equiv. of AgPF6 or SnCl4 completely reversed stereoselectivity to give α-
linked products.  It was assumed that similar to that proven for 2,3-oxazolidinones,186,187 the 
initially formed β-linked product anomerizes into the thermodynamically more stable α-anomer, 
and this anomerization is facilitated by Lewis acid additives.  
 
1.6.  Other effects and special methods 
High pressure applied to the reactions with participating glycosyl donors further enhances 
1,2-trans selectivity;252 when the high pressure conditions were applied for glycosylations with a 
non-participating glycosyl donor, remarkable increase in the reaction yield was noted with only 
marginal changes in stereoselectivity.253  Unfavorable steric interactions that occur between 
glycosyl donor and acceptor in the transition state or other factors or conditions may 
unexpectedly govern the course and outcome of the glycosylation process. One of the most 
remarkable effects, so-called “double stereodifferentiation” takes place when stereochemical 
interactions between bulky substituents in glycosyl donor and glycosyl acceptor may outperform 
even the strong stereodirecting effect of a neighboring participating group. The pair of reagents 
where these interactions occur is called a “mismatched pair”.254  
A number of methods have been developed that do not include a formal glycosylation 
step.255-257 Typically, these indirect procedures include multistep syntheses and are of lower 
efficiency than direct glycosylations. Therefore, practical application of these techniques is 
envisaged for the synthesis of glycosidic linkages that cannot be easily accessed by conventional 
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technologies. O’Doherty and co-workers developed a new method for the synthesis of di- and 
oligosaccharides that can be accomplished from non-carbohydrate precursors.90,232-234 The de 
novo asymmetric methodology was applied to the synthesis of mono-, di-, and oligosaccharides 
via palladium-catalyzed reaction. The synthesis of 1,2-cis linkages have not yet been 
accomplished. 
 
1.6.1.  Intramolecular aglycone delivery (IAD) 
Barresi and Hindsgaul were the first to apply the idea of intramolecular glycosylation, which 
was used for the synthesis of β-mannosides.258 Subsequently, it was demonstrated that silicon 
bridge-mediated aglycone delivery provides high yields and excellent stereocontrol.259,260 Further 
improvement emerged with the introduction of the allyl-mediated strategy that allows high yields 
and complete stereoselectivity in α-glucosylations and β-mannosylations.261 More recently Ito 
and co-workers invented naphthylmethyl ether (NAP)-mediated intramolecular aglycone 
delivery.262 The versatility of this approach is that it generally provides significantly higher 
yields in comparison to that of traditional approaches. Further value of this methodology is that it 
allows for stereoselective synthesis of various 1,2-cis linkages, such as β-Manp, β-Araf, and α-
Glcp. A representative example, the synthesis of disaccharide 1.129, is depicted in Scheme 1.18. 
Thus, when 2-O-NAP-protected thiomethyl glycosyl donor 1.126 was reacted with acceptor 
1.127 in the presence of DDQ, followed by the removal of NAP tether and acetylation, 
disaccharide 1.129 was obtained in 90% yield with complete β-selectivity.  
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Scheme 1.18.  β-Mannopyranosylation via NAP-tether mediated intramolecular aglycone 
delivery (IAD) 
 
 
1.6.2.  Supported and tagged synthesis 
The last decade has witnessed dramatic improvements in the area of solid phase-supported 
oligosaccharide synthesis.263-267 Polymer supported synthesis is very attractive because it allows 
to conduct the synthesis of oligosaccharide sequences without the necessity of purifying (and 
characterizing) the intermediates. Another important advantage of oligosaccharide synthesis on 
solid phase support is the ease of excess reagent removal (by filtration). This effort culminated in 
the automated synthesis by Seeberger, which was the first attempt to conquer the challenge on 
1,2-cis glycosidic bond formation using an automated approach.268 Careful refinement of 
reaction conditions allowed 1,2-cis galactosylation in dichloromethane-ether and Globo-H 
sequence was assembled as depicted in Scheme 1.19. First, glycosyl phosphate donor 1.130 was 
linked to the resin 1.136 via glycosylation using TMSOTf (repeated once) as the promoter, 
followed by deprotection of the Fmoc substituent with piperidine (repeated twice) to provide 
polymer-bound acceptor. The general synthetic protocol consists of repetitive cycles of 
glycosylation using either glycosyl phosphate (1.130-1.133) or glycosyl N-phenyl 
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trifluoroacetimidate donors (1.134 and 1.135) followed by the deprotection with piperidine. The 
final product 1.137 was obtained under an atmosphere of ethylene in the presence of Grubbs’ 
catalyst269 in an overall yield of 30%.  
Scheme 1.19.  Automated synthesis of Globo H hexasaccharide 
 
 
Very recently the same group has reported the total synthesis of O-antigen pentasaccharide 
repeating unit obtained from pathogenic E. coli. O111. With the synthetic challenge of 
constructing two unnatural and labile coitose units, the total synthesis was achieved in 21 steps 
with 1.5% overall yield.270  Boons et al. presented a very elegant synthesis of  α-linked 
oligosaccharide on polymer support using their recent chiral auxiliary –assisted synthesis of 1,2-
cis glycosides.124  
A promising technique for the tagged oligosaccharide synthesis that makes use of an ionic-
liquid support has recently emerged.271,272 As with the polymer-supported and fluorous tag-
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supported syntheses,273-275 ionic liquid-supported assembly expedites oligosaccharide synthesis 
by eliminating the need for chromatographic purification of the intermediates. 272,276-282 
Differently from insoluble polymer beads, ionic liquid supports allow for homogeneous 
conditions. This approach is illustrated by the synthesis of trisaccharide 1.141 (Scheme 1.20).283  
Scheme 1.20. Glycosylation on ionic liquid support and product isolation.  
 
 
In this synthetic strategy, the glycosyl acceptor 1.139 was grafted onto an ionic liquid support 
at C-6 position of the sugar moiety. The resulting tagged glycosyl acceptor 1.139 was reacted 
with trichloroacetimidate donor 1.138 to afford disaccharide 1.140 in 89% and high α-
stereoselectivity. The purification is accomplished by simple washing or liquid-liquid 
extractions. Disaccharide 1.140 was then reacted with acceptor 1.28 followed by the removal of 
the ionic liquid tag using LiOH-H2O to afford trisaccharide 1.141 in 87% yield. 
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1.7.  Conclusions and outlook 
The progress in the area of chemical glycosylation has significantly improved our ability to 
synthesize various glycosidic linkages with impressive yields and stereoselectivity. Can we 
conclude that we have entirely solved the problem of chemical glycosylation? Unfortunately not, 
and hopefully this Chapter has introduced the reader to the challenge of chemical glycosylation, 
a variety of factors, conditions, and driving forces influencing all aspects of this complex 
chemical reaction as well as informing the reader about the specialized material dedicated to 
particular methods and strategies employed in modern carbohydrate chemistry. Recent progress 
made in the area of development of new coupling methods and highly efficient strategies for 
oligosaccharide synthesis will ultimately provide an efficient and trouble-free access to complex 
saccharides. This goal cannot be achieved without the comprehensive knowledge of the 
glycosylation mechanism and the driving forces of glycosylation and competing side processes. 
It is likely that the consecutive scientific development in this field will be focusing on studying 
the fundamental mechanistic aspects of glycosylation rather than developing additional anomeric 
leaving groups. 
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2.1.  Introduction  
Complex carbohydrates play important roles in many life-sustaining and life-
threatening processes including embryonic growth, cell differentiation, immune response, 
infections, and carcinogenesis.1 Our understanding of these processes is often dependent 
on the knowledge of the structure and properties of the carbohydrates involved. Many 
classes of complex carbohydrates can be isolated from natural sources, but it is chemical 
or enzymatic synthesis that allows for obtaining sufficient quantities of pure natural 
compounds or unnatural mimetics thereof.2 Amongst the synthetic steps required to 
obtain complex carbohydrates from simple building blocks, chemical glycosylation 
reactions create the greatest synthetic hurdle for chemists.3,4 Hence, the development of 
new leaving groups for chemical glycosylation and the optimization of reaction 
conditions for their activation represents an important and challenging area of research.5 
The tremendous progress made in the area of glycosciences has resulted in the 
development of a variety of leaving groups amongst which O-trichloroacetimidates 
(TCAI)6 and thioglycosides7 have arguably become the most widespread glycosyl donors 
to date.  
Figure 2.1.  Designing new O-benzoxazolyl leaving group 
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As a part of the ongoing research effort to develop new methods for chemical 
glycosylation, our laboratory reported a series of new thioimidoyl leaving groups that 
have shown superior properties in glycosylation to that of many other methods.8,9 
Amongst these, S-benzoxazolyl donors (cyclic S-imidate)10-17 have shown excellent 
glycosyl donor properties for simple one-step glycosylations and easily fit into a variety 
of concepts for expeditious oligosaccharide synthesis.18 Aiming to develop a similar 
method for chemical glycosylation, we became interested in studying cyclic O-imidates. 
As the first step towards accomplishment of this aim, we report the investigation of a 
novel leaving group, O-benzoxazolyl (OBox), which represents a bridging structure 
between O-imidates and SBox glycosides (Figure 2.1). This study is also expected to 
complement previous work of Mukaiyama19-23 and Chirva24 dedicated to a study of 
structurally related O-imidate derivatives.   
 
2.2. Results and discussion 
We determined that the novel OBox leaving group can be introduced by several 
modes using commercially available and inexpensive precursors. For the sugar part, both 
hemiacetals and glycosyl bromides were found to be suitable starting materials. In this 
context, Mukaiyama’s imidate was similarly synthesized by direct condensation reaction 
between anomeric hydroxyl group and 2-chloro-6-nitrobenzthiazole giving a mixture of 
isomers.21 As summarized in Table 2.1, a variety of OBox derivatives of the D-gluco 
(2.2, 2.4, 2.8, 2.10), D-manno (2.6, 2.14), and D-galacto (2.12) series were readily 
obtained in yields up to 85%. The transformation of hemiacetals 2.1,25 2.3,25 and 2.526 
into the corresponding OBox imidates 2.2, 2.4, and 2.6 involved a base-catalyzed (DBU 
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or KOH) reaction with 2-chlorobenzoxazole (ClBox, entries 1-3, Table 2.1). With 
exception of benzylated OBox derivative 2.4 (entry 2) that was obtained as a mixture of 
anomers (α/β = 2.5/1), other substitutions proceeded stereoselectively.  
The OBox glycosides could also be obtained from halides using 2-benzoxazolinone 
(HOBox), but the conversion was more efficient when the corresponding silver salt 
(AgOBox) was used instead (entries 4-7). To our surprise, conversion of acetylated 
bromide 2.727 resulted in the formation of a relatively stable OBox orthoester 2.8 along 
with a small amount of the expected OBox derivative 2.2 (entry 4).  Orthoesters have 
been known for long time and found broad application in regioselective protection of 
carbohydrates and glycosylation.28 However, to the best of our knowledge, no occurrence 
of O-imidate-based orthoester derivatives has been reported. On the other hand, reaction 
of benzobromo derivatives of the gluco 2.9,29 galacto 2.11,30 and manno series 2.1331 
with AgOBox in the presence of Bu4NI and 2,6-lutidine afforded the corresponding 
OBox imidates 2.10, 2.12, and 2.14 in good yields with exclusive 1,2-trans anomeric 
selectivity and no orthoester formation detected.  In this context, transformation of the 
tetrabenzoylated hemiacetal to the corresponding OBox imidate 2.10 was found to be 
inefficient and incomplete probably due to the reversibility of the reaction.  The 
formation of the N-linked glycosides along with O- or S-linked derivatives upon reaction 
with bi- or multi-dentate aglycones is not uncommon.12,32,33 In this particular case, 
however, no N-linked products were isolated. 
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Table 2.1.  Synthesis of O-benzoxazolyl derivatives 
Entry  Starting material  Conditions,a time  Product  Yieldα/β ratio
1 
OH
O
AcO
AcO
AcO
AcO
2.1  
A, 2 h 
 
85% 
1.5/1 
2 
 
B, 2.5 h 
 
80%	
2.5/1	
3	
	
B, 2 h	
	
50%	
α only	
4	
	
C, 1.25 h	
	
79% 	
+ 9% 	
(β-2.2)	
5	
	
D, 10 h	
	
83% 
β only 
6 
 
D, 2.5 h 
 
82% 
β only 
7 
 
D, 1.5 h 
 
81% 
α only 
 
a – Conditions: A: ClBox, DBU, CH2Cl2, 0 oC; B: ClBox, KOH, acetone, molec. sieves 
3Å, 0 oC; C: AgOBox, CH2Cl2, molec. sieves 3Å, 40 oC; D: AgOBox, Bu4NI, 2,6-
lutidine, CH2Cl2, rt (entry 6 and 7) or 45 oC (entry 5)  
 
Occasionally, N-linked glycosides are also obtained as by-products of the synthesis of 
O- and S-imidates. Based on the literature data for per-acetylated SBox glycosides and 
their N-linked counterparts (2.17 and 2.18),34 we found that UV spectroscopy would 
90 
 
adequately serve our needs for structure determinations.15 To this end, it should be 
possible to unambiguously distinguish the isomers by simple and reproducible 
comparison of the absorption bands. Thus, the thioimide (SH) derivative has two narrow 
bands (λmax) at around 280 and 290 nm (C=N), whereas the thioamide (NH) has a single 
broad band at ~300 nm (C=S, entries 1 and 2, Table 2.2). Resultantly, we anticipated that 
UV spectroscopy could be used to differentiate O-imidates from their N-linked 
counterparts.  Indeed, OBox glycoside 2.2 showed two narrow bands at 273 and 279 nm 
indicative of the imide (C=N) structure (entry 3). Along these lines, HOBox derivative 
2.15 exists as an amide (C=O, single band at 275 nm, entry 4), whereas its silver salt 2.16 
is an imide (C=N, two bands at 274 and 280 nm, entry 5).  In addition to the previously 
reported data for per-benzylated S-benzoxazolyl (SBox) glycosides and their N-linked 
counterparts (2.19 and 2.20, entries 7 and 8, respectively),15 herein we report UV data for 
per-benzylated OBox derivative 2.4. The UV spectrum confirms the imide structure 
(C=N, λmax = 270 and 276, entry 8).  
Having performed the synthesis and thorough characterization of the novel OBox 
imidates, we turned our attention to studying their glycosyl donor properties. A typical 
activation of TCAI is affected under catalysis of a Lewis acid (BF3-OEt2 or TMSOTf) 
and leads to the corresponding disaccharides in good to excellent yields.6,35 A typical 
activation of SBox glycoside requires different reaction conditions and can be affected in 
the presence of stoichiometric amount of Ag(I), Cu(II), Bi(III), or TMS triflates. 
Alternatively, SBox glycosides can be activated in the presence of thiophilic promoters, 
typical for thioglycoside activation,7 including MeOTf, DMTST, NIS/TMSOTf, etc.9 
With this prior knowledge and a range of OBox donors in hand, we planned on studying 
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their reactivity in glycosylation reactions with standard glycosyl acceptors 2.21-2.24 
(Figure 2.2).36  
Table 2.2.  Comparative UV data for O, N and S-linked derivatives 
Entry  Compound  Band 1λmax (nm)
Band 2 
λmax (nm)  Ref. 
1  275  -  This work 
2 
 
274  280  This work 
3  280  290  34 
4  300  --  34 
5  273  279  This work 
6  274  280  This work 
7  280 290 15 
9  270 276 This work 
 
A coupling reaction of per-O-benzylated OBox imidate 2.4 with glycosyl acceptor 
2.2137 in the presence of MeOTf (10 mol %) was completed within 5 min at -78 oC and 
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provided the corresponding disaccharide 2.2538 in 97% (α/β = 1/1.7, entry 1, Table 2.3). 
Activation of OBox imidate 2.4 for reaction with acceptor 2.21 was nearly as efficient in 
the presence of either TfOH (10 mol %) or TMSOTf (10 mol %) and provided the 
corresponding disaccharide 2.25 in 85% (α/β = 1/1.2, entry 2) or 95% yield (α/β = 1/4.0, 
entry 3). Both reactions were completed in less than 5 min at -20 oC (entry 2) or -78 oC 
(entry 3). The latter reaction conditions (TMSOTf, -78 oC) were applied to glycosylation 
of secondary glycosyl acceptors 2.22-2.2439-41 with OBox donor 2.4. Again, all couplings 
were completed within 5 min and provided the corresponding disaccharides 2.26-2.2842-44 
in 89-95% yields (α/β = 1/1.0-2.4, entries 4-6). Other promoters including AgOTf, 
MeOTf, Bi(OTf)3, and Cu(OTf)2 also provided very efficient activation of OBox 
glycosides (vide infra). Although OBox donor 2.4 showed very satisfactory results, 
relatively low stereoselectivity was observed in practically all glycosidations of 2.4 using 
1,2-dichloroethane as the solvent. A similar reactivity profile was recorded for per-
benzylated mannosyl donor 2.6 with an exception that a moderate selectivity was 
obtained with primary acceptor 2.21 and complete 1,2-trans selectivity was observed with 
secondary acceptors 2.22-2.24 (entries 7-10) to provide the respective disaccharides 2.29-
2.32 in excellent yields of 90-94%. 
Figure 2.2.  Glycosyl acceptors investigated 
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Table 2.3.  Synthesis of 1,2-cis glycosides 
Entry Donor + Acceptor, Conditions,a time Product 
Yield, 
α/β ratio 
1 2.4 + 2.21 Method A, 15 min 
 
97%, 1/1.7 
2 2.4 + 2.21 Method B, 5 min 2.25 85%, 1/1.2 
3 2.4 + 2.21 Method C, 5 min 2.25 95%, 1/4.0 
4 2.4 + 2.22 Method C, 5 min 
 
89%, 1/1.5 
5 2.4 + 2.23 Method C, 5 min 
 
95%, 1/1.0 
6 2.4 +2.24 Method C, 5 min 
 
92%, 1/2.4 
7 2.6 + 2.21 Method C, 5 min 
 
93%, 2.9/1 
8 2.6 + 2.22 Method C, 5 min 
 
91%, 
α only 
9 2.6 + 2.23 Method C, 5 min 
 
90%, 
α only 
10 2.6 + 2.24 Method C, 5 min 
 
94%, 
α only 
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Having investigated the reactivity of per-O-benzylated OBox glycosyl donors 2.4 and 
2.6, we turned our attention to studying their per-O-acylated counterparts. The disarming 
(deactivating) effect of electron-withdrawing substituents on the reactivity of building 
blocks in glycosylation is well known.45-47 Therefore, we anticipated substantially 
reduced reactivity of per-acylated OBox derivatives. Surprisingly, the reactivity of per-
acylated derivatives was similar to that observed with their per-benzylated counterparts. 
Although the reactions were fast, per-acetylated OBox glycoside 2.2 provided somewhat 
low yields (data not shown) when TMSOTf was used as the promoter. We relate this to 
the competing acetyl migration from the O-2 of the glycosyl donor to the free hydroxyl of 
the glycosyl acceptor. In this context, SnCl4-promoted glycosidations of glycosyl donor 
2.2 with glycosyl acceptors 2.21 and 2.22 were much cleaner, showed minimal acetyl 
migration, and provided the corresponding 1,2-trans-linked disaccharides 2.3344 and 
2.3448 in good yields of 85% and 77%, respectively (entries 1 and 2, Table 2.4). SnCl4-
promoted glycosidation of the acetylated OBox orthoester 2.8 provided a very similar 
outcome in comparison to the glycosylation of glycosyl imidate 2.2 (entries 3 and 4).  
The reactivity of per-benzoylated glucose derivative 2.10 in presence of TMSOTf at -
78 oC was also quite similar to that observed with its per-benzylated counterpart 2.4. All 
glycosidations of donor 2.10 were completed within 5-10 min and provided the 
corresponding disaccharides 2.35-2.3836,49,50 in excellent yields of 87-97% (entries 5-8). 
Very high reactivity was also observed for per-benzoylated galactosyl and mannosyl 
donors 2.12 and 2.14, respectively. All glycosylations in the presence of TMSOTf at -78 
oC were completed within 5-15 min and provided the corresponding disaccharides 2.39-
2.4251-53 in excellent yields of 78-97% (entries 9-12). 
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Table 2.4.  Synthesis of 1,2-trans glycosides 
Entry Donor + Acceptor, Conditions,a time Product 
Yield, 
α/β ratio 
1 2.2 + 2.21 Method D, 5 min 
 
85%, 
β only 
2 2.2 + 2.22 Method D, 5 min 
 
77%, 
β only 
3 2.8 + 2.21 Method D, 15 min 2.33 
82%, 
β only 
4 2.8 + 2.22 Method D, 15 min 2.34 
75%, 
β only 
5 2.10 +2.21 Method C, 10 min 
 
89%, 
β only 
6 2.10 + 2.22 Method C, 10 min 
 
88%, 
β only 
7 2.10 + 2.23 Method C, 10 min 
 
88%, 
β only 
8 2.10 + 2.24 Method C, 10 min 
 
87%, 
β only 
9 2.12 + 2.21 Method C, 5 min 
 
83%, 
β only 
10 2.12 + 2.22 Method C, 5 min 
 
78%, 
β only 
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11 2.14 + 2.21 Method C, 15 min 
 
95%, 
α only 
12 2.14 + 2.22 Method C, 15 min 
 
97%, 
α only 
 
With the high reactivity of OBox glycosides observed even under relatively mild and 
catalytic activation conditions, we aimed at establishing the comparative reactivity profile 
of the OBox imidates along with known glycosyl donors. Using the previously 
established protocol for competitive glycosylations, two per-O-benzoylated glycosyl 
donors, OBox 2.10 and SBox 2.43,15 were set to compete for a limited quantity of 
glycosyl acceptor 2.21. Competitive glycosylations performed in the presence of 10 mol. 
% of TMSOTf, AgOTf or Cu(OTf)2 all showed OBox donor 2.10 to be much more 
reactive. This was judged by nearly complete recovery of the unreacted SBox donor 2.43 
(Table 2.5). Similar observations were made in the competitive reaction between OBox 
donor 2.10 and TCAI donor 2.44. Again, the OBox donor was more reactive under all of 
the following activation conditions: TMSOTf (0.05 equiv.), AgOTf (0.1 equiv.), or 
Bi(OTf)3 (0.03 equiv.), whereas TCAI donor 2.44 was recovered in 82-93% yield (Table 
2.5).  
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Table 2.5.  OBox imidate 2.10 showed consistently higher reactivity in 
comparison with SBox glycoside 2.43 and trichloroacetimidate 2.44 
 
Glycosyl donors Conditions,
a temp. Yield of 2.45 Donor recovery
2.10 + 2.43 
Method C, 0 oC 93% 2.43: 93% 
Method E, rt 94% 2.43: 92% 
Method F, rt 99% 2.43: 95% 
2.10 + 2.44 
Method C,b -78 oC 96% 2.44: 87% 
Method E, rt 91% 2.44: 82% 
Method G, rt 90% 2.44: 93% 
 
a – Method C: TMSOTf (0.1 equiv. to donor), molec. sieves 4Å, ClCH2CH2Cl; Method 
E: Cu(OTf)2 (0.1 equiv. to donor), molec. sieves 4Å, ClCH2CH2Cl; Method F: AgOTf 
(0.1 equiv. to donor), molec. sieves 4Å, ClCH2CH2Cl; Method G: Bi(OTf)3 (0.03 equiv. 
to donor), molec. sieves 4Å, ClCH2CH2Cl, rt; b – 0.05 equiv. of TMSOTf was used 
 
Polymer-supported synthesis is very attractive because it allows for rapid synthesis of 
oligosaccharide sequences without the necessity of purifying (and characterizing) the 
intermediates.54,55 On achieving a series of solution-based experiments, we decided to 
investigate possible beneficial effects of using highly reactive OBox imidates in 
glycosylations on polymer support using our recently developed HPLC-assisted 
automated technology.56  This experimental setup based on an unmodified HPLC 
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instrument was executed as follows. The Omnifit SolventPlus chromatography glass 
column was loaded with the resin-bond glycosyl acceptor. The loaded column was 
connected to the HPLC and solutions of glycosyl donor and promoter in CH2Cl2 were 
then delivered concomitantly using different heads of the multi-headed HPLC pump. 
Upon completion of glycosylation, as judged by the HPLC detector, the resulting 
disaccharide can be cleaved off from the polymer support or the oligosaccharide 
sequencing can be continued as desired.   
In this particular application, Tentagel resin-bound glycosyl acceptor 2.46,56 attached 
via the anomeric center, was loaded into the Omnifit column, which was connected to the 
HPLC equipment (Scheme 2.1). Reagent bottles, one containing a 22 mM solution of 
glycosyl donor 2.10 in CH2Cl2 and another one containing a 27 mM solution of TMSOTf 
in CH2Cl2 were connected to inlets for pumps A and B, respectively.  Pumps A/B were 
then programmed to deliver the mixed solution of donor/promoter concomitantly in the 
ratio of 4/1 (v/v) at the total flow rate of 0.3 mL/min. Upon exiting the column, a solution 
containing unreacted donor and promoter was collected in a separate vial that would be 
subsequently used as a recirculating chamber connected to Pump C. Upon consumption 
of the fresh solution of glycosyl donor 2.10 (10 equiv., ~20 min), Pump A was switched 
to Pump C connected to the recirculating chamber (80%), while Pump B continued to 
deliver fresh TMSOTf (20%) at a combined flow rate of 0.3 mL/min for 10 min. After 
that, Pump C was set to 100% flow rate and the information about the consumption of 
donor 2.10 and accumulation of the corresponding hemiacetal, the product of the 
competing hydrolysis, was acquired by periodic monitoring of the solution phase by 
TLC. Upon complete hydrolysis of glycosyl donor 2.10 (about 60 min of recirculation), 
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pump C was stopped and the column was purged with CH2Cl2 (pump A, 2.0 mL/min) for 
10 min.  The formation of disaccharide 2.4756 was determined by cleaving off the sugar 
molecule from the resin using 0.1 M solution of NaOCH3 in CH3OH/CH2Cl2 followed by 
acetylation (Ac2O/pyridine). The treatment with the NaOCH3 solution can be performed 
using either HPLC set-up directly or by transferring the resin into a separate flask and 
performing conventional deprotection. Resultantly, product 2.47 was isolated in 79% 
yield along with 2% of a monosaccharide product 2.4856 derived from the unreacted 
acceptor 2.46. 
Scheme 2.1.  Exploratory study of the coupling efficiency of glycosyl donor 2.10 with 
the polymer-bound acceptor 2.46 
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2.3.  Conclusions 
We have discovered a new class of O-imidoyl glycosyl donors that were shown to be 
more reactive than previously investigated O- and S-imidates. These donors can be 
activated using a catalytic amount of a Lewis acid, as little as 3 mol %. High reactivity 
profile of OBox imidates was confirmed in direct competitive experiments with known 
glycosyl donors and was applied to HPLC-assisted glycosylation on polymer support. 
Further application of OBox donors to automated oligosaccharide synthesis and 
investigation of their structure-reactivity-stereoselectivity profile is underway in our 
laboratories 
 
2.4. Experimental Section 
2.4.1. General Remarks 
All reactions were conducted under argon with dry, freshly distilled solvents unless 
otherwise noted. CH2Cl2, ClCH2CH2Cl, and acetone were distilled from CaH2 directly 
prior to application. 2-Chlorobenzoxazole and 2-benzoxazolinone were used as is. AgOTf 
was co-evaporated with toluene (3 x 10 mL) and dried for 2-3 h directly prior to 
application. Cu(OTf)2 and Bi(OTf)3 were dried in vacuo for 3-4 h directly prior to use. 
TMSOTf and SnCl4 were used as is. Molecular sieves (3 Å or 4 Å), used for reactions, 
were crushed and activated overnight at 390 oC and then for 2-3 h at 390 oC prior to 
application. Reactions were monitored by TLC on Kieselgel 60 F254 and the compounds 
were detected by examination under UV light and by charring with 10% sulfuric acid in 
methanol. Solvents were removed under reduced pressure at < 40 oC. Column 
chromatography was performed on silica gel 60 (70-230 mesh). Optical rotations were 
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measured at ‘Jasco P-1020’ polarimeter. 1H-NMR spectra were recorded at 300MHz, 
13C-NMR spectra were recorded at 75MHz (Bruker Avance). The 1H chemical shifts are 
referenced to the signal of the residual CHCl3 (δH = 7.27 ppm) for solutions in CDCl3. 
The 13C chemical shifts are referenced to the central signal of CDCl3 (δC = 77.23 ppm) for 
solutions in CDCl3. HRMS determinations were made with the use of JEOL MStation 
(JMS-700) Mass Spectrometer. 
 
Silver benzoxazol-2-olate (AgOBox, 2.16). A solution of 2-benzoxazolinone (HOBox, 
2.0 g, 14.8 mmol) and NaOH (0.6 g, 14.8 mmol) in water (14 mL) was added dropwise to 
a solution of AgNO3 (2.5 g, 14.8 mmol) in water (14 mL) and the resulting mixture was 
stirred for 10 min at rt. The solid was filtered off and rinsed successively with water (10 
mL), MeOH (3 mL), and water (10 mL). The solid was collected and dried in vacuo for 
16 h to afford the title compound (3.3 g, 92% yield) as a brown solid. The title compound 
can be stored for extended period of time but was additionally dried for 4-5 h directly 
prior to application. Analytical data for 2.16: 1H-NMR (300 MHz): δ, 6.77 (t, 1H, 
aromatic), 6.95 (m, 3H, aromatic); 13C-NMR (75 MHz): δ, 107.2, 111.5, 118.3, 121.9, 
142.5, 146.4, 163.3; UV: λmax = 274, 280 nm.  
 
2.4.2.  Synthesis of OBox glycosyl donors 
Benzoxazolyl 2,3,4,6-tetra-O-acetyl-α,β-D-glucopyranoside (2.2). 2-
Chlorobenzoxazole (79.5 μL, 0.7 mmol) and DBU (0.14 mL, 0.93 mmol) were added to a 
stirring solution of 2,3,4,6-tetra-O-acetyl-α,β-D-glucopyranose25 (2.1, 0.16 g, 0.46 mmol) 
in dry CH2Cl2 (1.6 mL) and the resulting mixture was stirred for 2 h at 0 oC. After that, 
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the solid was filtered off and washed successively with CH2Cl2. The combined filtrate 
(~60 mL) was washed with 1% aq. NaOH (2 x 20 mL), water (20 mL), and brine (20 
mL). The organic phase was separated, dried with MgSO4, and concentrated in vacuo. 
The residue was purified by column chromatography on silica gel (ethyl acetate - hexane 
gradient elution) to obtain the title compound (187 mg, 85% yield) as a white foam. 
Analytical data for α-2.2: Rf = 0.42 (ethyl acetate/hexanes, 1/1, v/v); [α]D22 +84.5 (c= 1.0, 
CHCl3); 1H-NMR (300 MHz): δ, 2.04-2.11 (m, 12H, 4 x COCH3), 4.13 (m, 1H, H-6a), 
4.30 (m, 2H, H-5, 6b), 5.25 (m, 2H, J2,3 =  9.9 Hz, J4,5 =  3.5 Hz, H-2, 4), 5.70 (dd, 1H, 
J3,4 = 9.9 Hz, H-3), 6.57 (d, 1H, J1,2 = 3.5 Hz, H-1), 7.20-7.50 (m, 4H, aromatic), 7.44 (d, 
1H, aromatic), 7.21-7.50 (m, 4H, aromatic) ppm; 13C-NMR (75 MHz): δ, 22.7 (x 4), 61.2, 
67.6, 69.3, 69.5, 70.1, 96.7, 110.2, 118.6, 123.6, 124.7, 140.4, 148.4, 161.5, 169.4, 169.9, 
170.1, 170.6; UV: λmax = 273, 279 nm; HR-FAB MS [M+Na]+ calculated for 
C21H23NO11Na+ 488.1168, found 488.1168. 
 
Benzoxazolyl 2,3,4,6-tetra-O-benzyl-α/β-D-glucopyranoside (2.4). 2-
Chlorobenzoxazole (0.20 g, 1.9 mmol) and KOH (0.021 g, 0.37 mmol) were added to a 
stirring solution of 2,3,4,6-tetra-O-benzyl-α/β-D-glucopyranose (2.3, 0.2 g, 0.37 mmol) in 
acetone (4.0 mL) and the resulting mixture was stirred for 3 h at 0 oC. After that, the solid 
was filtered off and washed successively with CH2Cl2. The combined filtrate (~60 mL) 
was washed with water (3 x 20 mL). The organic phase was separated, dried with 
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate – hexanes gradient elution) to obtain the title compound (195 
mg, 80% yield, α/β = 2.5/1) as a colorless syrup. Analytical data for α-2.4: Rf = 0.43 
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(ethyl acetate/hexanes, 1/4, v/v); 1H-NMR (300 MHz): δ, 3.61 (dd, 1H, J5,6a = 1.6 Hz, 
J6a,6b = 11.0 Hz, H-6a), 3.77 (m, 3H, H-2, 4, 6b), 4.00 (m, 1H, H-5), 4.11 (dd, 1H, J3,4 = 
9.4 Hz, H-3), 4.48 (dd, 2H, 2J = 12.0 Hz, CH2Ph), 4.67 (dd, 2H, 2J = 10.7 Hz, CH2Ph), 
4.73 (s, 2H, CH2Ph), 4.90 (dd, 2H, 2J = 10.9 Hz, CH2Ph), 6.47 (d, 1H, J1,2 = 3.3 Hz, H-1), 
7.17-7.31 (m, 24H, aromatic) ppm; 13C-NMR (75 MHz): δ, 68.1, 73.5, 73.7 (x 2), 75.4, 
76.0, 76.8, 79.2, 81.6, 98.8, 110.0, 118.6, 123.2, 124.5, 127.9 (x 2), 128.0 (x 3), 128.1 (x 
4), 128.2 (x 2), 128.6 (x 9), 137.6, 138.0, 138.3, 138.8, 141.0, 148.4, 162.3; UV: λmax = 
270, 276 nm; HR-FAB MS [M+Na]+ calculated for C41H39NO7Na+ 680.2624, found 
680.2624.  
 
Benzoxazolyl 2,3,4,6-tetra-O-benzyl-α-D-mannopyranoside (2.6). 2-
Chlorobenzoxazole (0.056 g, 0.37 mmol) and KOH (0.054 g, 0.96 mmol) were added to a 
stirring solution of 2,3,4,6-tetra-O-benzyl-D-mannopyranose26 (2.5, 0.2 g, 0.37 mmol) in 
acetone (4.0 mL) and the resulting mixture was stirred for 2 h at 0 oC.  After that, the 
solid was filtered off and washed successively with CH2Cl2. The combined filtrate (~60 
mL) was washed with water (3 x 20 mL).  The organic phase was separated, dried with 
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate - hexanes gradient elution) to obtain the title compound (122 
mg, 50 % yield) as a colorless syrup. Analytical data for 2.6: Rf = 0.4 (ethyl 
acetate/hexanes, 1/4, v/v); [α]D21 +36.2 (c= 1.0, CHCl3); 1H-NMR (300 MHz): δ, 3.65 
(dd, 1H, J5,6b =1.8 Hz, J6a,6b = 11.2 Hz, H-6b), 3.74 (dd, 1H, J5,6a = 4.4 Hz, H-6a), 3.90-
3.97 (m, 3H, J3,4 = 9.4 Hz, H-2, 3, 5), 4.09 (dd, 1H, J4,5 = 9.4 Hz, H-4), 4.50 (dd, 2H, 2J = 
12.0 Hz, CH2Ph), 4.54 (dd, 2H, 2J = 11.7 Hz, CH2Ph), 4.65 (dd, 2H, 2J = 10.8 Hz, 
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CH2Ph), 4.74 (dd, 2H, 2J = 12.3 Hz, CH2Ph), , 6.36 (d, 1H, J1,2 = 1.9 Hz, H-1), 7.11-7.51 
(m, 24H, aromatic) ppm; 13C-NMR (75 MHz): δ, 68.90, 72.68, 72.97, 73.51, 73.64, 
74.21, 75.01, 75.36, 79.21, 99.56, 110.04, 118.66, 123.36 (x 2), 124.60 (x 2), 127.66 (x 
2), 127.97 (x 2), 128.03 (x 2), 128.14 (x 2), 128.22 (x 2), 128.47 (x 2), 128.55 (x 2), 
137.89 (x 2), 138.29 (x 2), 138.43 (x 2), 138.47 (x 2), 141.03, 148.54, 161.60; HR-FAB 
MS [M+Na]+ calculated for C41H39NO7Na+ 680.2624, found 680.2626. 
 
3,4,6-Tri-O-acetyl-1,2-O-(1-benzoxazolyloxyethylidene)-α-D-glucopyranose (2.8). A 
mixture of 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide27 (2.7, 0.50 g, 1.2 mmol) 
and freshly activated molecular sieves (3Å, 1.5 g) in dry CH2Cl2 (5.0 mL) was stirred 
under argon for 1 h at rt. After that, AgOBox (2.16, 0.59 g, 2.43 mmol) was added and 
the resulting mixture was stirred for 1.5 h at 40 oC. The solid was filtered off and rinsed 
successively with CH2Cl2. The combined filtrate (~100 mL) was washed with 1% aq. 
NaOH (2 x 40 mL), water (2 x 40 mL), and brine (40 mL). The organic phase was 
separated, dried with MgSO4, and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate-hexanes gradient elution) to afford 
the title compound (447 mg, 79% yield) as a pale-yellow foam. Analytical data for 2.8: Rf 
= 0.5 (ethyl acetate/hexanes, 1/1, v/v); [α]D26 -3.7 (c = 1.0, CHCl3); 1H-NMR (300 MHz): 
δ, 2.08, 2.10, 2.13, 2.15 (4 s, 12H, 4 x COCH3), 4.06 (m, 1H, H-5), 4.25-4.28 (m, 3H, J2,3 
= 2.4 Hz, H-2, 6a, 6b), 4.95 (dd, 1H, J4,5 = 9.5 Hz, H-4), 5.32 (dd, 1H, J3,4 = 2.4 Hz, H-3), 
5.82 (d, 1H, J1,2 = 5.3 Hz, H-1), 7.10-7.47 (m, 4H, aromatic) ppm; 13C-NMR (75 MHz): 
δ, 20.7, 20.8, 20.9, 22.4, 63.0, 67.3, 68.0, 69.3, 73.1, 97.5, 110.2, 111.7, 113.5, 124.0, 
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124.4, 129.4, 142.5, 151.6, 169.0, 169.7, 170.7 ppm; UV: λmax = 274, 280 nm;  HR-FAB 
MS [M+Na]+ calculated for C21H23NO11Na+  488.1168, found 488.1170. 
 
Benzoxazolyl 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranoside (2.10).  A mixture of 
2,3,4,6-tetra-O-benzoyl-α-D-glucopyranosyl bromide29 (2.9, 0.40 g, 0.56 mmol) and 
freshly activated molecular sieves (3Å, 1.2 g) in dry CH2Cl2 (4.0 mL) was stirred under 
argon for 1 h at rt. After that, AgOBox (2.16, 0.20 g, 0.84 mmol), 2,6-lutidine (0.09 g, 
0.84 mmol), and tetrabutylammonium iodide (TBAI, 0.012 g, 0.033 mmol) were added 
and the resulting mixture was stirred for 10 h at rt. The solid was filtered off and rinsed 
successively with CH2Cl2. The combined filtrate (~60 mL) was washed with 1% aq. 
NaOH (2 x 20 mL), water (2 x 20 mL), and brine (20 mL). The organic phase was 
separated, dried with MgSO4, and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate-hexanes gradient elution) to afford 
the title compound (0.36 g, 83% yield) as a pale-yellow amorphous solid. Analytical data 
for 2.10: Rf = 0.46 (ethyl acetate/hexanes, 2/3, v/v); [α]D26 +35.9 (c= 1.0, CHCl3); 1H-
NMR (300 MHz): δ, 4.50 (m, 2H, J5,6a  = 3.2 Hz, H-5, 6a), 4.70 (dd, 1H, J5,6b = 1.5 Hz, 
H-6b), 5.76 (m, 1H, J2,3 = 5.5 Hz, H-2), 5.87 (dd, 1H, J4,5 = 4.6 Hz, H-4), 6.03 (dd, 1H, 
J3,4 = 9.2 Hz, H-3), 6.38 (d, 1H, J1,2 = 7.6 Hz, H-1), 7.15-7.92 (m, 24H, aromatic), ppm; 
13C-NMR: δ, 62.6, 68.9, 70.9, 72.5, 73.4, 98.7, 110.2, 118.5, 123.6 (x 2), 124.6 (x 2), 
128.4 (x 2), 128.4 (x 2), 128.5 (x 4), 128.6, 129.5, 129.8 (x 2), 129.9 (x 4), 130.0 (x 2), 
133.1, 133.5, 133.6 (x 2), 140.4, 148.5, 161.6, 164.9, 165.1, 165.7, 166.1 ppm; HR-FAB 
MS [M+Na]+ calculated for C41H31NO11Na+  736.1795, found 736.1794. 
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Benzoxazolyl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranoside (2.12). A mixture of 
2,3,4,6-tetra-O-benzoyl-α-D-galactopyranosyl bromide30 (2.11, 0.20 g, 0.28 mmol) and 
freshly activated molecular sieves (3Å, 0.6 g) in dry CH2Cl2 (2.0 mL) was stirred under 
argon for 1 h at rt. After that, AgOBox (2.16, 0.10 g, 0.42 mmol), 2,6-lutidine (0.045 g, 
0.42 mmol), TBAI (0.006 g, 0.016 mmol) were added and the resulting mixture was 
stirred for 3 h at rt. The solids were filtered off and rinsed successively with CH2Cl2. The 
combined filtrate (~40 mL) was washed with 1% aq. NaOH (2 x 10 mL), water (2 x 10 
mL), and brine (10 mL). The organic phase was separated, dried with MgSO4, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate-hexanes gradient elution) to afford the title compound (177 mg, 82% yield) 
as a yellow foam. Analytical data for 2.12: Rf  = 0.50 (ethyl acetate/hexanes, 2/3, v/v); 
[α]D26 +81.5 (c = 1.0, CHCl3); 1H-NMR (300 MHz): δ, 4.51 (m, 1H, J5,6a  = 5.2 Hz, J6a,6b = 
9.6 Hz, H-6a), 4.68 (m, 2H, J5,6b = 6.8 Hz, H-5, 6b), 5.78 (dd, 1H, J3,4 = 3.4 Hz, H-3), 
6.14 (m, 2H, J2,3 = 10.2 Hz, H-2, 4), 6.39 (d, 1H, J1,2 = 8.0 Hz, H-1), 7.19-8.13 (m, 24H, 
aromatic), ppm; 13C-NMR (75 MHz): δ, 61.8, 67.7, 68.8, 71.6, 72.6, 99.1, 110.2, 118.5, 
123.6, 124.6, 128.6 (x 6), 128.7, 128.8 (x 4), 129.3, 129.9 (x 4), 129.9 (x 2), 130.1 (x 2), 
133.3, 133.5, 133.6, 133.8, 140.4, 148.5, 161.7, 165.1, 165.5 (x 2), 166.0 ppm; HR-FAB 
MS [M+Na]+ calculated for C41H31NO11Na+  736.1795, found 736.1800. 
 
Benzoxazolyl 2,3,4,6-tetra-O-benzoyl-α-D-mannopyranoside (2.14).  A mixture of 
2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl bromide31 (2.13, 0.20 g, 0.28 mmol) and 
freshly activated molecular sieves (3Å, 0.6 g) in dry CH2Cl2 (2.0 mL) was stirred under 
argon for 1 h at rt. After that, AgOBox (2.16, 0.10 g, 0.42 mmol), 2,6-lutidine (0.045 g, 
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0.42 mmol), and TBAI (0.006 g, 0.016 mmol) were added and the resulting mixture was 
stirred for 1.5 h 45 oC. The solid was filtered off and rinsed successively with CH2Cl2. 
The combined filtrate (~40 mL) was washed with 1% aq. NaOH (2 x 10 mL), water (2 x 
10 mL), and brine (10 mL). The organic phase was separated, dried with MgSO4, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate-hexanes gradient elution) to afford the title compound (175.2 mg, 81% 
yield) as a white foam. Analytical data for 2.14: Rf  = 0.44 (ethyl acetate/hexanes, 3/7, 
v/v); [α]D22 +0.62 (c = 1.0, CHCl3); 1H-NMR (300 MHz): δ, 4.50 (dd, 1H, J5,6a = 4.9 Hz, 
J6a,6b = 12.9 Hz, H-6a), 4.68 (dd, 1H, J5,6b = 2.4 Hz, H-5, 6b), 6.04 (dd, 1H, J2,3 = 2.0 Hz, 
H-2), 6.09 (dd, 1H, J3.4 = 10.0 Hz, H-3), 6.25 (dd, 1H, J4,5 = 9.9 Hz, H-4), 6.64 (d, 1H, 
J1,2 = 1.9 Hz, H-1), 7.25-8.08 (m, 24H, aromatic), ppm; 13C-NMR (75 MHz): δ, 62.3, 
66.0, 68.8, 69.4, 71.3, 97.7, 110.1, 118.9, 123.7, 124.7, 128.4 (x 3), 128.6 (x 3), 128.7 (x 
3), 128.8 (x 2), 129.7, 129.7 (x 2), 129.8 (x 2), 129.9 (x 2), 130.0 (x 2), 133.1, 133.5, 
133.7, 133.8, 140.5, 148.6, 160.8, 165.1, 165.3, 165.5, 166.0 ppm; HR-FAB MS 
[M+Na]+ calculated for C41H31NO11Na+  736.1795, found 736.1769.  
 
2,3,4,6-Tetra-O-benzoyl-α-D-glucopyranosyl trichloroacetimidate (2.44). This 
compound was obtained from 2,3,4,6-tetra-O-benzoyl-α/β-D-glucopyranose57 by method 
previously described58 in 83% yield as a white foam.  Analytical data for 2.44: Rf = 0.44 
(ethyl acetate/hexanes, 3/7, v/v); [α]D27 +76.6 (c= 1.0, CHCl3); 1H-NMR (300 MHz): δ, 
4.49 (dd, 1H, J5,6a = 5.4 Hz, J6a,6b = 12.8 Hz, H-6a), 4.64 (m, 2H, J5,6b = 2.6 Hz, H-5, 6b), 
5.62 (dd, 1H, J2,3 = 9.8 Hz, H-2), 5.83 (dd, 1H, J4,5 = 9.8 Hz, H-4), 6.28 (dd, 1H, J3,4 = 
9.8  Hz, H-3), 6.84 (d, 1H, J1,2 = 3.7 Hz, H-1), 7.26-8.17 (m, 20H, aromatic), 8.64 (s, 1H, 
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-NH) ppm; 13C-NMR (75 MHz): δ, 62.7, 68.8, 70.4, 70.9, 90.9, 93.3, 128.6 (x 5), 128.7 
(x 5), 128.8 (x 1), 129.0, 129.7, 129.9 (x 2), 130.0 (x 5), 133.4, 133.5, 133.8 (x 2), 160.7, 
165.4, 165.6, 165.9, 166.3; HR-FAB MS [M+Na]+ calculated for C36H28Cl3NO10Na+ 
762.0676, found 762.0671. 
 
2.4.3.  General glycosylation procedures 
Method A. Typical MeOTf-promoted glycosylation procedure: A mixture of glycosyl 
donor (0.13 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular 
sieves (3 Å, 90 mg) in 1,2-dichloroethane (0.5 mL) was stirred under argon for 1 h at rt. 
The mixture was cooled to -20 oC, MeOTf (0.013 mmol) was added and the resulting 
mixture was stirred for 15 min. The solids were filtered off through a pad of Celite and 
rinsed successively with CH2Cl2. The combined filtrate (~30 mL) was washed with 1% 
aq. NaOH (2 x 5 mL) and water (2 x 5 mL). The organic phase was separated, dried with 
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate - hexanes gradient elution) to obtain the respective 
disaccharide in a yield listed in Table 2.3.  
 
Method B. Typical TfOH-promoted glycosylation procedure: A mixture of glycosyl 
donor (0.13 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular 
sieves (4 Å, 90 mg) in 1,2-dichloroethane (0.5 mL) was stirred under argon for 1 h at rt. 
The mixture was cooled to -20 oC, TfOH (0.013 mmol) was added and the resulting 
mixture was stirred for 10 min. The solids were filtered off through a pad of Celite and 
rinsed successively with CH2Cl2. The combined filtrate (~30 mL) was washed with 1% 
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aq. NaOH (2 x 5 mL) and water (2 x 5 mL). The organic phase was separated, dried with 
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate - hexanes gradient elution) to obtain the respective 
disaccharide in a yield listed in Table 2.3.  
 
Method C. Typical TMSOTf-promoted glycosylation procedure: A mixture of glycosyl 
donor (0.12 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular 
sieves (4Å, 90 mg) in 1,2-dichloroethane (0.5 mL) was stirred under argon for 1 h at rt. 
On most occasions (see Table 2.3) the mixture was cooled to -78 oC, TMSOTf (0.012 
mmol) was added and the resulting mixture was stirred for 5-15 min. The solids were 
filtered off through a pad of Celite and rinsed successively with CH2Cl2. The combined 
filtrate (~30 mL) was washed with 1% aq. NaOH (2 x 5 mL) and water (2 x 5 mL). The 
organic phase was separated, dried with MgSO4, and concentrated in vacuo. The residue 
was purified by column chromatography on silica gel (ethyl acetate - hexanes gradient 
elution) to obtain the respective disaccharide in a yield listed in Table 2.3.  
 
Method D. Typical SnCl4-promoted glycosylation procedure: A mixture of glycosyl 
donor (0.12 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular 
sieves (4 Å, 90 mg) in 1,2-dichloroethane (0.5 mL) was stirred under argon for 1 h at rt. 
After that, SnCl4 (0.012 mmol) was added and the resulting mixture was stirred for 5-15 
min at rt (Table 2.3). The solids were filtered off through a pad of Celite and rinsed 
successively with CH2Cl2. The combined filtrate (~30 mL) was washed with 1% aq. 
NaOH (2 x 5 mL) and water (2 x 5 mL). The organic phase was separated, dried with 
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MgSO4, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate - hexane gradient elution) to obtain the respective disaccharide 
in a yield listed in Table 2.4.  
 
2.4.4.  General procedures for competitive glycosylations 
Method E. Typical Cu(OTf)2-promoted glycosylation procedure: A mixture of glycosyl 
donor A (0.12 mmol), glycosyl donor B (0.12 mmol), glycosyl acceptor (0.10 mmol), and 
freshly activated molecular sieves (4Å, 90 mg) in 1,2-dichloroethane (0.5 mL) was stirred 
under argon for 1 h at rt. After that, Cu(OTf)2 (0.012 mmol) was added and the resulting 
mixture was stirred for 5 min. The solids were filtered off through a pad of Celite and 
rinsed successively with CH2Cl2. The combined filtrate (~30 mL) was washed with 1% 
aq. NaOH (2 x 5 mL) and water (2 x 5 mL). The organic phase was separated, dried with 
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate - hexane gradient elution) to obtain the respective disaccharide 
in a yield listed in Table 2.5.  
 
Method F. Typical AgOTf-promoted glycosylation procedure: A mixture of glycosyl 
donor A (0.12 mmol), glycosyl donor B (0.12 mmol), glycosyl acceptor (0.10 mmol), and 
freshly activated molecular sieves (4Å, 90 mg) in 1,2-dichloroethane (0.5 mL) was stirred 
under argon for 1 h at rt. After that, AgOTf (0.012 mmol) was added and the resulting 
mixture was stirred for 10 min. The solids were filtered off through a pad of Celite and 
rinsed successively with CH2Cl2. The combined filtrate (~30 mL) was washed with 1% 
aq. NaOH (2 x 5 mL) and water (2 x 5 mL). The organic phase was separated, dried with 
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MgSO4, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate - hexane gradient elution) to obtain the respective disaccharide 
in a yield listed in Table 2.5.  
 
Method G. Typical Bi(OTf)3-promoted glycosylation procedure: A mixture of glycosyl 
donor A (0.12 mmol), glycosyl donor B (0.12 mmol), glycosyl acceptor (0.10 mmol), and 
freshly activated molecular sieves (4Å, 90 mg) in 1,2-dichloroethane (0.5 mL) was stirred 
under argon for 1 h at rt. After that, Bi(OTf)3 (0.004 mmol) was added and the resulting 
mixture was stirred for 10 min. The solids were filtered off through a pad of Celite and 
rinsed successively with CH2Cl2. The combined filtrate (~30 mL) was washed with 1% 
aq. NaOH (2 x 5 mL) and water (2 x 5 mL). The organic phase was separated, dried with 
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate - hexane gradient elution) to obtain the respective disaccharide 
in a yield listed in Table 2.5.  
 
2.4.5.  HPLC-mediated synthesis of disaccharide 40  
General procedure for HPLC-mediated glycosylation of 2.46 with glycosyl donor 2.10. 
A solution of glycosyl donor 10 (78.5 mg, 0.11 mmol, pump A, percentage flow: 80%) in 
CH2Cl2 (5.0 mL) and a solution of TMSOTf (11 μL, 0.055 mmol, pump B, percentage 
flow: 20%) in CH2Cl2 (2.0 mL) were passed concomitantly through a column containing 
resin-bound acceptor (50 mg, 0.011 mmol) at the combined flow rate of 0.3 mL min−1 
for 20 min. The pump A was then switched to pump C (recirculating chamber, percentage 
flow: 80%) while pump B remained the same (TMSOTf soln., percentage flow: 20%) and 
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the resulting solutions were passed concomitantly through a column with the combined 
flow rate of 0.3 mL min−1 for 10 min. After that, the system was switched to pump C 
(recirculating chamber, percentage flow 100%) and the solution was recirculated at a 
flow rate of 0.3 mL min−1 for 1 h. Pump C was stopped and the column was purged with 
CH2Cl2 (pump A, 2.0 mL min−1) for 10 min.  
 
Procedure for cleavage of sugar from resin. A 1 M solution of sodium methoxide in 
methanol (0.3 mL) was added to a suspension or a mixture of resin in methanol (2.0 mL) 
and the resulting mixture was kept for 24 h at rt. After that, the reaction mixture was 
neutralized with Dowex H+ resin. The resin was filtered off and rinsed successively with 
MeOH (10 × 5 mL). The combined filtrate (∼50 mL) was separated, dried with MgSO4, 
concentrated in vacuo, and dried. The crude product obtained from this step was then 
acetylated according to the procedure described below. 
 
Acetylation of the crude product. Ac2O (0.3 mL) was added to a solution of the crude 
deacylated product (∼19.7 mg, 0.0079 mmol) in pyridine (0.5 mL) and the resulting 
mixture was stirred under argon for 16 h at rt. The reaction mixture was quenched by the 
addition of CH3OH (∼1.0 mL). The volatiles were evaporated under reduced pressure 
and the residue was co-evaporated with toluene (3 × 5 mL). The resulting residue was 
purified by column chromatography on silica gel (ethyl acetate–hexanes gradient elution) 
to afford the corresponding disaccharide 2.47 in 79% yield. 
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3.1.  Introduction 
Practically all complex carbohydrates have an oligomeric sequence wherein 
monosaccharide residues are linked via glycosidic linkages.1 Both simple methods and 
sophisticated strategies for glycoside synthesis and oligosaccharide assembly exist.2,3 
However, the complexity of glycosylation reactions4-7 is responsible for many drawbacks 
that all current methods experience. In spite of significant progress, chemical 
glycosylation remains challenging due to the requirement to achieve complete 
stereocontrol and to suppress side reactions.8 Amongst a plethora of leaving groups 
developed, a vast majority of glycosylations make use of thioglycosides9-12 and O-
trichloroacetimidates (TCAI).13-15 Our laboratory has also been developing new leaving 
groups for chemical glycosylation.16,17 For instance, we developed S-benzoxazolyl 
(SBox) donors18 and more recently introduced O-benzoxazolyl (OBox) imidates,19 which 
represent a hybrid structure between SBox and TCAI (Scheme 1), but it is more reactive 
than either.  
Scheme 3.1.  O-Imidates, established and new. 
 
 
Since the early days, stereoselective formation of glycosidic linkages has been the main 
challenge and the driving force for innovations in the area of carbohydrate chemistry. 
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Among a plethora of methods developed, glycosyl trichloroacetimidates (TCAI) 
introduced by Schmidt in 1980,20 exhibit excellent glycosyl donor properties and often 
lead to high stereocontrol during glycosidation.2 Despite their usefulness as glycosyl 
donors, the high reactivity and poor stability sometimes result in low yields during 
preparation, isolation, and glycosidation with TCAI.13-15,21,22 As a modification to this 
approach, Yu reported glycosyl N-phenyl trifluoroacetimidates (PTFAI) as a new class of 
glycosyl donors.23,24 Practically at the same time, Iadonisi and co-workers also reported 
the use of PTFAI as glycosyl donors.25,26 These O-imidates showed similar properties in 
terms of their reactivity in glycosylations, but also showed improved stability and higher 
reaction yields in comparison to those with TCAI.27  
 As described in Chapter 2, we introduced O-benzoxazolyl (OBox) imidates that also 
fall into this generic category of O-imidoyl glycosyl donors. 19 OBox imidates showed 
higher reactivity profile than similarly structured TCAI counterparts. However it lacked 
stability, which complicated its handling and reduced its shelf-life. Thus, with an aim of 
expanding the arsenal of heterocyclic O-imidates with enhanced glycosyl donor 
properties, herein we describe the investigation of novel 3,3-difluoro-3H-indol-2-yl 
(OFox) imidates.  
 
3.2.  Results and discussion 
3.2.1.  The synthesis of OFox glycosides 
3,3-Difluoroxindole aglycone (HOFox) was readily synthesized by reacting 
commercially available Isatin with a slight excess of DAST in anhydrous CH2Cl2 at room 
temperature.28 The 3,3-difluoroxindole group was then introduced at the anomeric 
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position by reaction of HOFox with different glycosyl halides (X = Br, Cl), used either 
directly or obtained in situ from the corresponding hemiacetals or esters, as suitable 
starting materials (Table 3.1). It was observed that almost all anomeric substitutions 
proceeded stereoselectively providing corresponding 1,2-trans or 1,2-cis-linked OFox 
imidates in 60-85% yields. Additionally, the synthesis of OFox glycosides was free of 
side reactions such as formation of N-glycosides or 1,2-dehydro derivatives (glycals).29 
As starting materials, a series of differentially protected glucosyl halides bearing arming 
(3.1), disarming (3.7, 3.9), and superdisarming (3.5) protecting group patterns have been 
investigated.  The synthesis of common D-galacto (3.12), D-manno (3.4 and 3.14) and 
azido (3.14) OFox glycosyl donors was also performed. The formation of OFox imidates 
was confirmed by changes in the 19F values from -112.4 ppm for 3,3-difluoro-2-oxindole 
to -121 to -122 ppm for the coupled product.30  
 
3.2.2. Comparative investigation of O-imidates 3.2, 3.17 and 3.18 
After synthesizing a variety of OFox imidates, we turned our focus to studying their 
properties in glycosylation reactions and stability under various acidic reaction 
conditions. These studies of OFox glycosyl donors were conducted as a comparison with 
similarly protected TCAI and PTFAI. It has been previously demonstrated that the 
activation of TCAI and PTFAI donors can be accomplished in the presence of the 
catalytic amount of promoters including TMSOTf,21 BF3OEt2,15 p-TsOH,20 Bi(OTf)3,31 
Yb(OTf)3,32 Sm(OTf)3,32 and AgOTf33 Among these, TMSOTf and BF3-OEt2 are 
arguably the most commonly used promoters. Hence our initial focus has been centered 
on examining the effect of these activators on OFox glycosides.   
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Table 3.1.  Synthesis of 3,3-difluoro-3H-indol-2-yl (OFox) imidates 
 
Entry Starting material 
Conditions,a 
temp, time Product Yield, α/β ratio 
1 A, rt, 8 h 
 
62%, 10/1 
2 A, rt, 12 h 
 
61%, α only 
3 
 
B, 0 oC, 40 min 
 
80%, β only 
4 3.5 B, rt, 5 h 
 
81%, α only 
5 
 
C, rt, 6 h 
 
80%, α only 
6 
 
B, rt, 10 h 
 
75%, α only 
7 D, 0 
oC to rt, 6 
h 
 
75%, β only 
8 
 
D, rt, 2.5 h 
 
84%, α only 
9 
 
B, 0 oC to rt, 3 
h 
 
70%, β only 
 
a – Conditions: A: i) SOCl2, DMF, CH2Cl2, ii) 3,3-difluoroxindole, Ag2O, DIPEA, 
CH2Cl2; B: 3,3-difluoroxindole, Ag2O, DIPEA, CH2Cl2; C: 3,3-difluoroxindole, Ag2O, 
DIPEA, toluene; D: i) 33% HBr/AcOH, CH2Cl2, ii) 3,3-difluoroxindole, Ag2O, DIPEA, 
CH2Cl2. 
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A comparative study of different O-imidates as glycosyl donors in TMSOTf-promoted 
glycosylations is summarized in Table 3.2. Thus, coupling of glycosyl donors 3.2, 3.16, 
3.17 with acceptor 3.18 produced disaccharide 3.19 in 5 min either at -78 oC or ambient 
temperature in comparable yields and stereoselectivities. Similar results were obtained in 
BF3-OEt2 promoted glycosylations. A further exploratory study of OFox imidates 
dedicated to investigating various factors that affect stereoselectivity and reactivity of 
these glycosyl donors was conducted and will be described in the following subchapter.  
Table 3.2.  Comparative investigation of glycosylations with O-imidates 3.2, 3.17, 
and 3.18 in the presence of TMSOTf 
 
Entry Donor Temp Yield of 3.20 Ratio, α/β 
1 3.17 -78 oC 92% 1/15 
2 3.17 rt 94% 4.0/1 
3 3.18 -78 oC 70% 1/4.4 
4 3.18 rt 91% 1/2.2 
5 3.2 -78 oC 94% 1/24 
6 3.2 rt 93% 1/1.2 
 
For conducting the comparative hydrolytic stability studies, per-benzoylated OFox 
glycosyl donor 3.10 was compared with 2,3,4,6-tetra-O-benzoyl-α-D-glucopyranosyl 
trichloroacetimidate 3.21 and 2,3,4,6-tetra-O-benzoyl-α,β-D-glucopyranosyl N-
phenyltrifluoroacetimidate 3.22. These studies summarized in Table 3.3 were performed 
in the presence of various Lewis acids in wet ClCH2CH2Cl.  A mixture of imidate (3.10, 
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3.21, or 3.22, 0.01 mmol), activator (conditions A-D, 0.013 mmol, Table 3.3) in 
ClCH2CH2Cl/H2O (0.5 mL, 500/1, v/v) was stirred for 24 h at rt. Quantitative estimates 
were made at 1, 16 and 24 h time points and are based on the accumulation of 2,3,4,6-
tetra-O-benzoyl-D-glucopyranose 3.23, as observed by TLC (Rf = 0.45, ethyl 
acetate/hexanes, 3/7, v/v). Among these, the first procedure involved hydrolysis in the 
presence of BF3-OEt2 as the activator (Table 3.3, entries 1-3).  
Table 3.3.  Comparative hydrolytic stability study of OFox imidates, TCAI, and 
PTFAI under various reaction conditions. 
 
Entry Donor Conditionsa % of hemiacetal 3.23 formed after           1 h                   16 h                24 h 
1 3.10 A quant. quant. quant. 
2 3.21 A 50 60 60 
3 3.22 A 40 50 50 
4 3.10 B 0 0 0 
5 3.21 B 0 0 0 
6 3.22 B 0 0 0 
7 3.10 C 0 quant. quant. 
8 3.21 C 0 0 20 
9 3.22 C 0 0 0 
10 3.10 D 0 0 50 
11 3.21 D 0 10 quant. 
12 3.22 D 0 70 quant. 
a Conditions: A: BF3-OEt2 (0.1 equiv.); B: Bi(OTf)3 (0.1equiv.); C: MeOTf (1.0 equiv.);  
D: PdCl2 (0.1 equiv.)  
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Under these reaction conditions, OFox imidate 3.10 underwent a nearly quantitative 
hydrolysis in 5 min, whereas their TCAI (3.21) PTFAI (3.22) counterparts showed 50% 
and 40% hydrolysis, respectively, in 5 min or even after 24 h of reaction. Yields listed in 
Table 3.3 are estimated based on TLC.  On the other hand, practically no hydrolysis in 
cases of all three imidates took place in the presence of Bi(OTf)3 (0.1 equiv., entries 4-6). 
In a similar series of experiments, we determined that PTFAI 3.22 could be reliably 
differentiated from the OFox donor 3.10 and TCAI counterpart 3.21 under MeOTf-
mediated activation conditions (entries 7-9). Conversely, we found out that PdCl2 
mediated reactions OFox donor 3.10 and TCAI donor 3.21 are more stable than their 
PTFAI counterpart 3.22 (entries 12-14). 
 
3.2.4.  Glycosidation of OFox donors: optimization of the reaction conditions 
Encouraged by the observed selectivity and overall high reactivity of OFox imidates, 
we planned on exploring the effect of different experimental conditions and factors 
including the structure of glycosyl donor, glycosyl acceptor, activator, solvent, and 
temperature on the reaction outcome.  
The effect of solvents on the stereoselectivity of glycosidation has been studied for a 
long time and resulted in a good level of understanding of the modes by which solvents 
may affect the reaction. For instance, it has been shown that nitrilic solvents strongly 
favor the formation of equatorial (β-D) glycosides, whereas ethereal solvents are often 
beneficial for the synthesis of axial (α-D) glycosides. With the exploration of the solvent 
effect on the stereoselectivity of glycosidation of OFox donors in mind, glycosylation in 
CH2Cl2 was chosen as the benchmark. Along this study, we also investigated the 
temperature effect of glycosylation with OFox imidates with the anticipation that low 
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temperatures will favor the equatorial (kinetic) product, whereas high temperature would 
be beneficial for axial (thermodynamic) product.   
Thus, glycosylation of 3,3-difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-benzyl-α/β-D-
glucopyranoside 3.2 with glycosyl acceptor 3.19 was performed in the presence of 
TMSOTf (5 mol %) at -40 oC. Resultantly, disaccharide 3.20 was obtained in 97% yield 
and good β-selectivity (α/β = 1/8.0, entry 1, Table 3.4). A notable improvement of 
already commendable β-selectivity was achieved by changing the reaction solvent from 
CH2Cl2 to CH3CN. Under these reaction conditions disaccharide 3.20 was obtained in 
87% yield (α/β = 1/14, entry 2). Interestingly, when a solvent mixture of CH2Cl2/CH3CN 
(1/2, v/v) was used a decrease in stereoselectivity was recorded (α/β = 1/6.0, entry 3).  
Table 3.4.  The effect of solvents and temperature on the stereoselectivity of 
glycosidation of per-benzylated OFox donor 3.2. 
 
Entry Solvent Temp Yield of 3.20 α/β ratio
1 CH2Cl2 -40 oC 97% 1/8.0 
2 CH3CN -40 oC 87% 1/14 
3 CH2Cl2/CH3CN (1/2, v/v) -40 
oC 96% 1/6.0 
4 CH2Cl2 -78 oC 94% 1/24 
5 CH2Cl2/CH3CN/EtCN (1/2/1, v/v/v) -78 oC 99% β only 
6 EtCN -78 oC 99% β only 
7 Et2O -78 oC 84% 1/5.0 
8 Et2O 50 oC 81% 1.6/1 
9 THF 50 oC 79% 1.4/1 
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The use of acetonitrile as the reaction solvent has its limitations because the reactions 
cannot be cooled below -40 oC. Therefore, to achieve direct comparison of excellent β-
selectivity (α/β = 1/24, entry 4) obtained in CH2Cl2 at -78 oC we incorporated 
propionitrile (EtCN) in our study.  To our delight, when MeCN was used either as an 
additive or neat, disaccharide 3.20 was obtained in a nearly quantitative yield and 
complete β-stereoselectivity (entries 5 and 6). Along similar lines, the effect of diethyl 
ether as the reaction solvent was also investigated. Since diethyl ether favors the 
formation of α-glucosides, we observed dramatically reduced β-stereoselectivity in 
reactions at -78 oC (α/β = 1/5.0, entry 7). The same reaction performed at higher 
temperatures of 50 oC, gave disaccharide 3.20 with preferential α-stereoselectivity. (α/β = 
1.6/1, entry 7). Similar results were obtained using THF as the reaction solvent. 
A result of this study confirmed that OFox imidates adequately respond to the solvent 
and temperature effects.  A similar trend to that established for other classes of glycosyl 
donors was also observed herein. As an expansion of this study we investigated whether 
different Lewis acid activators would provide further enhancement of the OFox based 
glycosylation method. A valuable insight into the mode of activation and departure of the 
OFox leaving group would be another anticipated outcome of this study. A majority of 
leaving groups in carbohydrate chemistry, even the most reactive ones, would not depart 
on their own. Instead, the leaving group departure is typically affected via the interaction 
with electrophilic promoters.  Resultantly, the leaving group ability is further enhanced 
and it departs as neutral species or a complex.  For the glycosyl imidate series, the 
activation can be affected directly, via the anomeric atom (oxygen or sulfur), or remotely, 
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via the nitrogen atom (Figure 3.1). For instance, it has become common knowledge that 
TCAI donors are activated via the remote nitrogen.  
Figure 3.1.  Direct vs. remote activation of S- and O-imidates. 
 
 
In principle, the activation mode can be determined by means of isolation and 
characterization of the departed aglycone that represents the leaving group-promoter 
conjugate.  As previously shown in our laboratory, S-thiazolinyl donors are activated via 
the remote nitrogen.34 In strong contrast, bicyclic leaving groups SBox or OBox are 
activated via the anomeric sulfur or oxygen atom, respectively (Figure 3.1).35  This is due 
to the propensity of the benzoxazolyl group to retain the aromaticity of its heterocyclic 
ring, which otherwise would have been disrupted if the activation were taking place via 
the endocyclic nitrogen. In regards to the OFox imidates, the five-membered ring is non-
aromatic, therefore, our working hypothesis was that the activation of the OFox leaving 
group is affected via the remote nitrogen. Further experiments were dedicated to studying 
various activators, designed with proving the viability of this hypothesis. However, since 
all the reactions were done in 5-10 min in the presence of only catalytic amount of the 
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promoter, the isolation of the departed leaving group as an elusive OFox-promoter 
conjugate was proven impossible. Instead, only “free” HOFox could be isolated from the 
reaction medium because the departed aglycone would release the activator. The latter 
would be then available for the next catalytic cycle. 
A study dedicated to the activation of OFox imidate 3.2 using common promoters for 
the activation of imidate donors is summarized in Table 3.5. Glycosylations using 
TMSOTf as the promoter have been used as the benchmark (entries 1 and 2). Using BF3-
OEt2, Cu(OTf)2 or MeOTf as promoters gave very comparable results (entries 3-5) to 
those achieved with TMSOTf. All of these reactions proceeded with a nearly complete β-
selectivity for the formation of disaccharide 3.20, which is rather unusual for benzylated 
glycosyl donors.  
Table 3.5.  The effect of promoter on the stereoselectivity of glycosidation of per-
benzylated OFox donor 3.2 with acceptor 3.19 
Entry Promoter (equiv.) Temp, time Yield of 3.20 α/β ratio 
1 TMSOTf (0.05 equiv.) -78 oC, 5 min 94% 1/24 
2 TMSOTf (0.05 equiv.)a -78 oC, 10 min 84% 1/5.0 
3 BF3-OEt2 (0.1 equiv.) -78 oC, 5 min 93% 1/20 
4 Cu(OTf)2 (0.2 equiv.) -78 oC, 5 min 97% β only 
5 MeOTf (0.2 equiv.) -78 oC, 10 min 91% 1/>25 
6 AgOTf (0.5 equiv.) rt, 24 h 71% 1/1.6 
7 PdCl2 (0.3 equiv.) rt, 36 h 57% 1/1.7 
8 Bi(OTf)3 (0.1 equiv.) -78 oC, 5 min 85% 1/7 
9 TMSClO4 (0.1 equiv.)a rt, 5 min 75% 5.0/1 
10 TMSClO4 (0.1 equiv.)b rt, 5 min 54% 6.2/1 
a -  Et2O was used as the reaction solvent 
b - A mixture of Et2O/1,4-dioxane (1/1, v/v) was used as the reaction solvent 
 
When metal salt-based promoters AgOTf or PdCl2 were used, the reactions became 
much slower, did not proceed to completion even in 24-36 h, and stereoselectivity also 
dropped (entries 6 and 7). Bi(OTf)3-promoted reactions were swift (entry 8), but the 
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stereoselectivity has dropped in all cases of metal promoter-based activations. As a result 
of the preliminary screening of reaction conditions; we conclude that reactions in the 
presence of 5 mol % of TMSOTf in either CH2Cl2 or EtCN at -78 oC were found to be the 
most effective for β-glycosidation of OFox imidate 3.2. 
Having obtained high, and rather unexpected, levels of β-selectivity in glycosylations 
with OFox imidates, we were curious to investigate whether by changing the activation 
conditions, OFox glycosides could provide α-selectivity. For this purpose we chose 
trimethylsilyl perchlorate (TMSClO4) as an activator because our recent study dedicated 
to the effect of the counter anion on the stereoselectivity showed that perchlorates 
typically outperform other counter ions and provide superior α-selectivity. To further 
shift the selectivity towards α-linked products, TMSClO4 was used in cooperation with 
ethereal solvents that are known to favor axially substituted products. Thus, reaction in 
diethyl ether gave disaccharide 3.20 in 75% yield in good α-selectivity (α/β = 5.0/1, entry 
9). The stereoselectivity was further improved when diethyl ether/1,4-dioxane (1/1, v/v) 
was used as a solvent mixture (α/β = 6.2/1, entry 10)   
With the most favorable reaction conditions for glycosidation of the OFox donors, we 
were bound to extend the scope of this procedure to glycosylation of various glycosyl 
acceptors ranging from highly reactive primary alcohols to sterically hindered and less 
reactive or sterically hindered secondary alcohols. The result of this study is summarized 
in Table 3.6. As aforementioned, glycosidation of donor 3.2 with primary acceptor 3.19 
gave glycoside 3.20 in a nearly quantitative yield and complete β-selectivity using either 
CH2Cl2 or EtCN reaction solvent (entries 1 and 2). Glycosidation of donor 3.2 with 2-
propanol 3.26 was also quite selective and gave glycoside 3.27 in 77% yield and  
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Table 3.6.  TMSOTf-promoted glycosidation of OFox donor 3.2 with different 
acceptors in CH2Cl2 or EtCN at -78 oC 
 
Entry Acceptor Solvent Product Yieldb α/β ratioc 
1 3.19 CH2Cl2 94% 1/24 
2 3.19 EtCN 3.20 99% β only 
3 2-propanol 3.26 EtCN 77% β only 
4 
 
CH2Cl2 89% 1/11 
5 3.28 EtCN 3.29 87% 1/18 
6 
 
CH2Cl2 
 
85% 1/12 
7 3.30 EtCN 3.31 89% β only 
8 
 
CH2Cl2 94% 1/4.0 
9 3.32 EtCN 3.33 92% 1/12 
10 
 
CH2Cl2 90% 1/6.0 
11 3.24 EtCN 3.25 88% 1/15 
12 
 
CH2Cl2 86% β-only 
13 
 
CH2Cl2 88% 1/23 
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complete β-selectivity (entry 3). Along similar lines, glycosylations with other primary 
acceptors 3.28 and 3.30 provided similar results, and afforded the corresponding 
disaccharides 3.29 and 3.31 in good yields and high 1,2-trans selectivity (up to α/β = 
1/18, entries 4-7).  On the other hand, reactions with secondary acceptors 3.32 and 3.34 
showed somewhat lower selectivity for the synthesis of disaccharides 3.33 and 3.35 (up 
to α/β = 1/15, entries 8-11). Glycosylations with sterically hindered alcohols, cholesterol 
3.34 and adamantanol 3.36, proceeded smoothly generating the desired glycosides 3.35 
and adamantanol 3.37 in good yields and nearly complete 1,2-trans stereoselectivity 
(entries 12 and 13). These glycosylations indicate that OFox glycosyl donors can be used 
to obtain β-linked glycosides in high yields and selectivities. It is noteworthy that the 
high β-selectivity obtained from glycosyl donors without the neighboring participating 
acyl group is relatively rare.  
With success in achieving excellent glycosylation yields and 1,2-trans stereoselectivity 
using per-O-benzylated (armed) OFox imidate donor 3.2, we turned our attention to 
studying their expectedly less reactive acylated counterparts. It should be noted that 
glycosyl donors of this class would provide an even more straightforward access to 1,2-
trans-linked products. As discussed in the previous Chapter, the presence of acyl 
substituents provides a disarming effect thereby substantially reducing the reactivity of 
acylated glycosyl donors. However, as in case with OBox glycosides, even acylated 
OFox imidates showed similar level of reactivity to that observed with their per-
benzylated counterparts.  
Starting with per-acetylated donor 3.8, in the reaction with acceptor 3.19 in the 
presence of TMSOTf we observed very low yields for the formation of 3.38 due to high  
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Table 3.7.  Glycosylation with per-acylated glucosyl, galactosyl, and mannosyl OFox 
donors in CH2Cl2 with TMSOTf as a promoter at rt. 
Entry Donor Acceptor Product Yield 
1a 
 
3.19 
 
80% 
2 3.19 
 
94% 
3 3.10 3.30 
 
86% 
4 3.10 3.32 
 
90% 
5 3.10 3.24 
 
93% 
6 
 
3.19 98% 
7 3.12 3.32 
 
98% 
9 
 
3.19 
 
93% 
10 3.14 3.32 
 
90% 
a – SnCl4 was used as a promoter to prevent acetyl migration to the C-6 of acceptor that 
was observed in the presence of TMSOTf. 
 
rates of the competing acetyl migration to the C-6 of the glycosyl acceptor. Interestingly, 
we were able to overcome this issue by performing essentially the same glycosylation 
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reaction using SnCl4 as an activator. As a result of this experiment, disaccharide 3.38 was 
obtained in 80% with very minimal impact from the acetyl migration (Table 3.7, entry 1). 
Nevertheless, to avoid complications related to possible competing acetyl migration, 
further study was conducted with per-benzoylated OFox imidates of the D-gluco, D-
galacto, and D-manno series (3.10, 3.12, and 3.14, respectively) using glycosyl acceptors 
3.19, 3.30, 3.32, and 3.24.  All these glycosylations proceeded smoothly giving excellent 
yields and complete 1,2-trans stereoselectivity (entries 2-10).  
Since per-benzylated OFox donor 3.2 was generally β-selective, in the expansion of our 
studies to obtaining 1,2-cis glycosides we wanted to investigate whether OFox imidates 
with the superdisarming 2-O-benzyl-3,4,6-tri-O-acyl protecting group pattern would be 
beneficial for the synthesis of α-glucosides.  For this purpose we obtained OFox imidate 
3.6, which was subjected to comparative glycosylations along with the standard 
perbenzylated OFox donor 3.2. Alongside, we wanted to look into the possible effect of 
the anomeric group orientation on the stereoselectivity of glycosylations. For this 
purpose, we obtained α-3.6 and β-3.6 and glycosylations were performed with primary 
and secondary acceptors 3.19 and 3.24. The result of this study is summarized in Table 
3.8. Thus, perbenzylated OFox donor 3.2 (α/β = 10/1) gave essentially the same result as 
that obtained with α-3.2. In both cases, disaccharide 3.20 was obtained with excellent 
selectivity of α/β = 1/24. Even more dramatic result was obtained with the superdisarmed 
glycosyl donor 3.6.  Thus, both α-3.2 and β-3.2 provided the corresponding disaccharide 
3.25 in practically identical yield of 88-89% and complete α-stereoselectivity. As a result 
of this study, we conclude that irrespective of the orientation of the OFox group of the 
glycosyl donor, complete 1,2-cis stereoselectivity was achieved in all reactions.  
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Table 3.8.  The effect of anomeric configuration on the stereoselectivity of 
glycosidation of OFox donors 3.2 and 3.6 
O
OR
RO
RO
BnO
OFox
3.2: R = Bn
3.6: R = Ac
O
OH
BnO
BnO
BnOOMe
TMSOTf (10 mol %)
molec. sieve 4Å
CH2Cl2
OMe
O
BnO
O
BnO
BnO
O
BnO
BnO
BnO
BnO
3.19
+
O
OBn
BnO
BnO
HOOMe3.24
3.20
O
AcO
OAc
AcO
BnO
OMeO
O
BnOOBn
OBn3.25  
Entry Donor Acceptor Temp, time Product, yield, % α/β ratio
1 3.2 (α/β = 10/1) 3.19 -78 oC, 5min 3.20, 94 1/24 
2 α-3.2  3.19 -78 oC, 5min 3.20, 98 1/24 
3 α-3.6  3.24 rt, 15min 3.25, 88 α only 
4 β-3.6 3.24 rt, 15min 3.25, 89 α only 
 
3.3. Regenerative glycosylation  
While developing the new class of O-imidates we noticed a feature of the OFox 
leaving group that differentiates it from all others. The aglycone structure needed to 
introduce OFox and that of the departed leaving group are essentially the same cyclic 
amide 3,3-difluoroxindole (HOFox).28,36 The significance of this observation is that, in 
principle, one should be able to conduct both the introduction and activation of this 
leaving group in the catalytic “donor-regenerative” fashion, which is routinely done in 
enzymatic glycosylations,37,38 but represents a new direction in the field of chemical 
glycosylation.  
Having established basic principles of the synthesis and activation of OFox imidates, 
we turned our attention to the investigation of the regenerative glycosylation, a concept 
that sets OFox donors apart from other known methods for glycosylation.  Both TCAI 
and PTFAI are obtained from hemiacetal precursors, using cheap trichloroacetonitrile or 
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rather costly 2,2,2-trifluoro-N-phenylacetimidoyl chloride, respectively, but their 
synthesis is often originated from thioglycosides (Scheme 3.2). The use of thioglycosides 
as general building blocks is very broad. Thioglycosides are also excellent glycosyl 
donors, but their relatively low reactivity profile and the requirement for stoichiometric 
promoters limit their application. Conversely, O-imidates are very reactive and require 
only catalytic amount of the activator. Many O-imidates can be purified, but none can be 
stored and hence have to be used in glycosidations right away. Leaving groups in the 
previously studied imidates TCAI or PTFAI depart as unreactive amides, 
trichloroacetamide or 2,2,2-trifluoro-N-phenylacetamide, respectively, and cannot be 
reused directly (Scheme 3.2).   
Scheme 3.2.  Common approaches and the new concept 
 
 
Differently, since both the reagent for the introduction of the OFox leaving group and 
the departed leaving group are essentially the same (HOFox), both the synthesis and 
glycosidation of OFox imidates can be conducted using catalytic amount of the HOFox 
 140 
 
aglycone. HOFox aglycone will first react with a stable precursor to form highly reactive 
OFox imidate donor. The latter will then react with the acceptor while regenerating 
HOFox aglycone, which will be available for the next catalytic cycle to regenerate the 
OFox donor. Resultantly, only a small amount of the reactive donor is present in the 
reaction depending on the amount of added HOFox, whereas the OFox donor gets 
regenerated only upon its consumption (Scheme 3.2).  
In our preliminary study of the regenerative concept, we first reacted S-ethyl glycoside 
3.47 with stoichiometric bromine to form glycosyl bromide 3.48. The latter gets readily 
converted into OFox imidate 3.2 in the presence of HOFox. OFox imidates have 
reasonable shelf-life but are readily activated with TMSOTf, Bi(OTf)3 or other Lewis 
acid promoters (10 mol %). The amount of the reactive glycosyl donor present in the 
reaction medium can be controlled by the amount of HOFox added (range studied 0.1-1.0 
equiv.). We managed to achieve reasonable glycosylation rates (5 h) with as little as 10% 
of HOFox aglycone and with yields between 79-90% (entries 2-6, Table 3.9). For 
comparison, bromide 3.48 would require at least 16-24 h to react completely under these 
reaction conditions (entry 1). After confirming the effectiveness of the regenerative 
glycosylation procedure, we next investigated its scope towards secondary acceptors. For 
comparison, these reactions were performed using 0.1 and 0.25 equiv. of OFox, and the 
glycosylations proceeded smoothly providing corresponding disaccharides in 75% and 
62% yields respectively (entries 7 and 8). At the same time, the procedure was also 
performed on galactosyl and mannosyl sugars.  However, the reaction yields were on 
average lower than those observed with glucosyl donor (entries 9 and 10). 
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Table 3.9.  Regenerative glycosylation 
 
Entry Donor Acceptor HOFox (equiv.)
Reaction 
time Product Yield
Ratio 
α/β 
1 
 
0 5 h 
 
9% 1/1.1
2 3.47 3.19 0.10 3 h 3.20 84% 1/1.9
3 3.47 3.19 0.25 2 h 3.20 79% 1/1.9
4 3.47 3.19 0.50 40 min 3.20 86% 1/1.2
5 3.47 3.19 0.75 30 min 3.20 88% 1/1.2
6 3.47 3.19 1.0 10 min 3.20 90% 1/1.2
7 3.47 0.1 3 h 
 
72% 1/1.7
8 3.47 0.25 3 h 
 
62% 1/1.0
9 
 
3.19 0.1 2.5 h 
 
69% 1/1.1
10 
 
3.19 0.1 3 h 
 
75% 2.5/1
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To obtain the ultimate proof that the regenerative reaction proceeds via the formal 
formation of the OFox imidate, we performed an NMR monitoring as follows. A reaction 
using bromide donor 3.48 and Ag2O (3 equiv.) in CD2Cl2 was set up in the standard 5 
mm NMR tube at 0 oC in absence of a glycosyl acceptor. HOFox (0.25 equiv.) was then 
added and the 1H NMR spectrum recorded after 5 min clearly showed the formation of 
OFox imidate (Scheme 3.3). Thus, two new peaks, one at around 5.87 ppm, indicative of 
the formation of β-OFox imidate 3.2, and one at around 6.50 ppm indicative of the 
formation of α-OFox imidate were formed. In our opinion, this NMR-monitoring 
experiment clearly proves that OFox imidates are the essential intermediates en route to 
the glycosylation prodicts.  
Scheme 3.3.  “Regenerative glycosylation” monitored by the NMR 
6.50 6.45 6.40 6.35 6.30 6.25 6.20 6.15 6.10 6.05 6.00 5.95 5.90 5.85
Chemical Shift (ppm)
0.170.820.03
 
         
3.4. Conclusions 
A new class compounds, OFox imidates, have been synthesized in high yields and 
employed as versatile glycosyl donors in the synthesis of 1,2-cis and 1,2-trans glycosides. 
These glycosylations show notable features such as operational simplicity, rapid reaction 
times, high yields and excellent stereocontrol in presence of Lewis acids used in catalytic 
amounts. Achieving complete β-stereoselectivity with the use of propionitrile as the 
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solvent, suggests a possibility of solvent participation during glycosylation. At the same 
time, good α-selectivities could also be achieved by changing the promoter or using 
OFox of the superdisarmed series. A new regenerative concept for chemical 
glycosylation that proceeds via reactive glycosyl OFox intermediates and activation 
thereof in the catalytic fashion in situ was discovered. The concept has some similarities 
with the two-step activation by Nicolaou39-41 and Danishefsky42-45 and preactivation 
strategy by Huang and Ye,46-49 but differs in the catalytic conversion and continuous 
regeneration of the glycosyl donor. In the previous methods, the entire precursor 
(thioglycoside or glycal) is first converted into reactive intermediates (Br, F, OTf/NTf2 or 
epoxide) and then acceptor is added. This regenerative approach is expected to help 
reduce side reactions commonly found in conventional glycosylations wherein excess of 
the highly reactive or stoichiometrically preactivated glycosyl donor is present from the 
beginning.  
 
3.5. Experimental Section 
3.5.1.  General Remarks 
All reactions were performed under argon with dry, freshly distilled solvents unless 
otherwise noted. CH2Cl2, ClCH2CH2Cl, toluene, CH3CN, and EtCN were distilled from 
CaH2 directly prior to application. Anhydrous 1,4-dioxane, tetrahydrofuran, and diethyl 
ether were used as is. AgOTf was co-evaporated with toluene (3 x 10 mL) and dried in 
vacuo for 2-3 h directly prior to application. TMSOTf, SnCl4, MeOTf, BF3-OEt2, 
Cu(OTf)2, PdCl2, TMSClO4 and Bi(OTf)3 were used as is. Molecular sieves (3 Å or 4 Å), 
used for the reactions, were crushed and activated at 390 °C and then for 2-3 h at 390 °C 
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prior to application. Reactions were monitored by TLC on Kieselgel 60 F254 and the 
compounds were detected by examination under UV light and by charring with 10% 
sulfuric acid in methanol. Solvents were removed under reduced pressure at < 40 oC. 
Column chromatography was performed on silica gel 60 (70-230 mesh). Optical rotations 
were measured at ‘Jasco P-1020’ polarimeter. 1H n.m.r. spectra were recorded at 300 
MHz, 500 MHz, or 600 MHz. 13C n.m.r. spectra were recorded at 75 MHz or 150 MHz. 
19F spectra were recorded at 282.2 MHz. The 1H chemical shifts are referenced to the 
signal of the residual CHCl3 (δH = 7.27 ppm) for solutions in CDCl3. The 13C chemical 
shifts are referenced to the central signal of CDCl3 (δC = 77.23 ppm) for solutions in 
CDCl3. HRMS determinations were made with the use of JEOL MStation (JMS-700) 
Mass Spectrometer. 
 
3.5.2.  Synthesis of 3,3-difluoroxindole (HOFox, 3,3-difluoroindolin-2-one).  
HOFox was obtained from Isatin and DAST as previously described. Analytical data 
were in accordance with that previously reported.28 
 
3.5.3.  Preparation of OFox imidates 
Method A. A typical procedure for the preparation from hemiacetals via glycosyl 
chlorides.  SOCl2 (81.1 μL, 1.11 mmol) was added dropwise to a solution of hemiacetal 
(3.1 or 3.3, 0.20 g, 0.37 mmol) in dry CH2Cl2 (2.0 mL) and dry DMF (14.3 μL) and the 
resulting mixture was stirred under argon for 7 h at rt. Upon completion, the reaction 
mixture was diluted with CH2Cl2 (~30 mL) and washed with sat. aq. NaHCO3 (2 x 15 
mL) and cold water (2 x 15 mL). The organic phase was separated, dried with MgSO4, 
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and concentrated in vacuo. The residue containing crude glycosyl halide (0.37 mmol) was 
dried under high vacuum for 4 h. Freshly activated molecular sieves (3 Å, 600 mg) and 
dry CH2Cl2 (2.0 mL) were added and the resulting mixture was stirred under argon for 1 h 
at rt. After that, 3,3-difluorooxindole (69 mg, 0.41 mmol), Ag2O (258 mg, 1.11 mmol), 
and diisopropylethylamine (DIPEA, 97 μL, 0.56 mmol) were added and the resulting 
mixture was stirred for 8-12 h. The solids were filtered off through a pad of Celite and 
rinsed successively with CH2Cl2. The combined filtrate (~40 mL) was washed with 1% 
aq. NaOH (2 x 15 mL) and water (2 x 15 mL). The organic phase was separated, dried 
with MgSO4, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate-hexanes gradient elution) to afford the 
corresponding OFox imidates 3.2 or 3.4 in yields listed in Table 3.1. 
 
Methods B and C.  A typical procedure for the preparation from glycosyl bromides.  A 
mixture of a glycosyl bromide (3.5, 3.7, 3.9 or 3.15, 0.15 mmol) and freshly activated 
molecular sieves (3 Å, 300 mg) in dry CH2Cl2 (Method B, 1.0 mL) or toluene (Method C, 
1.0 mL) was stirred under argon for 1 h at rt. After that, 3,3-difluorooxindole (25.7 mg, 
0.15 mmol), Ag2O (105 mg,  0.45 mmol), and DIPEA (39.7 μL, 0.23 mmol) were added 
and the resulting mixture was stirred for 40 min-10 h at the temperature indicated in 
Table 1S. The solids were filtered off through a pad of Celite and rinsed successively 
with CH2Cl2. The combined filtrate (~40 mL) was washed with 1% aq. NaOH (2 x 15 
mL) and water (2 x 15 mL). The organic phase was separated, dried with MgSO4, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
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(ethyl acetate-hexanes gradient elution) to afford the corresponding OFox imidates in 
yields listed in Table 3.1. 
 
Method D.  A typical procedure for the preparation from pentabenzoates via glycosyl 
bromides.  A 33% solution of HBr in AcOH (0.10 mL, 1.7 mmol) was added to a solution 
of a 1,2,3,4,6-penta-O-benzoyl-D-galacto or mannopyranose (3.11 or 3.13, 100 mg, 0.14 
mmol) in dry CH2Cl2 (0.2 mL) and the resulting mixture was stirred under argon for 2-4 h 
at rt. The reaction mixture was then diluted with CH2Cl2 (~40 mL) and washed with cold 
sat. aq. NaHCO3 (2 x 15 mL) and cold water (2 x 15 mL). The organic phase was 
separated, dried with MgSO4, and concentrated in vacuo. The residue containing crude 
glycosyl bromide (0.14 mmol) was dried under high vacuum for 4 h. After that, freshly 
activated molecular sieves (3 Å) and dry CH2Cl2 (1.4 mL) were added and the resulting 
mixture was stirred under argon for 1 h at rt. After that, the resulting mixture was cooled 
to 0 oC in case of galactose sugar and at rt for mannose sugar, followed by addition of 
3,3-difluorooxindole (26.7 mg, 0.16 mmol), Ag2O (99.2 mg, 0.43 mmol) and DIPEA 
(37.4 μL, 0.21 mmol) were added and the resulting mixture was stirred for 2-6 h as 
indicated in Table 3.1. The solids were then filtered off through a pad of Celite and rinsed 
successively with CH2Cl2. The combined filtrate (~40 mL) was washed with 1% aq. 
NaOH (2 x 15 mL) and water (2 x 15 mL). The organic phase was separated, dried with 
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate-hexanes gradient elution) to afford the corresponding OFox 
imidates in yields listed in Table 3.1. 
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3,3-Difluoro-3H-indol-2-yl  2,3,4,6-tetra-O-benzyl-α/β-D-glucopyranoside (3.2).  The 
title compound was obtained from 2,3,4,6-tetra-O-benzyl-D-glucopyranose 3.150 by 
Method B in 62% yield (α/β = 10/1) as a white foam. Analytical data for α-3.2: Rf = 0.43 
(ethyl acetate/hexanes, 1/4, v/v); 1H n.m.r. (300 MHz): δ, 3.66 (dd, 1H, J5,6a = 1.8 Hz, 
J6a,6b = 10.9 Hz, H-6a), 3.79 (dd, 1H, J2,3 = 9.3 Hz, H-2, ), 3.79 (dd, 1H, J5,6b = 3.3 Hz, H-
6b), 3.83 (dd, 1H, J4,5 = 9.3 Hz, H-4), 4.01 (m, 1H, H-5), 4.13 (dd, 1H, J3,4 = 9.3 Hz, H-
3), 4.52 (dd, 2H, 2J = 12.0 Hz, CH2Ph), 4.69 (dd, 2H, 2J = 10.5 Hz, CH2Ph), 4.73 (s, 2H, 
CH2Ph), 4.93 (dd, 2H, 2J = 10.9 Hz, CH2Ph), 6.50 (d, 1H, J1,2 = 3.3 Hz, H-1), 7.11-7.42 
(m, 24H, aromatic) ppm; 13C n.m.r. (75 MHz): δ, 68.1, 73.2, 73.5, 73.6 (x 2), 75.2, 75.3, 
79.4, 81.5, 99.8, 117.4, 120.4, 123.3, 125.7, 127.8, 127.9, 128.0 (x 4), 128.0 (x 2), 128.1 
(x 7), 128.6 (x 8), 133.6, 137.9, 138.0, 138.2, 138.8 ppm; 19F n.m.r.: δ, -121.3 (s, 2F, CF2) 
ppm; HR-FAB MS [M+Na]+ calculated for C42H39F2NO6Na+ 714.2643, found 714.2645. 
 
3,3-Difluoro-3H-indol-2-yl  2,3,4,6-tetra-O-benzyl-α-D-mannopyranoside (3.4).  The 
title compound was obtained from 2,3,4,6-tetra-O-benzyl-α/β-D-mannopyranose 3.351 by 
Method A in 61% yield as a white foam. Analytical data for 3.4: Rf = 0.45 (ethyl 
acetate/hexanes, 2/3, v/v); [α]D24 +13.7 (c = 1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 3.74 
(dd, 1H, J5,6a = 1.8 Hz, J6a,6b = 11.3 Hz, H-6a), 3.84 (dd, 1H, J5,6b = 4.3 Hz, H-6b), 3.95-
4.03 (m, 3H, H-2, 4, 5), 4.14 (m, 1H, J3,4 = 9.5 Hz, H-3), 4.60 (dd, 2H, 2J = 11.6 Hz, 
CH2Ph), 4.62 (dd, 2H, 2J = 12.1 Hz, CH2Ph), 4.70 (dd, 2H, 2J = 10.7 Hz, CH2Ph), 4.78 
(s, 2H, CH2Ph), 6.40 (d, 1H, J1,2 = 1.1 Hz, H-1), 7.15-7.47 (m, 24H, aromatic) ppm; 13C 
n.m.r. (75 MHz): δ, 69.1, 72.6, 72.8, 73.1, 73.4, 74.0, 74.8, 75.3, 79.0, 97.7, 120.5 (x 2), 
123.4 (x 2), 125.9, 126.7, 127.7, 127.7 (x 2), 128.0 (x 3), 128.1 (x 2), 128.2 (x 2), 128.3 
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(x 3), 128.5 (x 2), 128.6 (x 6), 133.7, 138.0, 138.2, 138.4 (x 2), ppm; 19F n.m.r.: δ, -121.5 
(s, 2F, CF2) ppm; HR-FAB MS [M+Na]+ calculated for C42H39F2NO6Na+ 714.2643, 
found 714.2639. 
 
3,4,6-Tri-O-acetyl-2-O-benzyl-α-D-glucopyranosyl bromide (3.5).  The title compound 
was obtained from 1,3,4,6-tetra-O-acetyl-2-O-benzyl-D-glucopyranose52 in 90% yield as 
a white foam as previously described.53 Analytical data for 3.5: Rf = 0.43 (ethyl 
acetate/hexanes, 2/3, v/v); 1H n.m.r. (300 MHz): δ, 1.96, 1.98, 2.00 (3s, 9H, 3 x COCH3), 
3.57 (dd, 1H, J2,3 = 9.6 Hz, H-2), 4.12 (m, 1H, J5,6a = 4.1 Hz, H-6a), 4.22 (m, 1H, H-5), 
4.27 (dd, 1H, J5,6b = 4.0 Hz, J6a,6b = 12.6 Hz, 6b), 4.63 (dd, 2H, 2J = 12.3 Hz, CH2Ph), 
5.06 (dd, 1H, J4,5 = 9.8 Hz, H-4), 5.48 (dd, 1H, J3,4 = 9.5 Hz, H-3), 6.34 (d, 1H, J1,2 = 3.9 
Hz, H-1) ppm; 13C n.m.r. (75 MHz): δ, 20.8, 20.9 (x 2), 61.3, 67.3, 72.2 (x 2), 72.9, 76.5, 
89.2, 128.1 (x 2), 128.5, 128.8 (x 2), 137.0, 169.9, 170.1, 170.7 ppm; HR-FAB MS 
[M+Na]+ calculated for C19H23BrO8Na+ 481.0474, found 481.0483. 
 
3,3-Difluoro-3H-indol-2-yl  3,4,6-tri-O-acetyl-2-O-benzyl-β-D-glucopyranoside (β-
3.6).  The title compound was obtained from 3,4,6-tri-O-acetyl-2-O-benzyl-α-D-
glucopyranosyl bromide 3.5 by Method B at rt in 80% yield as a white foam. Analytical 
data for β-3.6: Rf = 0.39 (ethyl acetate/hexanes, 2/3, v/v); [α]D26 +13.7 (c = 1.0, CHCl3); 
1H n.m.r. (300 MHz): δ, 1.95, 2.03, 2.07 (3s, 9H, 3 x COCH3), 3.80 (dd, 1H, J2,3 = 7.9 
Hz, H-2), 3.95 (m, 1H, H-5), 4.14 (dd, 1H, J5,6a = 2.3 Hz, J6a,6b = 12.5 Hz, H-6a), 4.34 
(dd, 1H, J5,6b = 4.4 Hz, H-6b), 4.74 (dd, 2H, 2J = 11.6 Hz, CH2Ph), 5.11 (dd, 1H, J4,5 = 
9.5 Hz, H-4), 5.27 (dd, 1H, J3,4 = 9.2 Hz, H-3), 5.94 (d, 1H, J1,2 = 7.8 Hz, H-1), 7.18-7.49 
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(m, 9H, aromatic) ppm; 13C n.m.r. (75 MHz): δ, 20.7 (x 2), 20.8, 61.5, 67.9, 72.6, 73.6, 
74.7, 77.6, 99.1, 120.6, 123.3, 126.2, 128.1 (x 2), 128.3 (x 3), 128.5 (x 3), 133.7, 137.1, 
150.3, 169.7, 170.0, 170.7 ppm; 19F n.m.r.: δ, -122.0 (d, 2F, CF2) ppm; HR-FAB MS 
[M+Na]+ calculated for C27H27F2NO9Na+ 570.1552, found 570.1562. 
 
3,3-Difluoro-3H-indol-2-yl  3,4,6-tri-O-acetyl-2-O-benzyl-α-D-glucopyranoside (α-
3.6).  The title compound was obtained from 3,4,6-tri-O-acetyl-2-O-benzyl-α-D-
glucopyranosyl bromide 3.5 by Method B at 0 oC in 81% yield as a white foam. 
Analytical data for α-3.6: Rf = 0.38 (ethyl acetate/hexanes, 2/3, v/v); [α]D25 +101.4 (c = 
1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 2.02, 2.03, 2.05 (3s, 9H, 3 x COCH3), 3.81 (dd, 1H, 
J2,3 = 9.9 Hz, H-2), 4.06 (dd, 1H, J5,6a = 2.0 Hz, J6a,6b = 12.4 Hz, H-6a), 4.18 (m, 1H, H-
5), 4,29 (dd, 1H, J5,6b = 4.1 Hz, H-6b), 4.67 (s, 2H, CH2Ph), 5.11 (dd, 1H, J4,5 = 10.0 Hz, 
H-4), 5.57 (d, 1H, J3,4 = 9.7 Hz, H-3), 6.45 (d, 1H, J1,2 = 3.5 Hz, H-1), 7.17-7.40 (m, 9H, 
aromatic) ppm; 13C n.m.r. (75 MHz): δ, 20.7 (x 2), 20.8, 61.4, 67.8, 69.8, 71.4, 73.3, 75.7, 
95.0, 120.4, 123.3, 125.9, 126.8, 127.9 (x 3), 128.2, 128.6 (x 3), 133.5, 137.2, 150.4, 
168.7, 169.8, 170.1 ppm; 19F n.m.r.: δ, -121.6 (s, 1F, CF2a), -121.5 (s, 1F, CF2b); HR-FAB 
MS [M+Na]+ calculated for C27H27F2NO9Na+ 570.1552, found 570.1569. 
 
3,3-Difluoro-3H-indol-2-yl  2,3,4,6-tetra-O-acetyl-α-D-glucopyranoside (3.8).  The 
title compound was obtained from 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide 
3.754 by Method C in 62% yield as a white foam. Analytical data for 3.8: Rf = 0.42 (ethyl 
acetate/hexanes, 1/1, v/v); [α]D21 +5.2 (c= 1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 1.96, 
1.97, 1.98, 2.01 (4s, 12H, 4 x COCH3), 3.95 (m, 1H, H-5), 4.15 (dd, 1H, J5,6a = 2.3 Hz, 
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J6a,6b = 12.5 Hz, H-6a), 4.30 (dd, 1H, J5,6b = 4.3 Hz, H-6b), 5.17-5.32 (m, 3H, H-2, 3, 4), 
5.95 (m, 1H, H-1), 7.14-7.40 (m, 4H, aromatic) ppm; 13C n.m.r. (75 MHz): δ, 20.4, 20.6 
(x 2), 20.7, 61.4, 67.6, 70.3, 72.4, 72.9, 96.6, 120.5 (x 2), 123.3 (x 2), 126.2, 126.8, 133.6, 
150.0, 169.3, 169.4, 170.2, 170.8 ppm; 19F n.m.r.: δ, -122.4 (s, 1F, CF2a), -122.3 (s, 1F, 
CF2b) ppm; HR-FAB MS [M+H]+ calculated for C22H23F2NO10 500.1290, found 
500.1361. 
 
3,3-Difluoro-3H-indol-2-yl  2,3,4,6-tetra-O-benzoyl-α-D-glucopyranoside (3.10).  The 
title compound was obtained from 2,3,4,6-tetra-O-benzoyl-α-D-glucopyranosyl bromide 
3.955 by Method B in 75% yield as a pale yellow foam. Analytical data for 3.10: Rf = 0.41 
(ethyl acetate/hexanes, 3/7, v/v); [α]D23 +45.8 (c= 1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 
4.48 (dd, 1H, J5,6a = 4.7 Hz, J6a,6b = 12.4 Hz, H-6a), 4.64 (m, 2H, J5,6b = 2.3 Hz, H-5, 6b), 
5.69 (dd, 1H, J2,3 = 10.2 Hz, H-2), 5.83 (dd, 1H, J4,5 = 10.0 Hz, H-4), 6.31 (dd, 1H, J3,4 = 
10.0 Hz, H-3), 6.82 (d, 1H, J1,2 = 3.7 Hz, H-1), 7.05-7.99 (m, 24H, aromatic) ppm; 13C 
n.m.r. (75 MHz): δ, 62.4, 68.6, 70.1, 70.3, 70.6, 94.8, 120.6, 123.2, 126.0, 126.5, 128.3, 
128.4 (x 2), 128.4 (x 2), 128.5 (x 4), 128.6 (x 2), 128.8, 129.1, 129.5, 129.7 (x 2), 129.8 
(x 2), 130.0 (x 4), 133.1, 133.4 , 133.5, 133.6, 133.7, 150.1, 165.2, 165.5, 165.6, 166.0 
ppm; 19F n.m.r.: δ, -121.8 (s, 1F, CF2a), -121.6 (s, 1F, CF2b) ppm; HR-FAB MS [M+Na]+ 
calculated for C42H31F2NO10Na+ 770.1813, found 770.1800. 
 
3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranoside (3.12). 
The title compound was obtained from 2,3,4,6-tetra-O-benzoyl-α-D-galactopyranosyl 
bromide 3.1156 by Method D in 75% yield as a white foam. Analytical data for 3.12: Rf = 
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0.39 (ethyl acetate/hexanes, 3/7, v/v); [α]D22 +2.7 (c= 1.0, CHCl3); 1H n.m.r. (300 MHz): 
δ, 4.51 (dd, 1H, J5,6a = 5.9 Hz, J6a,6b = 10.6 Hz, H-6a), 4.63 (m, 1H, H-5), 4.72 (dd, 1H, 
J5,6b = 6.6 Hz, H-6b), 5.75 (dd, 1H, J3,4 = 3.4 Hz, H-3), 6.11 (m, 2H, H-2, 4), 6.34 (d, 1H, 
J1,2 = 7.8 Hz, H-1), 7.14-8.14 (m, 24H, aromatic) ppm; 13C n.m.r. (75 MHz): δ, 61.8, 
67.6, 68.9, 71.4, 72.7, 97.4, 120.4, 123.6, 124.7, 125.4, 128.3, 128.6 (x 4), 128.7, 128.8, 
128.9 (x 2), 129.0, 129.2 (x 2), 129.4, 129.9 (x 9), 130.1 (x 2), 133.3, 133.5, 133.6, 133.8, 
165.1, 165.5 (x 2), 166.0 ppm; 19F n.m.r.: δ, -122.2 (s, 2F, CF2); HR-FAB MS [M+Na]+ 
calculated for C42H31F2NO10Na+ 770.1813, found 770.1791. 
 
3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-benzoyl-α-D-mannopyranoside (3.14). The 
title compound was obtained from 2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl bromide 
3.1357 by Method D in 84% yield as a white foam. Analytical data for 3.14: Rf = 0.43 
(ethyl acetate/hexanes, 3/7, v/v); [α]D21 -5.3 (c = 1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 
4.52 (dd, 1H, J5,6a = 4.4 Hz, J6a,6b = 12.1 Hz, H-6a), 4.62 (m, 1H, H-5), 4.70 (dd, 1H, J5,6b 
= 2.2 Hz, H-6b), 6.02 (dd, 1H, J2,3 = 3.3 Hz, H-2), 6.07 (dd, 1H, J3,4 = 10.0 Hz, H-3), 
6.24 (dd, 1H, J4,5 = 10.0 Hz, H-4), 6.64 (d, 1H, J1,2 = 1.7 Hz, H-1), 7.16-8.09 (m, 24H, 
aromatic) ppm; 13C n.m.r. (75 MHz): δ, 62.5, 66.2, 69.0, 69.6, 71.5, 96.0, 121.0, 123.5, 
125.5, 126.4, 126.8, 128.4, 128.5 (x 2), 128.6 (x 2), 128.7 (x 2), 128.8, 128.9 (x 2), 128.9, 
129.0, 129.2, 129.8, 129.9 (x 2), 130.0 (x 2), 130.1 (x 4), 133.2, 133.6, 133.8, 134.0, 
138.1, 165.2, 165.5, 165.6, 166.1 ppm; 19F n.m.r.: δ, -121.8 (s, 1F, CF2a), -121.5 (s, 1F, 
CF2b); HR-FAB MS [M+Na]+ calculated for C42H31F2NO10Na+ 770.1813, found 
770.1814.  
 152 
 
3,4,6-Tri-O-acetyl-2-azido-2-deoxy-α-D-glucopyranosyl bromide (3.15).  The title 
compound was obtained from 1,3,4,6-tetra-O-acetyl-2-azido-2-deoxy-D-
glucopyranose58,59 in 90% yield as a white foam as previously described.{Paulsen, 1988 
#2816{Rowan, 2009 #3894} Analytical data for 3.15: Rf = 0.46 (ethyl acetate/hexanes, 
2/3, v/v); [α]D19 +146.9 (c= 1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 2.06, 2.09, 2.11 (3s, 9H, 
3 x COCH3), 3.81 (dd, 1H, J2,3 = 10.2 Hz, H-2), 4.12 (m, 1H, J5,6a = 1.9 Hz, J6a,6b = 8.5 
Hz, H-6a), 4.33 (m, 2H, J5,6b = 4.1 Hz, H-5, 6b), 5.14 (dd, 1H, J4,5 = 9.8 Hz, H-4), 5.5 
(dd, 1H, J3,4 = 10.0 Hz, H-3), 6.42 (d, 1H, J1,2 = 3.8 Hz, H-1) ppm; 13C n.m.r. (75 MHz): 
δ, 20.5, 20.6 (x 2), 61.0, 62.3, 67.3, 71.7, 72.4, 87.4, 169.6, 169.7, 170.4 ppm; HR-FAB 
MS [M+Na]+ calculated for C12H16BrN3O7Na+ 416.0069, found 416.0065. 
 
3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl-2-azido-2-deoxy-β-D-glucopyranoside 
(3.16).  The title compound was obtained from 3,4,6-tri-O-acetyl-2-azido-2-deoxy-α-D-
glucopyranosyl bromide 3.15 by Method B in 70% yield as a white foam. Analytical data 
for 3.16: Rf = 0.43 (ethyl acetate/hexanes, 2/3, v/v); [α]D24 +8.4 (c= 1.0, CHCl3); 1H n.m.r. 
(300 MHz): δ, 2.05, 2.08, 2.12 (3s, 9H, 3 x COCH3), 3.88 (dd, 1H, J2,3 = 9.2 Hz, H-2), 
3.93 (m, 1H, H-5), 4.16 (dd, 1H, J5,6a = 2.3 Hz, H-6a), 4.35 (dd, 1H, J5,6b = 4.3 Hz, J6a,6b 
= 12.6 Hz, H-6b), 5.13 (dd, 1H, J4,5 = 8.9 Hz, H-4), 5.17 (dd, 1H, J3,4 = 9.2 Hz, H-3), 
5.82 (d, 1H, J1,2 = 8.3 Hz, H-1), 7.19-7.43 (m, 4H, aromatic) ppm; 13C n.m.r. (75 MHz): 
δ, 20.7, 20.8, 20.9, 60.6, 63.1, 67.8, 72.7, 73.0, 97.6, 120.7, 123.5, 126.5, 126.7, 127.0, 
127.3, 133.8, 150.1, 169.8, 170.0, 170.7 ppm; 19F n.m.r.: δ, -122.2 (s, 2F, CF2). HR-FAB 
MS [M+Na]+ calculated for C20H20F2N4O8Na+ 505.1147, found 505.1142. 
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2,3,4,6-Tetra-O-benzyl-α/β-D-glucopyranosyl trichloroacetimidate (3.17).  The title 
compound was obtained from 2,3,4,6-tetra-O-benzyl-D-glucopyranose 3.150 in 62% yield 
as a white foam as previously described.60 Analytical data for is this for α-3.17: Rf = 0.43 
(ethyl acetate/hexanes, 1/4 v/v); 1H n.m.r. (300 MHz): δ, 3.67 (dd, 1H, J5,6a = 1.9 Hz, 
J6a,6b = 10.9 Hz, H-6a), 3.74-3.80 (m, 3H, H-2, 4, 6b), 3.99 (m, 1H, H-5), 4.05 (dd, 1H, 
J3,4 = 9.4 Hz, H-3), 4.53 (dd, 2H, 2J = 12.0 Hz, CH2Ph), 4.71 (dd, 2H, 2J = 11.7 Hz, 
CH2Ph), 4.73 (dd, 2H, 2J = 10.7 Hz, CH2Ph), 4.84 (dd, 2H, 2J = 7.6 Hz, CH2Ph) , 6.50 (d, 
1H, J1,2 = 3.4 Hz, H-1), 7.12-7.33 (m, 24H, aromatic), 8.57 (s, 1H, NH) ppm; 13C n.m.r. 
(75 MHz): δ, 68.1, 73.0, 73.2, 73.6, 75.5, 75.8, 79.5, 81.5, 91.4, 94.5, 127.8 (x 3), 127.9 
(x 2), 128.0, 128.1 (x 2), 128.2 (x 4), 128.5 (x 4), 128.6 (x 4), 137.9, 138.1, 138.2, 138.7, 
161.4 ppm; HR-ESI MS [M+Na]+ calculated for C36H36Cl3NO6Na+ 706.1506, found 
706.1500. 
 
2,3,4-Tri-O-benzyl-α,β-D-glucopyranosyl N-phenyltrifluoroacetimidate (3.18). The 
title compound was obtained from 2,3,4,6-tetra-O-benzyl-D-glucopyranose 3.150 by 
adapting previously published procedure.23 To a mixture of 2,3,4,6-tetra-O-benzyl-α/β-D-
glucopyranose 3.150 (150 mg, 0.28 mmol) and 2,2,2,-Trifluoro-N-phenylethanimidoyl 
chloride (89.4 μL, 0.55 mmol), was added K2CO3 (55 mg, 0.55 mmol) in acetone (1.5 
mL) and the resulting mixture was stirred for 3 h at rt. The solids were filtered off 
through a pad of Celite and the solvent was concentrated in vacuo. The residue was 
purified by column chromatography on silica gel (ethyl acetate-hexanes gradient elution) 
to afford the corresponding N-phenyltrifluoroacetimidate in 72 % yield as a white 
amorphous solid. Analytical data for β-3.18: Rf = 0.5 (ethyl acetate/hexanes, 1/4, v/v); 1H 
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n.m.r. (500 MHz): δ, 3.56-3.95 (m, 6H, H-2, 3, 4, 5, 6a, 6b), 4.58 (dd, 2H, 2J = 9.5 Hz, 
CH2Ph), 4.69 (dd, 2H, 2J = 12.2 Hz, CH2Ph), 4.88 (s, 2H, CH2Ph), 5.00 (dd, 2H, 2J = 
10.2 Hz, CH2Ph) , 5.74 (d, 1H, J1,2 = 8.0 Hz, H-1), 6.78-7.5 (m, 25H, aromatic); 13C 
n.m.r. (75 MHz): δ, 73.6, 75.3, 75.4, 75.8 (x 2), 75.9 (x 2), 75.8, 81.1, 84.7, 119.5, 124.5,  
127.9, 128.0 (x 2), 128.1 (x 3), 128.2 (x 3), 128.4 (x 2), 128.6 (x 6), 128.7 (x 7), 128.9 (x 
2), 137.9, 138.1 (x 2), 138.5, 143.6 ppm; HR-FAB MS [M+Na]+ calculated for 
C42H40F3NO6Na+ 734.2705, found 734.2720. 
 
2,3,4,6-Tetra-O-benzoyl-α-D-glucopyranosyl trichloroacetimidate (3.21). The title 
compound was obtained from 2,3,4,6-tetra-O-benzoyl-D-glucopyranose in 83% yield as a 
white foam as previously described.61 Analytical data for 3.21 was in accordance with 
that reported previously.19  
 
2,3,4,6-Tetra-O-benzoyl-α-D-glucopyranosyl N-phenyltrifluoroacetimidate (3.22).  
The title compound was obtained from 2,3,4,6-tetra-O-benzoyl-D-glucopyranose by 
adapting previously published procedure.23 To a mixture of 2,3,4,6-tetra-O-benzoyl-α/β-
D-glucopyranose (2.17 g, 3.64 mmol) and 2,2,2,-trifluoro-N-phenylethanimidoyl chloride 
(0.7 mL, 4.37 mmol), was added K2CO3 (0.54 g, 5.46 mmol) in acetone (20 mL) and the 
resulting mixture was stirred for 5 h at rt. The solids were filtered off through a pad of 
Celite and the solvent was concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate-hexanes gradient elution) to afford the 
corresponding N-phenyltrifluoroacetimidate in 86 % yield as a white foam. Analytical 
data for α-3.22: Rf = 0.5 (ethyl acetate/hexanes, 3/7, v/v); [α]D27 +49.4 (c= 1.0, CHCl3); 
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1H n.m.r. (500 MHz): δ, 4.51 (dd, 1H, J5,6a = 4.4 Hz, J6a,6b = 12.5 Hz, H-6a), 4.69 (m, 1H, 
H-5), 4.77 (dd, 1H, J5,6b = 1.8 Hz, H-6b), 5.67 (dd, 1H, J2,3 = 10.3 Hz, H-2), 5.93 (dd, 1H, 
J4,5 = 10.1 Hz, H-4), 6.30 (m, 3H, H-3, 2’, 6’), 6.92 (d, 1H, J1,2 = 3.6 Hz, H-1), 7.00-8.15 
(m, 25H, aromatic) ppm; 13C n.m.r. (125 MHz): δ, 62.4, 68.6, 70.0, 70.5, 70.8, 92.3, 
119.1, 124.4, 128.6 (x 2), 128.7 (x 5), 128.8 (x 5), 128.9, 129.7, 129.9 (x 2), 130.0 (x 8), 
133.3, 133.4, 133.7, 133.8, 142.8, 143.0, 165.2, 165.4, 165.7, 166.1; 19F n.m.r.: δ, -65.51 
(s, 3F, CF3) ppm; HR-FAB MS [M+Na]+ calculated for C42H31F2NO10Na+ 790.1876, 
found 790.1886. 
 
3.5.4.  General glycosylation procedures and the synthesis of glycosides 
Method A.  A typical TMSOTf-promoted glycosylation procedure. A mixture of glycosyl 
donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular 
sieves (4Å, 90 mg) in CH2Cl2 (0.5 mL) or other solvent as indicated in Tables was stirred 
under argon for 1 h at rt. The mixture was cooled to -78 oC or other temperature as 
indicated in Tables, TMSOTf (0.0055-0.011 mmol) was added, and the resulting mixture 
was stirred for 10-15 min as indicated in Tables. The solids were filtered off through a 
pad of Celite and rinsed successively with CH2Cl2. The combined filtrate (~40 mL) was 
washed with 1% aq. NaOH (2 x 10 mL) and water (2 x 10 mL). The organic phase was 
separated, dried with MgSO4, and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate - hexane gradient elution) to afford a 
glycoside derivative in yields listed in Tables.  
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Method B.  A typical BF3-OEt2-promoted glycosylation procedure. A mixture of 3,3-
difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-benzyl-α-D-glucopyranoside 3.2 (32.7 mg, 0.047 
mmol), methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside 3.19 (18.3 mg, 0.043 mmol), and 
freshly activated molecular sieves (4Å, 95 mg) in CH2Cl2 (0.6 mL) was stirred under 
argon for 1 h at rt. The mixture was cooled to -78 oC, BF3-OEt2 (0.3 μL, 0.002 mmol) 
was added, and the resulting mixture was stirred for 5 min. The solids were filtered off 
through a pad of Celite and rinsed successively with CH2Cl2. The combined filtrate (~40 
mL) was washed with 1% aq. NaOH (2 x 10 mL) and water (2 x 10 mL). The organic 
phase was separated, dried with MgSO4, and concentrated in vacuo. The residue was 
purified by column chromatography on silica gel (ethyl acetate - hexane gradient elution) 
to afford disaccharide 3.20 in 93% yield (α/β = 1/20, Table 3.5). 
 
Method C.  A typical Cu(OTf)2-promoted glycosylation procedure. A mixture of donor 
3.2 (38.3 mg, 0.055 mmol), methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside 3.19 (23.4 
mg, 0.05 mmol), and freshly activated molecular sieves (3 Å, 110 mg) in CH2Cl2 (0.64 
mL) was stirred under argon for 1 h at rt. Cu(OTf)2 (2.0 mg, 0.003 mmol) was added and 
the resulting mixture was stirred for 5 min. The solids were filtered off through a pad of 
Celite and rinsed successively with CH2Cl2. The combined filtrate (~40 mL) was washed 
with 1% aq. NaOH (2 x 10 mL) and water (2 x 10 mL). The organic phase was separated, 
dried with MgSO4, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate - hexane gradient elution) to afford 
disaccharide 3.20 in 97% yield (β only, Table 3.5). 
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Method D.  A typical MeOTf-promoted glycosylation procedure. A mixture of donor 3.2 
(30.6 mg, 0.044 mmol), acceptor 3.19 (18.7 mg, 0.040 mmol), and freshly activated 
molecular sieves (4Å, 90 mg) in CH2Cl2 (0.5 mL) was stirred under argon for 1 h at rt. 
MeOTf (0.55 μL, 0.0044 mmol) was added and the resulting mixture was stirred for 10 
min. The solids were filtered off through a pad of Celite and rinsed successively with 
CH2Cl2. The combined filtrate (~40 mL) was washed with 1% aq. NaOH (2 x 10 mL) and 
water (2 x 10 mL). The organic phase was separated, dried with MgSO4, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - hexane gradient elution) to afford disaccharide 3.20 in 91% yield (α/β = 
1/>25, Table3.5). 
 
Method E.  A typical AgOTf-promoted glycosylation procedure. A mixture of donor 3.2 
(43.5 mg, 0.062 mmol), acceptor 3.19 (26.7 mg, 0.057 mmol), and freshly activated 
molecular sieves (4Å, 120 mg) in CH2Cl2 (0.73 mL) was stirred under argon for 1 h at rt. 
AgOTf (7.3 mg, 0.028 mmol) was added and the resulting mixture was stirred for 24 h. 
The solids were filtered off through a pad of Celite and rinsed successively with CH2Cl2. 
The combined filtrate (~40 mL) was washed with 1% aq. NaOH (2 x 10 mL) and water 
(2 x 10 mL). The organic phase was separated, dried with MgSO4, and concentrated in 
vacuo. The residue was purified by column chromatography on silica gel (ethyl acetate - 
hexane gradient elution) to afford disaccharide 3.20 in 71% yield (α/β = 1/1.6, Table 3.5). 
 
Method F.  A typical PdCl2-promoted glycosylation procedure. A mixture of donor 3.2 
(33.2 mg, 0.048 mmol), acceptor 3.19 (20.3 mg, 0.044 mmol), and freshly activated 
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molecular sieves (4Å, 90 mg) in CH2Cl2 (0.55 mL) was stirred under argon for 1 h at rt. 
PdCl2 (2.55 mg, 0.014 mmol) was added and the resulting mixture was stirred for 36 h. 
The solids were filtered off through a pad of Celite and rinsed successively with CH2Cl2. 
The combined filtrate (~40 mL) was washed with 1% aq. NaOH (2 x 10 mL) and water 
(2 x 10 mL). The organic phase was separated, dried with MgSO4, and concentrated in 
vacuo. The residue was purified by column chromatography on silica gel (ethyl acetate - 
hexane gradient elution) to afford disaccharide 3.20 in 57% yield (α/β = 1/1.7, Table 3.5).  
 
Method G.  A typical TMSClO4-promoted glycosylation procedure. A mixture of donor 
3.2 (0.11 mmol), acceptor 3.19 (0.10 mmol), and freshly activated molecular sieves (3 Å, 
90 mg) in Et2O (0.5 mL) or Et2O/1.4-dioxane (0.5 mL, 1/1, v/v) was stirred under argon 
for 1 h at rt. TMSClO462 (0.011 mmol) was added and the resulting mixture was stirred 
for 5 min. The solids were filtered off through a pad of Celite and rinsed successively 
with CH2Cl2. The combined filtrate (~40 mL) was washed with 1% aq. NaOH (2 x 10 
mL) and water (2 x 10 mL). The organic phase was separated, dried with MgSO4, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - hexane gradient elution) to afford disaccharide 3.20 in 75% (α/β = 5/1, 
Table 3.5) or 54% yield (α/β = 6.2/1), respectively.  
 
Method H.  A typical Bi(OTf)3-promoted glycosylation procedure. A mixture of donor 3.2 
(41.3 mg, 0.059 mmol), acceptor 3.19 (25.2 mg, 0.054 mmol), and freshly activated 
molecular sieves (4Å, 120 mg) in CH2Cl2 (0.7 mL) was stirred under argon for 1 h at rt. 
The reaction was cooled to -60 oC followed by the addition of Bi(OTf)3 (3.9 mg, 0.006 
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mmol) and the resulting mixture was stirred for 20 min. The solids were filtered off 
through a pad of Celite and rinsed successively with CH2Cl2. The combined filtrate (~40 
mL) was washed with 1% aq. NaOH (2 x 10 mL) and water (2 x 10 mL). The organic 
phase was separated, dried with MgSO4, and concentrated in vacuo. The residue was 
purified by column chromatography on silica gel (ethyl acetate - hexane gradient elution) 
to afford disaccharide 3.20 in 85% yield, (α/β = 1/7.0, Table 3.5). 
 
Method I.  A typical SnCl4-promoted glycosylation procedure. A mixture of 3,3-difluoro-
3H-indol-2-yl 2,3,4,6-tetra-O-acetyl-α-D-glucopyranoside 3.8 (25.8 mg, 0.051 mmol), 
acceptor 3.19 (21.8 mg, 0.046 mmol), and freshly activated molecular sieves (4Å, 90 mg) 
in CH2Cl2 (0.5 mL) was stirred under argon for 1 h at rt. SnCl4 (0.6 μL, 0.005 mmol) was 
added and the resulting mixture was stirred for 10 min (Table 4). The solids were filtered 
off through a pad of Celite and rinsed successively with CH2Cl2. The combined filtrate 
(~40 mL) was washed with 1% aq. NaOH (2 x 10 mL) and water (2 x 10 mL). The 
organic phase was separated, dried with MgSO4, and concentrated in vacuo. The residue 
was purified by column chromatography on silica gel (ethyl acetate - hexane gradient 
elution) to afford disaccharide 3.38 in 80% yield (Table 3.5). 
 
Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)-α-D-
glucopyranoside (3.20). The title compound was obtained by Methods A-H from donor 
3.2 and acceptor 3.1963 in 54-97% yield (α/β ranging from 6.2/1 to β-only, see Tables). 
Analytical data for 3.20 was in accordance with that reported previously.64,65  
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2-Propyl  2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside (3.27).  The title compound was 
obtained by Method A from donor 3.2 and isopropanol 3.26 as a white amorphous solid 
in 77% yield (β only). Analytical data for 3.27 was in accordance with that reported 
previously.66  
 
Methyl 2,3,4-tri-O-benzoyl-6-O-(2,3,4,6-tetra-O-benzyl-D-glucopyranosyl)-α-D-
glucopyranoside (3.29).  The title compound was obtained by Method A from donor 3.2 
and methyl 2,3,4-tri-O-benzoyl-α-D-glucopyranoside 3.2867 in CH2Cl2 or EtCN in 89% 
(α/β = 1/11) or 87% yield (α/β = 1/18), respectively. Analytical data for 3.29 was in 
accordance with that reported previously.68  
 
6-O-(2,3,4,6-Tetra-O-benzyl-β-D-glucopyranosyl)-1,2:3,4-di-O-isopropylidene-α-D-
galactopyranose (3.31).  The title compound was obtained by Method A from donor 3.2 
and 1,2:3,4-di-O-isopropylidene-α-D-galactopyranose 3.30 in CH2Cl2 or EtCN in 85% 
(α/β = 1/12) or 89% yield (β only), respectively. Analytical data for 3.31 was in 
accordance with that reported previously. 
 
Methyl 2,3,6-tri-O-benzyl-4-O-(2,3,4,6-tetra-O-benzyl-D-glucopyranosyl)-α-D-
glucopyranoside (3.33).  The title compound was obtained by Method A from donor 3.2 
and methyl 2,3,6-tri-O-benzyl-α-D-glucopyranoside 3.3263 in CH2Cl2 or EtCN in 94% 
(α/β = 1/4) or 92% yield (α/β = 1/12), respectively. Analytical data for 3.33 was in 
accordance with that reported previously.68 
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Methyl 2-O-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-
glucopyranoside (3.25).  The title compound was obtained by Method A from donor 3.2 
and methyl 3,4,6-tri-O-benzyl-α-D-glucopyranoside 3.2463 in CH2Cl2 or EtCN in 90% 
(α/β = 1/6.0) or 88% yield (α/β = 1/15), respectively. Analytical data for 3.25 was in 
accordance with that reported previously.29  
 
(3β)-Cholest-5-en-3-yl  2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside (3.35).  The title 
compound was obtained by Method A from donor 3.2 and (3β)-cholest-5-en-3-ol 3.34 as 
a white amorphous solid in 86% yield (β-only). Analytical data for 3.35 was in 
accordance with that reported previously.69  
 
1-Adamantyl  2,3,4,6-tetra-O-benzyl-D-glucopyranoside (3.37).  The title compound 
was obtained by Method A from donor 3.2 and 1-adamantol 3.36 as a white amorphous 
solid in 88% yield (α/β = 1/23). Analytical data for 3.37 was in accordance with that 
reported previously.69  
 
Methyl 2-O-(3,4,6-tri-O-acetyl-2-O-benzyl-α-D-glucopyranosyl)-3,4,6-tri-O-benzyl-
α-D-glucopyranoside (40).  The title compound was obtained by Method A from donor 
α-12 or donor β-12 and acceptor 3463 as a clear film in 89% or 88% yield (α only), 
respectively. Analytical data for 40 was in accordance with that reported previously.29  
 
Methyl 6-O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-
glucopyranoside (3.38).  The title compound was obtained by Method I from donor 3.8 
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and acceptor 3.1963 as a clear film in 80% yield. Analytical data for 3.38 were essentially 
the same as reported previously.70 
 
Methyl 6-O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-
glucopyranoside (3.39).  The title compound was obtained by Method A from donor 
3.10 and acceptor 3.1963 as a clear film in 94% yield. Analytical data for 3.39 were 
essentially the same as reported previously.63  
 
6-O-(2,3,4,6-Tetra-O-benzoyl-β-D-glucopyranosyl)-1,2:3,4-di-O-isopropylidene-α-D-
galactopyranose (3.40).  The title compound was obtained by Method A from donor 
3.10 and acceptor 3.30 in 86% yield. Analytical data for 3.40 were essentially similar as 
reported previously.29  
 
Methyl 4-O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-2,3,6-tri-O-benzyl-α-D-
glucopyranoside (3.41).  The title compound was obtained by Method A from donor 
3.10 and acceptor 3.3263 as a clear film in 90% yield. Analytical data for 3.41 were 
essentially the same as reported previously.63  
 
Methyl 2-O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-
glucopyranoside (3.42).  The title compound was obtained by Method A from donor 
3.10 and acceptor 3.2463 as a clear film in 93% yield. Analytical data for 3.42 were 
essentially the same as reported previously.63 
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Methyl 6-O-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-2,3,4-tri-O-benzyl-α-D-
glucopyranoside (3.43).  The title compound was obtained by Method A from donor 
3.12 and acceptor 3.1963 as a clear film in 98% yield. Analytical data for 3.43 were 
essentially the same as reported previously.71 
 
Methyl 4-O-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-2,3,6-tri-O-benzyl-α-D-
glucopyranoside (3.44).  The title compound was obtained by Method A from donor 
3.12 and acceptor 3.3263 as a clear film in 98% yield. Analytical data for 3.44 were 
essentially the same as reported previously.29  
 
Methyl 6-O-(2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl)-2,3,4-tri-O-benzyl-α-D-
glucopyranoside (3.45).  The title compound was obtained by Method A from donor 
3.14 and acceptor 3.1963 as a clear film in 93% yield. Analytical data for 3.45 were 
essentially the same as reported previously.29 
 
Methyl 4-O-(2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl)-2,3,6-tri-O-benzyl-α-D-
glucopyranoside (3.46).  The title compound was obtained by Method A from donor 
3.14 and acceptor 3.3263 as a clear film in 90% yield. Analytical data for 3.46 were 
essentially the same as reported previously.72  
 
3.5.5.  A typical procedure for regenerative glycosylation 
A mixture of ethyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside 3.4773 (30 mg, 
0.051 mmol) and activated molecular sieves (3 Å, 90 mg) in CH2Cl2 (0.5 mL) was stirred 
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under argon for 1 h at rt. The mixture was cooled to 0 oC, bromine (0.27 μL, 0.01 mmol) 
was added, and the resulting mixture was kept for 15 min at 0 oC. After that, 3,3-
difluorooxindole (0.9 mg - 8.9 mg, 0.0051-0.051 mmol, see Table 2 of the manuscript), 
and Ag2O (35.5 mg, 0.16 mmol) were added to the reaction mixture and the resulting 
mixture was stirred for 1h. Methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside 3.19  (18.3 
mg, 0.039 mmol) and BF3-OEt2 (0.33 μL, 0.0025 mmol) were added and the reaction was 
stirred for 10 min - 5 h (see Table 2 of the manuscript). The solids were filtered off 
through a pad of Celite and rinsed successively with CH2Cl2. The combined filtrate (~20 
mL) was washed with 1% aq. NaOH (2 x 10 mL) and water (2 x 10 mL). The organic 
phase was separated, dried with MgSO4, and concentrated in vacuo. The residue was 
purified by column chromatography on silica gel (ethyl acetate-hexanes gradient elution) 
to afford disaccharide 3.20 in 9-90% yield (see Table 2 of the manuscript). 
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4.1.  Introduction 
Whether in the form of simple monosaccharides or as a part of complex natural 
products, conjugates or biomarkers, carbohydrates are involved in a wide variety of 
fundamental or disease-related processes. As a result, carbohydrates and their conjugates 
show tremendous diagnostic and therapeutic potential. With the advent of modern 
technology, the need for elucidating the exact mechanism by which these carbohydrates 
interact with other biomolecules, and features that are responsible for these interactions, 
has been particularly stimulating in the field. While scientists have been able to 
successfully isolate certain classes of natural carbohydrates, the availability of pure 
natural isolates is still inadequate to address challenges offered by modern glycosciences.  
As a consequence, chemical synthesis has become a viable means to obtain both natural 
complex carbohydrates and unnatural analogues thereof. With the immense task of 
conducting efficient drug design and the search for new pharmaceuticals, the chemical 
synthesis of complex carbohydrate structures and/or mimetics thereof falls short.   
 
4.1.1.  Chemical Synthesis of Oligosaccharides  
Practically all complex carbohydrates bear an oligomeric sequence wherein 
monosaccharide residues are linked via O-glycosidic linkages. This linkage is obtained 
by a glycosylation reaction that typically involves a nucleophilic displacement of a 
leaving group (LG, Scheme 4.1.) on the glycosyl donor by a hydroxyl group of the 
acceptor.1 The remaining functional groups of both components are temporarily masked 
with protecting groups (Ps).2-25 Despite significant progress, chemical glycosylation 
remains challenging due to the requirements of achieving complete stereocontrol and  
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suppressing side reactions.1 Further elongation of the saccharide chain for the synthesis 
of oligomeric structures requires additional protecting/leaving group modifications 
between each glycosylation step. Fraser-Reid,26,27 Nicolaou,28 Danishefsky,29 Kahne,30 
Wong,31 Boons,32 Crich,19 Huang,33 and others34 developed advanced strategies that allow 
for streamlining the oligosaccharide synthesis. Nevertheless, chemical synthesis of 
oligosaccharides of even moderate complexity still remains a considerable challenge.  As 
such, the development of efficient methods for chemical glycosylation1 and expeditious 
oligosaccharide34 and glycoconjugate synthesis remains a demanding area of research.  
Scheme 4.1.  Conventional solution-phase synthesis 
 
 
4.1.2.  Solid phase oligosaccharide synthesis  
Solid-phase synthesis using insoluble polymer supports35,36 has been widely used in 
the preparation of many organic molecules35-38 including peptides39 and 
oligonucleotides.40 The early example of solid phase peptide synthesis by Merrifield41 
was followed by oligosaccharide synthesis by Fréchet and Schuerch that emerged shortly 
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thereafter.42 Since early attempts, the polymer-supported oligosaccharide synthesis has 
become a viable means for the synthesis of oligosaccharide sequences without the 
necessity of purifying, and characterizing, and even isolating the intermediates.43-46 
Another important advantage of oligosaccharide synthesis on a solid support is the ease 
of excess reagent removal (usually can be achieved by filtration and rinsing).  
There are two main strategies for solid phase saccharide synthesis that differ in the 
type of the attachment (Scheme 4.2). In strategy A, the glycosyl acceptor unit is bound to 
the solid support either at the anomeric position or at another suitable hydroxyl.  In this 
case, an excess of the glycosyl donor and promoter are in the solution. The periodic 
monitoring of the solution phase by TLC can provide information on whether the 
glycosyl donor is still remaining in the solution.  The completeness of the coupling can be 
determined experimentally by performing the Kaiser test,47 or by cleaving the product off 
the polymer support followed by characterization.  Routinely, the coupling step is 
repeated multiple times using fresh reagents to ensure that all glycosyl acceptor is 
consumed. 
Scheme 4.2.  General strategies for glycosylation on polymer support 
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In approach B, the glycosyl donor unit, linked to the solid support via a suitable 
hydroxyl group, is reacted with the excess of the solution phase acceptor. Two-directional 
techniques, combining approaches A and B are also known.48,49 To improve the 
operational simplicity of the oligosaccharide assembly Seeberger developed an 
automated approach, which is based on strategy A: using a solid phase acceptor and a 
liquid phase donor (vide infra).50 
 
4.1.3. Key aspects of the solid phase synthesis 
The solid support, a functionalized polymer used in a majority of applications, is an 
insoluble material that is usually used in the form of a bead, a gel-like spherical 
microparticle. The beads have good swelling properties in organic solvents that allows 
for diffusion and hence facilitates the reagent delivery to the reactive sites.51 The 
polymeric bead is then covalently linked to (or loaded with) a sugar moiety, typically via 
a linker (or a spacer). It is known that the efficiency of the synthesis using solid supports 
depends on the following factors: 
1) The loading efficiency of the resin to the first anchoring unit. 
2) The amount of cross-linking: It’s believed that lesser the amount of cross-linking, 
the better is the stability and swelling capacity of the resin; resins wherein 1-2% 
of monomers are cross-linked are considered ideal. 
3) The material from which the support is constructed.  
4) Chemical stability. The functional groups present on the resin might also react 
with (or trap) the reagents, thereby poisoning (contaminating) the resin.  
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5) Physical stability. Resin beads can disintegrate or collapse if out-of-range 
(excessive) temperature or pressure is applied. 
Among various resins studied, the three dominant resins currently used for 
oligosaccharide synthesis are chloromethyl-, hydroxymethyl- and aminomethyl-
polystyrene resins. Amongst these, use of chloromethylpolystyrene cross-linked with 
divinyl benzene (Merrifield resin), has been widely used for a variety of applications.51 
The low cost and its compatibility with a variety of reagents and solvents makes the 
Merrifield resin a popular choice for oligosaccharide synthesis. Nevertheless, the search 
of other suitable polymer supports is ongoing and other polystyrene based supports, such 
as JandaGel, Tentagel, ArgoGel, etc. have also shown wide applicability. Though most of 
the polymer supported oligosaccharide synthesis has been performed on insoluble 
supports, for oligosaccharides synthesis using soluble polymer supports, fluorous tag or 
ionic liquid supports have been introduced.    
The linker, or a linker/spacer combination, is used to connect (covalently bind) the 
solid support and the first sugar building block. The chemical composition and the size 
(length) of the linker are known to have an effect on the outcome of reactions. But it is 
the type of the bond between the linker and the sugar as well between the linker and the 
resin that are of the key importance.  The linker has to withstand all reaction conditions 
required for glycosylation and protecting group manipulations, yet it should be easily 
removable using mild reagents at the end of the synthesis.52 Many different linkers have 
been developed and classified based on the reaction conditions required, acidic or basic, 
reductive or oxidative, for linker cleavage. In the recent years, photo-cleavable or 
metathesis cleavable linkers have also been developed. Among other linkers, silyl ether, 
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1,2-di(hydroxymethyl)-benzene,53 alkene,54 and acylsulfonamide have been successfully 
employed in polymer supported oligosaccharide syntheses.51,55-57 
 
4.1.4.  Automation of oligosaccharide synthesis 
In spite of remarkable progress, the solid phase technique still suffers from significant 
limitations: the need for large reagent excess, limited use of molecular sieves, large 
volume of waste solvent, cumbersome analysis of intermediates, lower anomeric 
stereoselectivity, loss and poisoning of resin, reagent trapping, etc. To expedite solid-
phase oligosaccharide synthesis further, Seeberger and co-workers developed an 
automated approach in 2001.50,58,59 The automation was initially accomplished by using a 
peptide synthesizer that has evolved into “the first fully automated solid-phase 
oligosaccharide synthesizer” (2012),60 which was recently commercialized (Glyconeer 
2.1, sold by GlycoUniverse). Although the automated platform developed by Seeberger 
introduces an idea of operational simplicity, the technology remains over-engineered and 
underdeveloped. It offers very little promise to become universally available, 
operationally simple or inexpensive.  
To overcome these limitations, recently our group has expanded technologies 
available for the synthesis of oligosaccharides using polymer supports. The new 
experimental set-up was based on modified HPLC61 equipment that is broadly available 
in most of synthetic or analytical laboratories and requires practically no investment for 
the basic setup. The modular character of HPLC allows for opportunities to implement 
attachments, vary reagent delivery modes, modify detection systems, accessories, and 
vary software packages. HPLC-based automation allows for real-time reaction 
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monitoring, which, in turn, helps reduce the reaction time and the amount of reagents 
needed. In brief, a chromatography column (Omnifit glass column) was loosely packed 
with the pre-swelled polymer resin loaded with the glycosyl acceptor. The column was 
then connected to the HPLC system containing a three-headed pump, a detector, and a 
computer equipped with the standard HPLC-operating software (Scheme 4.3). The 
column was then purged with solvent and the glycosyl donor and promoter delivered 
using a multi-headed HPLC pump.  After a relatively short reaction time, typically 60 
min, the system was purged with the solvent to rinse off any excess reagents.  At this 
time, the resin was loaded with the disaccharide derivative that can be either cleaved off 
from the polymer support or the oligosaccharide elongation can be continued via 
alternating deprotection/glycosylation steps.  
Scheme 4.3.  HPLC-based automation of oligosaccharide synthesis 
 
 
4.2.  Results and Discussion 
Preliminary work in our laboratory has clearly shown the advantages of the new 
technology in comparison to that of the state-of-the-art polymer-supported synthesis. This 
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method has shown a promise in reducing the amount of reagents and solvents via 
recirculation, achieving faster reaction times, and performing real-time reaction 
monitoring using a UV detector. With success in developing this new technology to 
perform automated oligosaccharide synthesis, herein we aimed at optimizing all the 
aspects of the HPLC-based automated synthesis. For this purpose, we will investigate 
different types and classes of polymeric supports, linkers, glycosyl donors, and activation 
conditions to identify the best conditions for reaction set-up, monitoring, and quenching – 
all performed in the automated manner using standard HPLC-operating software.  
 
4.2.1.  Synthesis of the polymer-bound acceptor 
In the preliminary study of the HLPC automation, the monosaccharide glycosyl 
acceptor was first attached to the linker and spacer and then tethered to the resin at the 
end (Procedure A, Scheme 4.4a). Precursor A bearing a trityl group as the temporary 
protecting group at the primary C-6 position (P1) was first glycosidated with linker B. 
The resulting conjugate C was then attached to the spacer by first carrying out 
deprotection of the temporary protecting group on the linker (P3) and then coupling with 
the spacer to yield compound D. The latter was then tethered to Tentagel MB-NH2 resin 
using EDC (3.0 equiv.) and DMAP (1.0 equiv.) mediated coupling to give precursor E. 
The temporary protecting group (trityl) was then cleaved off to afford the polymer bound 
acceptor F.  
Inspired by recent work by Seeberger,60 we have begun loading the spacer/linker first 
(Procedure B, Scheme 4.4b).  Our modified approach begins with the coupling of linker 
B to the spacer unit followed by treatment with EDC (3.0 equiv.) and DMAP (1.0 equiv.) 
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on Tentagel MB-NH2 resin to form precursor H. The temporary protecting group of 
precursor H is then removed to afford acceptor molecule I. The latter is then glycosylated 
with donor A and the elongation is performed by simple reiteration of deprotection and 
glycosylation steps until the oligosaccharide of the desired length is generated.   
Scheme 4.4.  Strategic adjustment to the loading sequence 
 
 
We believe that Procedure B is much more convenient for the HPLC-based 
automation platform. During the preliminary study the monosaccharide glycosyl acceptor 
was manually loaded on the resin and only afterwards was it subjected to the automation 
sequence. In our present study, all the steps starting from loading of compound G to the 
resin are automated. The modified OH resin precursor I can also be stored and used for 
multiple automated oligosaccharide syntheses as needed via the operationally simple 
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iterative glycosylations and deprotection steps. This strategic adjustment is expected to 
enhance the reliability of the HPLC-based automation.  
Herein, we illustrate the synthesis of the polymer-bound glycosyl acceptor using a C4 
(butyl), C8 (octyl) and C16 (hexadecyl) spacer, succinoyl linker and Tentagel MB-NH2 
resin as the solid support. The synthesis began with monotritylation of (1,4-butanediol, 
1,8-octanediol, and 1,16-hexadecanediol) to give spacer precursors 4.1, 4.2, and 4.3 
respectively (Scheme 4.5). The latter was then reacted with succinic anhydride in the 
presence of DMAP to give conjugate 4.4, 4.5, and 4.6 respectively. The carboxyl on 4.4, 
4.5, and 4.6 was then manually coupled with the free amine group of the Tentagel resin 
using a flask on a shaker in the presence of EDC (3.0 equiv.) and DMAP (1.0 equiv.) to 
give 4.7, 4.8, and 4.9 respectively, with a loading capacity of 0.23/ 0.29/ 0.30 mmol/g, 
respectively, in 72 h.  
Scheme 4.5.  Synthesis of the polymer-bound acceptor 4.4 
 
 
Alternatively, the same coupling was performed using the HPLC-based set up as 
follows. Tentagel resin was packed into the glass Omnifit column and swelled for 1 h in 
CH2Cl2. Linker-spacer conjugate 4.4, 4.5, and 4.6 along with the coupling reagents, EDC 
(1 equiv.) and DMAP, were then passed through the column at a flow rate of 1.0 mL/min 
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for 3 h. After that, the column was washed with CH2Cl2 (1 x 10 mL), acetone (1 x 10 mL) 
and CH2Cl2 (2 x 10 mL) to ensure complete removal of the remaining reactants. The resin 
was then dried and the loading capacity (0.23 mmol/g) was calculated based on the 
increase in weight of the resin. Detritylation was then performed using 90% 
trifluoroacetic acid in water to yield the polymer bound acceptor 4.10, 4.11, and 4.12, 
respectively.  
During our exploratory study with JandaGel and Tentagel resins, it was observed that 
the desired loading capacities could be achieved much faster using HPLC-based reagent 
delivery rather than the manual loading in a flask. Thus, loading capacities of 0.4 and 
0.23 mmol/g for JandaGel (entry 1, Table 4.1) and Tentagel (entry 2) respectively, were 
obtained. Based on the periodic monitoring using Kaiser test, both manual loading 
procedures required a minimum reaction time of 72 h. However, when the same 
couplings were performed using the HPLC-assisted experimental set-up, similar loading 
capacities were obtained within 2-3 h (entries 3 and 4). We also noticed that HPLC-based 
automation allowed us to reduce the amount of the coupling reagent (EDC) to a very 
minimal 1.0 equiv. whereas manual experiments required at least 3.0 equiv. of EDC. 
Table 4.1.  Comparison of the loading efficiency between manual and HPLC-
based automated experiments 
 
Entry Resin Experimentalset-up 
EDC 
(equiv.)
Loading 
Time 
Loading 
capacity, mmol/g
1 JandaGel Manual 3 72 h 0.40 
2 Tentagel Manual 3 72 h 0.23 
3 JandaGel HPLC-based 1 2 h 0.38 
4 Tentagel HPLC-based 1 3 h 0.24 
187 
 
4.2.2.  Screening of different glycosyl donors 
The original development of the HPLC-based synthesis was solely based on utilizing 
glycosyl trichloroacetimidates (TCAI) as glycosyl donors. In order to expand the utility 
of this technology, we wanted to investigate whether other classes of glycosyl donors 
would be suitable. Our laboratory has been developing new methods for chemical 
glycosylation with the central focus on glycosyl thioimidates and thioglycosides.62 The 
use of thioglycosides as donors in glycosylations of solid-supported acceptors has been 
reported, but the relatively low reactivity profile of thioglycosides and the requirement 
for stoichiometric promoters limits their application. Also under HPLC-assisted synthesis 
ethyl, phenyl or tolyl thioglycosides were quite inefficient as glycosyl donors, which 
resulted in very low yields (~5%) of the coupling products. In this context, we had no 
success in using glycosyl bromides and fluorides as glycosyl donors.  
Based on the previous studies with S-benzoxazolyl (SBox) imidates,63 we already 
knew that these glycosyl donors offer superior properties for reactions in solution.64,65 
The SBox donors were also found suitable for the solid phase synthesis using polymer66 
and nanoporous gold supports.67 In these applications, SBox donors were activated with 
TMSOTf. When essentially the same activations conditions were applied to glycosylation 
of glycosyl acceptor 4.10 with SBox donor 4.13 using the HPLC-based experimental set 
up, compound 4.18 was obtained in a good yield of 67% (entry 1, Table 4.2.). This 
reaction was performed by passing solutions of the glycosyl donor 4.13 in CH2Cl2 and 
TMSOTf in CH2Cl2 through the column packed with acceptor 4.10 using a multi-headed 
HPLC pump. The reaction mixture that eluted from the column was then recirculated for 
4 h to ensure completion of the reaction.  It should be noted that all yields reported here 
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are isolated yields after HPLC-based coupling and cleavage from the solid support with 
recirculating solution of MeONa in MeOH, followed by manual acetylation with Ac2O 
and pyridine.  
Table 4.2.  Comparative study of different S/O-imidoyl donors using HPLC-assisted 
experimental set-up 
N
H
O
O
O OH
Acceptor
O
LG
BzO
OBz
BzO
BzO
O
O
OAc
OAc
AcO
AcO OAc2) NaOMe,
MeOH
3) Ac2O, py
1) TMSOTf (0.5-4 equiv.),
CH2Cl2Donor
4.10
4.13-4.17
4.18
 
Entry Donor, 10 equiv. Time for recirculation Yield 
1 4 h 67% 
2 
O
O
BzO
OBz
BzO
BzO CCl3
NH4.14
1 h 83% 
3 1 h 85% 
4 2 h 90% 
5 2 h 87 
 
Although acceptable yield were obtained in SBox-mediated couplings, it has also 
become apparent that highly reactive TCAI donors easily outperform SBox imidates. 
Thus, a high yield of 83% was obtained in the TMSOTf-promoted synthesis of 4.18 from 
donor 4.14 and the solid phase-bound acceptor 4.10 (entry 2). As shown in Chapter 2, O-
benzoxazolyl (OBox) imidates, which represent a hybrid structure between SBox and 
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TCAI, are more reactive than either leaving group. Hence, we were curious to investigate 
whether the higher reactivity of OBox imidates would be beneficial for HPLC-based 
applications. Indeed, a similar reactivity profile and yields to those obtained with TCAI 
were achieved with OBox imidates. Thus, on reacting OBox donor 4.15 with acceptor 
4.10, compound 4.18 was obtained in 85% yields (entry 3).  
Inspired by promising results obtained with TCAI and OBox leaving groups, we 
continued the search of suitable glycosyl donors by studying other O-imidates in the 
HPLC-based applications. Over the course of this study we noticed that although N-
phenyl trifluoroacetimidates (PTFAI)68,69 are more stable than their TCAI or OBox 
counterparts, they often outperform TCAI in glycosylations. Thus, when glycosylation of 
glycosyl donor 4.16 with acceptor 4.10 was carried out in the presence of TMSOTf 
compound 4.18 was obtained in an excellent yield of 90%. However, since PTFAI 
imidates are less reactive than their TCAI or OBox counterparts, higher amounts of 
TMSOTf (2.5 equiv.) was used for their activation versus 0.5 equiv. required for the 
activation of other O-imidates.  
This stimulated our interest in investigating structurally similar OFox imidates (see 
Chapter 3) as glycosyl donors for HPLC-assisted glycosylations. As expected, results 
similar to those obtained with PTFAI donors were achieved (87% yield, entry 5, Table 
4.2.). Under solid-supported synthesis, the OFox glycosides showed similar reactivity to 
PTFAI glycosides and still required 2 equiv. of TMSOTf. This represents a significantly 
larger amount of the activator in comparison to that required for the activation of OFox 
imidates in solution (0.03-0.10 equiv.). As an outcome of this comparison study, we 
conclude that reactive, but comparatively stable PTFAI and OFox imidates, achieve the 
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best yields with HPLC-assisted glycosylations. Nevertheless, a relatively high amount of 
TMSOTf required for their activation represents a drawback. This stimulated our further 
search of suitable reaction conditions and we decided to apply the regenerative concept 
for glycosylation to the HPLC-based automated set-up.  
 
4.2.3.  Application of the regenerative concept to HPLC-assisted automated synthesis 
It is widely acknowledged that glycosylations on a solid phase offer different 
challenges than those in solution. Additional hurdles relate to the mismatch between 
highly reactive solution-based vs. unreactive solid-phase-immobilized reactants.45,70 Yet, 
little has been done to develop dedicated methods, and all solid-phase glycosylations use 
donors that have been developed for couplings in solution. Low efficiency of solid-phase 
reactions has been addressed by a “cavalier approach”: applying a large excess of the 
glycosyl donor (5-10 equiv.) and repeating the glycosylation step 2-3 times. In our 
opinion, this approach is destined to fail, from an efficiency perspective, because 80-90% 
of the donor goes to waste.46 Automation offers some operational simplicity, but the 
entire concept suffers from the inherited drawbacks of conventional methods.  
To overcome these limitations, we wanted to investigate whether the conditions 
established for the OFox leaving group-based regenerative concept (see Chapter 3) would 
be beneficial to HPLC-assisted synthesis. Since the 3,3-difluoroxindole (HOFox)71,72 
aglycone has the same structure before and after glycosylation, the synthesis and 
glycosidation of OFox imidates can be conducted using catalytic reagents: HOFox 
aglycone will first react with a stable precursor to form highly reactive OFox imidate. 
The latter will then react with the polymer-bound glycosyl acceptor while regenerating 
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HOFox aglycone, which will be available for the next catalytic cycle to generate 
additional quantities of the OFox donor, etc. As a result, only a small amount of the 
reactive OFox donor is present in the reaction medium (which depends on the amount of 
HOFox added), and the donor gets regenerated only upon its consumption.  
In our opinion, the implementation of the OFox-based regenerative concept into the 
HPLC-based automated set-up would have a conservatively estimated three-fold benefit. 
First, the reactive donor would be generated in small amounts, which will help to 
minimize side reactions. Second, the donor would be constantly regenerated ensuring 
continuous feeding of the system with the “fresh” donor. Third, a stable precursor can be 
used, and careful monitoring of glycosylation will ensure that only a minimal amount is 
delivered.   
Scheme 4.6.  Outline of the OFox-mediated regenerative glycosylation 
on solid support 
 
 
As illustrated in Scheme 4.6, a stable thioglycoside (SEt) donor is first converted to 
glycosyl bromide. 3,3-Difluoroxindole and Ag2O are then added to the same reaction 
flask. This solution is then passed through a column containing the polymer-bound 
acceptor. After 1 hour, TMSOTf is added to the same reaction flask to activate the OFox 
formed. The reaction is continued until all glycosyl bromide has been consumed 
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(glycosidated or hydrolyzed). Over the course of the reaction, the consumption of HOFox 
to form the OFox imidate can be monitored using the HPLC-detector. The resin is then 
washed several times to remove excess reagents. The sugar moiety is then cleaved off 
from the solid support using NaOMe in MeOH and then purified to get the desired 
monosaccharide.  
Table 4.3.  Manual solid-phase synthesis using regenerative glycosylation 
 
Entry Donor, equiv. Linker 
Amount of OFox 
added, equiv. 
Promoter 
(equiv.) Time 
Yield of  
4.20-4.22 
1 10  C-4 (4.10) 0.2 Ag2O (5) 48 h No reaction
2 10  C-8 (4.11) 0.2 Ag2O (5) 48 h No reaction
3 10  C-16 (4.13) 0.2 Ag2O (5) 48 h 20% 
4 10  C-16 (4.13) 0.2 AgOTf (4) 48 h 21% 
5 10  C-16 (4.13) 0.4 AgOTf (4) 48 h 23% 
6 10  C-16 (4.13) 0.2 
AgOTf (4)/ 
TMSOTf (2) 48 h 10% 
 
With these considerations in mind, we began a dedicated study of regenerative 
glycosylations on a solid phase support using both a manual and HPLC-based 
experimental set-up. Alongside with this study, we also wanted to investigate the effect 
of the linker. Starting with the four-carbon alkyl chain linker, we also obtained C8 and 
C16 linkers using essentially the same method as that described for the synthesis of the 
C4 linker (see Scheme 4.5). Manual solid-supported synthesis was carried our as follows. 
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The resin-bound acceptor (4.10-4.12) was swelled in dry CH2Cl2 for 1 h. To the same 
flask, S-ethyl glycoside 4.19 and bromine were added to form the desired glycosyl 
bromide. The latter is stable in the presence of TMSOTf, but can be readily converted to 
the corresponding OFox imidate in the presence of HOFox and Ag2O. The OFox imidate 
is then reacted with the solid support bound acceptor (4.10-4.12) in the presence of 
TMSOTf.  During our initial experimentation, regenerative glycosylations performed 
using C4 or C8 linker, did not proceed. At this instant, we realized that the longer the 
linker, the better will be the availability of the free hydroxyl of the glycosyl acceptor 
since it creates more reaction space by extending the acceptor away from the bulky solid 
support.The assumption was in accordance to the results obtained from our previous 
study where we showed that higher reaction yield and improved selectivities were 
obtained using C8-O-C8 spacer. Inded, when glycosylations were performed using C16 
linker, some conversion (~20%, Table 4.3, entry 3) was observed.   
While performing solid-phase regenerative glycosylations, we encountered some 
difficulties with respect to filtering of the resin and further steps associated with the 
synthesis. The reason behind that was the insolubility of silver oxide in the solvent used 
for glycosylation. As a result, we decided to use silver triflate instead of silver oxide. 
Because of its solubility in acetone, AgOTf can be easily washed off during filtration. 
Also when present in stiochiometric amounts, it activates both bromides and OFox 
imidates. Thus, regenerative glycosylation using stiochiometric amounts (4.0 equiv.) of 
silver triflate provided 4.22 in 21% yield. When the same reaction was performed in the 
presence of AgOTf/TfOH (4.0 equiv./1.0 equiv.) only 10% conversion was observed. 
When the amount of HOFox was increased from 0.2 equiv. to 0.4 equiv. there was no 
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significant change in the yields obtained. Further investigation of this regenerative 
glycosylation approach to solid supported synthesis and HPLC-assisted automated 
oligosaccharide synthesis are currently underway in our laboratory. 
 
4.3.  Conclusions 
Our laboratory had shown a new automation platform based on HPLC (high-
performance liquid chromatography) equipment to be a very promising new technology 
for the synthesis of oligosaccharides. Refinement of chemical aspects of HPLC-based 
experimental set-up was performed in terms of studying various linkers, resins, and 
glycosyl donors. We also implemented the regenerative glycosylation concept to the 
HPLC-assisted automated synthesis. With the application of the regenerative concept, we 
have observed faster reaction times and achieved lower reagent excesses in comparison to 
that of all other known approaches for solid-phase synthesis. With the ultimate goal of 
developing universal conditions for HPLC-assisted synthesis, we expect that the 
regenerative concept will significantly enhance our ability to conduct solid-supported 
glycosylations.  
  
4.4.  Experimental Section 
4.4.1.  General Remarks 
All reactions were performed under argon with dry, freshly distilled solvents unless 
otherwise noted. CH2Cl2, EtCN were distilled from CaH2 directly prior to application. 
TMSOTf, BF3-OEt2 and TMSClO4 were used as is. Molecular sieves (3Å) used for the 
reactions were activated at 390 °C and then for 2-3 h at 390 °C under reduced pressure 
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prior to application. Reactions were monitored by TLC on Kieselgel 60 F254 and the 
compounds were detected by examination under UV light and by charring with 10% 
sulfuric acid in methanol. Solvents were removed under reduced pressure at < 40 oC. 
Column chromatography was performed on silica gel 60 (70-230 mesh). Optical rotations 
were measured at ‘Jasco P-1020’ polarimeter. 1H n.m.r. spectra were recorded at 300 
MHz, 500 MHz, or 600 MHz. 13C n.m.r. spectra were recorded at 75 MHz or 150 MHz. 
19F spectra were recorded at 282.2 MHz. The 1H chemical shifts are referenced to the 
signal of the residual CHCl3 (δH = 7.27 ppm) for solutions in CDCl3. The 13C chemical 
shifts are referenced to the central signal of CDCl3 (δC = 77.23 ppm) for solutions in 
CDCl3. HRMS determinations were made with the use of JEOL MStation (JMS-700) 
Mass Spectrometer. 
 
4.4.2.  Synthesis of linkers and glycosyl acceptors  
4-Trityloxybutan-1-ol (4.1).  The title compound was obtained from 1,4-butanediol 
according to the procedure reported previously73 in 85% yield as a white amorphous 
powder. Analytical data for 4.1: Rf = 0.44 (ethyl acetate/hexanes, 3/7, v/v); 1H-n.m.r. 
(300 MHz): δ, 1.67 (m, 4H, -CH2), 3.08 (t, 2H, 2J = 5.9 Hz, -CH2), 4.08 (t, 2H, 2J = 5.9 
Hz, -CH2), 7.20-7.42 (m, 15H, aromatic); 13C-n.m.r. (75 MHz): δ, 26.8, 30.2, 63.1, 63.7, 
86.8, 127.1 (x 3), 128.0 (x 6), 128.8 (x 6), 144.4 (x 3) ppm; HR-FAB MS [M+Na]+ 
calculated for C23H24O2Na+ 355.1674, found 355.1676. 
 
4-(4-Trityloxy)butoxy-4-oxobutanoic acid (4.4).  The title compound was obtained 
from 4.1 and succinic anhydride as described previously61 in 93 % yield as a colorless 
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syrup. Analytical data for 4.4: Rf = 0.42 (methanol/dichloromethane, 1/9, v/v); 1H-n.m.r. 
(300 MHz): δ, 1.71 (m, 4H, CH2), 2.61 (m, 4H, CH2), 3.08 (t, 2H, 2J = 6.2 Hz, CH2), 4.08 
(t, 2H, 2J = 6.2 Hz, CH2), 7.19-7.48 (m, 15H, aromatic); 13C-n.m.r. (75 MHz): δ, 25.8, 
26.7, 29.1, 63.2, 65.1, 86.6, 127.1 (x 4), 127.9 (x 7), 128.8 (x 7), 144.5 (x 3), 172.4, 177.3 
ppm; HR-FAB MS [M+Na]+ calculated for C27H28O5Na+ 455.1834, found 455.1824. 
 
8-Trityloxyoctan-1-ol (4.2).  The title compound was obtained from 1,8-octanediol as 
described previously74 in 73 % yield as an amorphous powder. Analytical data for 4.2: Rf 
= 0.5 (ethyl acetate/hexanes, 2/3 v/v); 1H-n.m.r. (300 MHz): δ, 1.32 (m, 6H, 3 x CH2), 
1.58 (m, 6H, 3 x CH2), 3.04 (t, 2H, 2J = 6.6 Hz, CH2), 3.63 (t, 2H, 2J = 6.6 Hz, CH2), 
7.20-7.49 (m, 15H, aromatic); 13C-n.m.r. (75 MHz): δ, 26.8, 30.2, 63.1, 63.7, 86.8, 127.0 
(x 3), 127.9 (x 6), 128.9 (x 6), 144.7 (x 3) ppm; HR-FAB MS [M+Na]+ calculated for 
C27H32O2Na+ 411.2300, found 411.2296. 
 
4-(8-Trityloxy)octyloxy-4-oxobutanoic acid (4.5).  The title compound was obtained 
from 4.2 and succinic anhydride as described previously61 in 76% yield as a colorless 
syrup. Analytical data for 4.5: Rf = 0.38 (ethyl acetate/hexanes, 2/3 v/v); 1H-n.m.r. (300 
MHz): δ, 1.20-1.40 (m, 9H, -OH, CH2), 1.61 (m, 4H, CH2), 2.64 (t, 4H, CH2), 3.03 (t, 2H, 
2J = 6.6 Hz, CH2), 4.08 (t, 2H, 2J = 6.7 Hz, CH2), 7.19-7.49 (m, 15H, aromatic); 13C-
n.m.r. (75 MHz): δ, 26.0, 26.4, 28.7, 29.1, 29.3, 29.5, 30.2, 63.8, 65.2, 86.5, 127.0, 127.9, 
128.1, 144.7, 172.4, 178.0 ppm; HR-FAB MS [M+Na]+ calculated for C31H36O5Na+ 
511.2460, found 511.2459. 
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16-Trityloxyhexadecane-1-ol (4.3).  The title compound was obtained from 1,16-
hexadecanediol as described previously74 in 52% yield as a colorless syrup. Analytical 
data for 4.3: Rf = 0.33 (ethyl acetate/hexanes, 1/4 v/v); 1H- n.m.r. (500 MHz): δ, 1.19-
1.34  (m, 28H, 16 x CH2), 1.46-1.58 (m, 4H, 2 x CH2), 2.98 (t, 2H, 2J = 6.6 Hz, CH2), 
3.57 (t, 2H, 2J = 6.6 Hz, CH2), 7.16-7.45 (m, 15H, aromatic); 13C- n.m.r. (75 MHz): δ, 
26.0, 26.5, 29.7 (x 2), 29.8 (x 7), 29.9, 30.3, 33.1, 63.3, 64.0, 86.6, 127.0, 127.5, 127.9 (x 
4), 128.1 ( x3), 128.2 (x 3), 129.0 (x 4), 144.9, 147.2 ppm. 
 
4-(16-Trityloxy)hexadecyloxy-4-oxobutanoic acid (4.6).  The title compound was 
obtained from 4.3 and succinic anhydride as described previously61 in 72% yield as a 
colorless syrup. Analytical data for 4.6: Rf = 0.44 (ethyl acetate/hexanes, 1/1 v/v); 1H- 
n.m.r. (300 MHz): δ, 1.12-1.42 (m, 27H, CH2), 1.52-1.68 (m, 4H, CH2), 2.58-2.70 (m , 
4H, CH2), 3.04 (t, 2H, 2J = 6.6 Hz, CH2), 4.09 (t, 2H, 2J = 6.7 Hz, CH2), 7.19-7.48 (m, 
15H, aromatic); 13C- n.m.r. (75 MHz): δ, 28.8, 29.2 (x 2), 29.4, 29.7 (x 2), 29.8 (x 6), 
29.9 (x 3), 30.3, 63.9, 65.2, 86.6, 127.0 (x 2), 127.4, 127.8 (x 4), 128.1 (x 2) 128.2 (x 2), 
128.9 (x 4), 144.8 (x 2), 147.2, 172.4, 177.3 ppm. 
 
4.4.3.  Synthesis of glycosyl donors  
S-Benzoxazolyl 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranoside (4.13).  The title 
compound was obtained in 75% yield as a pale yellow foam as previously described.75 
Analytical data for 4.13 was in accordance with that reported previously.75 
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2,3,4,6-Tetra-O-benzoyl-α-D-glucopyranosyl trichloroacetimidate (4.14). The title 
compound was obtained in 83% yield as a white foam as previously described.76 
Analytical data for 4.14 was in accordance with that reported previously.77  
 
Benzoxazolyl 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranoside (4.15).  The title 
compound was obtained in 75% yield as a pale yellow foam as previously described.77 
Analytical data for 4.15 was in accordance with that reported previously.77  
 
2,3,4,6-Tetra-O-benzoyl-α-D-glucopyranosyl N-phenyltrifluoroacetimidate (4.16).  
The title compound was obtained in 86% yield as a white foam as previously described.68 
Analytical data for 4.16 was in accordance with that reported previously.78  
 
3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-benzoyl-α-D-glucopyranoside (4.17).  The 
title compound was obtained in 75% yield as a pale yellow foam as previously 
described.78 Analytical data for 4.17 was in accordance with that reported previously.78  
 
Ethyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (4.19). The title compound 
was obtained as previously described.79  
 
4.4.4.  Manual and HPLC-mediated polymer supported synthesis 
General glycosylation procedure using HPLC-assisted automated set-up.  A solution of 
glycosyl donor 4.13-4.17 (39 mM in CH2Cl2, Pump A, percentage flow: 80%), and a 
solution of TMSOTf (0.28 mM in CH2Cl2, Pump B, percentage flow: 20%) were passed 
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concomitantly through a column containing resin-bound glycosyl acceptor 4.10-4.12 at 
the combined flow rate of 0.3 mL/min for 20 min. The pump A was then switched to 
pump C (recirculating chamber, percentage flow: 80%) while pump B remained the same 
(TMSOTf soln., percentage flow: 20%) and the resulting solutions were passed 
concomitantly through a column with the combined flow rate of 0.3 mL/min for 10 min. 
After that, the system was switched to pump C (recirculating chamber, percentage flow 
100%) and the solution was recirculated at a flow rate of 0.3 mL/min for 1-4 h. Pump C 
was stopped and the column was purged with CH2Cl2 (pump A, 10.0 mL/min), acetone 
(pump A, 10.0 mL/min), and again with CH2Cl2 (pump A, 20.0 mL/min). 
 
Procedure for manual cleavage of the products from the resin.  A 1 M solution of sodium 
methoxide in methanol (0.3 mL) was added to a suspension or a mixture of resin in 
methanol (2.0 mL) and the resulting mixture was kept for 24 h at rt. After that, the 
reaction mixture was neutralized with Dowex H+ resin. The resin was filtered off and 
rinsed successively with MeOH (10 × 5 mL). The combined filtrate (∼50 mL) was 
separated, dried with MgSO4, concentrated in vacuo, and dried. The crude product 
obtained from this step was then acetylated according to the procedure described below.   
 
Acetylation of the crude product.  To a stirred solution of crude monosaccharide (0.0482 
mmol) in pyridine (2 mL) Ac2O (73 mL, 0.771 mmol) was added dropwise in the 
presence of catalytic DMAP. The reaction mixture was stirred under argon for 6 h at 
room temperature. The reaction mixture was quenched with CH3OH (1 mL) and the 
resulting mixture was concentrated under reduced pressure. The residue was purified by 
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column chromatography on silica gel (ethyl acetate – toluene gradient elution) to afford 
corresponding monosaccharide 4.18 in 67-90% yield.  
 
Procedure for the manual regenerative glycosylation on solid phase.  A mixture of resin-
bound acceptor 4.10-4.12 (0.028 mmol) and ethyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-
glucopyranoside 4.1979 (0.28 mmol) in dry dichloromethane (2 mL) was agitated for 2 h 
at room temperature. After that, bromine (0.01 mmol) was added, and the resulting 
mixture was kept for 30 min at rt. After that, 3,3-difluorooxindole (0.056-0.14 mmol), 
and Ag2O/AgOTf (1.4/1.12 mmol) were added to the reaction mixture and the resulting 
mixture was stirred for 1 h at rt.  After 1h, TMSOTf (0.56 mmol) was added and the 
mixture was agitated for 24-36 h at room temperature under argon. The resin was 
separated by sintered filter, washed successively with dichloromethane (5 x 5 mL), 
acetone (5 x 5 mL) and again dichloromethane (5 x 5 mL) followed by drying in vacuo. 
The residual resin was suspended in dry dichloromethane (1 mL) before adding 1 N 
sodium methoxide solution in methanol (2 mL). The reaction mixture was agitated at 
room temperature for 5 h; the pH was monitored and adjusted within pH ̴ 8-9 range with 
1 N sodium methoxide solution, if needed. The resin was separated by sintered filter, 
washed successively with methanol (3 x 5 mL) and dichloromethane (3 x 5 mL), and 
dried in vacuo. The combined filtrate was neutralized with Dowex (H+), the resin was 
filtered off, and the solvent was removed under reduced pressure. The residue was 
purified by column chromatography on silica gel (ethyl acetate – hexanes gradient 
elution) to afford corresponding monosaccharide.  
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Procedure for HPLC-mediated regenerative glycosylation.  A mixture of ethyl 2,3,4,6-
tetra-O-benzyl-1-thio-β-D-glucopyranoside 4.1979 (0.028-0.28 mmol) and activated 
molecular sieves beads (3 Å, 90 mg) in CH2Cl2 (0.5 mL) was stirred under argon for 1 h 
at rt. The mixture was cooled to 0 oC, bromine (0.01 mmol) was added, and the resulting 
mixture was kept for 15 min at 0 oC. After that, 3,3-difluorooxindole (0.0056-0.mmol, 
and Ag2O (36 mg, 0.16 mmol) were added to the reaction mixture and the resulting 
mixture connected to HPLC (Pump A, percentage flow: 100%), and recirculated through 
the column containing the resin bound acceptor 4.10-4.12 for 1h. Following that, 
TMSOTf (4.5 µL) was added to the chamber containing the bromide, HOFox and Ag2O 
and passed concomitantly through the column at a flow rate of 0.5 mL/min for 5 h. Pump 
A was stopped and the column was purged with CH2Cl2 (pump A, 10.0 mL/min), acetone 
(pump A, 10.0 mL/min), and again with CH2Cl2 (pump A, 20.0 mL/min). 
 
Procedure for manual cleavage of the products from the resin.  A 1 M solution of sodium 
methoxide in methanol (0.3 mL) was added to a suspension or a mixture of resin in 
methanol (1.0 mL) and the resulting mixture was kept for 24 h at rt. After that, the 
reaction mixture was neutralized with Dowex H+ resin. The resin was filtered off and 
rinsed successively with MeOH (10 × 5 mL). The combined filtrate (∼50 mL) was 
separated, dried with MgSO4, concentrated in vacuo, and dried. The crude product 
obtained from this step was then acetylated according to the procedure described below.   
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4-Acetoxybutyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside (4.18).  The title 
compound was obtained in yields shown in Tables as a white solid. Analytical data for 
4.18 was in accordance with that reported previously.80 
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Figure A-1: 1H NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-acetyl-α-D-
glucopyranoside (2.2) 
 
 
Figure A-2: 13C NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-acetyl-α-D-
glucopyranoside (2.2)  
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Figure A-3: 2D NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-acetyl-α-D-
glucopyranoside (2.2)  
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Figure A-4: 1H NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-benzyl-α/β-D-
glucopyranoside (2.4)  
  
Figure A-5: 13C NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-benzyl-α/β-D-
glucopyranoside (2.4)  
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Figure A-6: 2D NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-benzyl-α/β-D-
glucopyranoside (2.4)  
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Figure A-7: 1H NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-benzyl-α-D-
mannopyranoside (2.6)  
  
 
Figure A-8: 13C NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-benzyl-α-D-
mannopyranoside (2.6)  
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   Figure A-9: 2D NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-benzyl-α-D-
mannopyranoside (2.6) 
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Figure A-10: 1H NMR spectrum of Benzoxazolyl 3,4,6-Tri-O-acetyl-1,2-O-(1-
benzoxazolyloxyethylidene)-α-D-glucopyranose (2.8) 
 
 
Figure A-11: 13C NMR spectrum of Benzoxazolyl 3,4,6-Tri-O-acetyl-1,2-O-(1-
benzoxazolyloxyethylidene)-α-D-glucopyranose (2.8) 
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Figure A-12: 2D NMR spectrum of Benzoxazolyl 3,4,6-Tri-O-acetyl-1,2-O-(1-
benzoxazolyloxyethylidene)-α-D-glucopyranose (2.8) 
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Figure A-13: 1H NMR spectrum of Benzoxazolyl Benzoxazolyl 2,3,4,6-tetra-O-
benzoyl-β-D-glucopyranoside (2.10)  
  
  
 
Figure A-14: 13C NMR spectrum of Benzoxazolyl Benzoxazolyl 2,3,4,6-tetra-O-
benzoyl-β-D-glucopyranoside (2.10) 
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Figure A-15: 2D NMR spectrum of Benzoxazolyl Benzoxazolyl 2,3,4,6-tetra-O-
benzoyl-β-D-glucopyranoside (2.10) 
 
  
ppm
4.55.05.56.06.57.07.58.0 ppm
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
 
 
224 
 
  
 
Figure A-16: 1H NMR spectrum of Benzoxazolyl-2,3,4,6-tetra-O-benzoyl-α-D-
galactopyranoside (2.12) 
 
  
Figure A-17: 13C NMR spectrum of Benzoxazolyl-2,3,4,6-tetra-O-benzoyl-α-D-
galactopyranoside (2.12) 
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Figure A-18: 2D NMR spectrum of Benzoxazolyl-2,3,4,6-tetra-O-benzoyl-α-D-
galactopyranoside (2.12) 
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Figure A-19: 1H NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-benzoyl-α-D-
mannopyranoside (2.14) 
 
 
Figure A-20: 13C NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-benzoyl-α-D-
mannopyranoside (2.14) 
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Figure A-21: 2D NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-benzoyl-α-D-
mannopyranoside (2.14) 
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Figure A-22: 1H NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-
benzyl-α-D-glucopyranoside (3.2) 
  
  
Figure A-23: 13C NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-
benzyl-α-D-glucopyranoside (3.2) 
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Figure A-24: 2D NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-
benzyl-α-D-glucopyranoside (3.2) 
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Figure A-25: 1H NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-
benzyl-α-D-mannopyranoside (3.4) 
  
 
 
Figure A-26: 13C NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-
benzyl-α-D-mannopyranoside (3.4) 
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Figure A-27: 2D NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-
benzyl-α-D-mannopyranoside (3.4) 
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Figure A-28: 1H NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl-
2-O-benzyl-β-D-glucopyranoside (β-3.6) 
 
 
Figure A-29: 13C NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl-
2-O-benzyl-β-D-glucopyranoside (β-3.6) 
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Figure A-30: 2D NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl-
2-O-benzyl-β-D-glucopyranoside (β-3.6) 
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Figure A-31: 1H NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl-
2-O-benzyl-α-D-glucopyranoside (α-3.6) 
 
 
 
Figure A-32: 13C NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl-
2-O-benzyl-α-D-glucopyranoside (α-3.6) 
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Figure A-33: 2D NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl-
2-O-benzyl-α-D-glucopyranoside (α-3.6) 
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Figure A-34: 1H NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-
acetyl-α-D-glucopyranoside (3.8)  
 
 
 
Figure A-35: 13C NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-
acetyl-α-D-glucopyranoside (3.8)  
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Figure A-36: 2D NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-
acetyl-α-D-glucopyranoside (3.8)  
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Figure A-37: 1H NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-
benzoyl-α-D-glucopyranoside (3.10)  
 
 
 
Figure A-38: 13C NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-
benzoyl-α-D-glucopyranoside (3.10)  
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Figure A-39: 2D NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-
benzoyl-α-D-glucopyranoside (3.10)  
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Figure A-40: 1H NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-
benzoyl-β-D-galactopyranoside (3.12) 
 
 
 
 
Figure A-41: 13C NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-
benzoyl-β-D-galactopyranoside (3.12) 
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Figure A-42: 2D NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-
benzoyl-β-D-galactopyranoside (3.12) 
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Figure A-43: 1H NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-
benzoyl-α-D-mannopyranoside (3.14) 
 
 
 
Figure A-44: 13C NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-
benzoyl-α-D-mannopyranoside (3.14) 
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Figure A-45: 2D NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-
benzoyl-α-D-mannopyranoside (3.14) 
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Figure A-46: 1H NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl-
2-azido-2-deoxy-β-D-glucopyranoside (3.16) 
 
 
 
Figure A-47: 13C NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl-
2-azido-2-deoxy-β-D-glucopyranoside (3.16) 
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Figure A-48: 2D NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl-
2-azido-2-deoxy-β-D-glucopyranoside (3.16) 
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Figure A-49: 1H NMR spectrum of 4-Trityloxybutan-1-ol (4.1) 
 
 
 
Figure A-50: 13C NMR spectrum of  4-Trityloxybutan-1-ol (4.1) 
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Figure A-51: 1H NMR spectrum of 4-(4-Trityloxy)butoxy-4-oxobutanoic acid (4.4)   
 
 
Figure A-52: 13C NMR spectrum of 4-(4-Trityloxy)butoxy-4-oxobutanoic acid (4.4)  
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Figure A-53: 1H NMR spectrum of 8-Trityloxyoctan-1-ol (4.2) 
 
 
Figure A-54: 13C NMR spectrum of 8-Trityloxyoctan-1-ol (4.2) 
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Figure A-55: 1H NMR spectrum of 4-(8-Trityloxy)octyloxy-4-oxobutanoic acid (4.5)   
 
 
Figure A-56: 13C NMR spectrum of 4-(8-Trityloxy)octyloxy-4-oxobutanoic acid (4.5)   
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Figure A-57: 1H NMR spectrum of 16-Trityloxyhexadecane-1-ol (4.3) 
 
 
 
Figure A-58: 13C NMR spectrum of 16-Trityloxyhexadecane-1-ol (4.3) 
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Figure A-59: 1H NMR spectrum of 4-(16-Trityloxy)hexadecyloxy-4-oxobutanoic 
acid (4.6) 
 
 
Figure A-60: 13C NMR spectrum of 4-(16-Trityloxy)hexadecyloxy-4-oxobutanoic 
acid (4.6) 
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